Previous Article | Next Article ![]()
Clinical Microbiology Reviews, July 2001, p. 584-640, Vol. 14, No. 3
Grupo de Patogénesis Molecular
Bacteriana, Facultad de Veterinaria, Universidad Complutense de Madrid,
Madrid,1 and Universidad de León,
León,2 Spain; Unité
INSERM U411, Faculté de Médecine Necker, 75730 Paris,
France4; and Lehrstuhl für
Mikrobiologie, Theodor-Boveri-Institut für Biowissenschaften der
Universität Würzburg, 97074 Würzburg,3 Institut für
Medizinische Mikrobiologie, Justus-Liebig-Universität,
35392 Giessen,5 and Department of Cell
Biology and Immunology, Gesellschaft für Biotechnologische
Forschung (GBF), 38124 Braunschweig,6 Germany
0893-8512/01/$04.00+0 DOI: 10.1128/CMR.14.3.584-640.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Listeria Pathogenesis and Molecular
Virulence Determinants
SUMMARY
INTRODUCTION
PATHOPHYSIOLOGY OF LISTERIA INFECTION
Clinical Features
Fetomaternal and neonatal listeriosis.
Listeriosis in adults.
Pathogenesis
Pathogenicity of L. monocytogenes.
Host risk factors.
Entry and colonization of host tissues.
(i) Crossing
the intestinal barrier.
(ii) Multiplication in the liver.
(iii) Colonization of gravid uterus and fetus.
(iv) Invasion of the brain.
Hypothetical scenario.
INTRACELLULAR INFECTIOUS CYCLE
Internalization
Intracellular Proliferation and Intercellular Spread
VIRULENCE FACTORS
Hemolysin
Characterization and role in escape from phagosome.
Structure-function.
Other roles in infection.
Phospholipases
Characterization.
Role in virulence.
ActA
Internalins
Other Virulence Factors
p60 (iap).
Antioxidant factors.
Metal ion uptake.
Stress response mediators.
GENETIC ORGANIZATION AND EVOLUTION OF VIRULENCE
DETERMINANTS
Central Virulencee Gene Cluster
Internalin Islands
REGULATION OF VIRULENCE GENE EXPRESSION
PrfA, Master Regulator of Virulence
Environmental Control of Virulence Gene Expression
Carbon Source Regulation of Virulence Genes
Regulatory Mechanism of PrfA
Fine Regulation of Virulence Determinants
HOST CELL RESPONSES TO INFECTION
Signal Transduction Pathways Associated with Epithelial
Cell Invasion
Activation of NF-
B and Modulation of Host Gene
Expression in Macrophages
Host Responses during Infection of Endothelial Cells
Apoptosis
CONCLUDING REMARKS AND FUTURE PERSPECTIVES
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
The gram-positive bacterium Listeria monocytogenes is the causative agent of listeriosis, a highly fatal opportunistic foodborne infection. Pregnant women, neonates, the elderly, and debilitated or immunocompromised patients in general are predominantly affected, although the disease can also develop in normal individuals. Clinical manifestations of invasive listeriosis are usually severe and include abortion, sepsis, and meningoencephalitis. Listeriosis can also manifest as a febrile gastroenteritis syndrome. In addition to humans, L. monocytogenes affects many vertebrate species, including birds. Listeria ivanovii, a second pathogenic species of the genus, is specific for ruminants. Our current view of the pathophysiology of listeriosis derives largely from studies with the mouse infection model. Pathogenic listeriae enter the host primarily through the intestine. The liver is thought to be their first target organ after intestinal translocation. In the liver, listeriae actively multiply until the infection is controlled by a cell-mediated immune response. This initial, subclinical step of listeriosis is thought to be common due to the frequent presence of pathogenic L. monocytogenes in food. In normal indivuals, the continual exposure to listerial antigens probably contributes to the maintenance of anti-Listeria memory T cells. However, in debilitated and immunocompromised patients, the unrestricted proliferation of listeriae in the liver may result in prolonged low-level bacteremia, leading to invasion of the preferred secondary target organs (the brain and the gravid uterus) and to overt clinical disease. L. monocytogenes and L. ivanovii are facultative intracellular parasites able to survive in macrophages and to invade a variety of normally nonphagocytic cells, such as epithelial cells, hepatocytes, and endothelial cells. In all these cell types, pathogenic listeriae go through an intracellular life cycle involving early escape from the phagocytic vacuole, rapid intracytoplasmic multiplication, bacterially induced actin-based motility, and direct spread to neighboring cells, in which they reinitiate the cycle. In this way, listeriae disseminate in host tissues sheltered from the humoral arm of the immune system. Over the last 15 years, a number of virulence factors involved in key steps of this intracellular life cycle have been identified. This review describes in detail the molecular determinants of Listeria virulence and their mechanism of action and summarizes the current knowledge on the pathophysiology of listeriosis and the cell biology and host cell responses to Listeria infection. This article provides an updated perspective of the development of our understanding of Listeria pathogenesis from the first molecular genetic analyses of virulence mechanisms reported in 1985 until the start of the genomic era of Listeria research.
INTRODUCTION
|
|
|---|
The genus Listeria consists of a group of gram-positive bacteria of low G+C content closely related to Bacillus, Clostridium, Enterococcus, Streptococcus, and Staphylococcus. Listeria spp. are facultative anaerobic rods of 0.4 by 1 to 1.5 µm that do not form spores, have no capsule, and are motile at 10 to 25°C (98, 552, 579). Listeria spp. are isolated from a diversity of environmental sources, including soil, water, effluents, a large variety of foods, and the feces of humans and animals. The natural habitat of these bacteria is thought to be decomposing plant matter, in which they live as saprophytes. Domesticated ruminants probably play a key role in the maintenance of Listeria spp. in the rural environment via a continuous fecal-oral enrichment cycle (178, 318, 420, 559, 682, 687, 692). The genus Listeria currently includes six species: L. monocytogenes, L. ivanovii, L. seeligeri, L. innocua, L. welshimeri, and L. grayi. Two of these species, L. monocytogenes and L. ivanovii, are potentially pathogenic. The infectious disease caused by these bacteria is known as listeriosis. L. monocytogenes causes serious localized and generalized infections in humans and a variety of other vertebrates, including domesticated and wild birds and mammals. The official discovery of Listeria microorganisms dates back to 1924, when E. G. D. Murray, R. A. Webb, and M. B. R. Swann isolated L. monocytogenes as the etiological agent of a septicemic disease affecting rabbits and guinea pigs in their laboratory at Cambridge in England (458). The first cases of human listeriosis were reported in 1929 in Denmark (481). However, the first recorded culture of L. monocytogenes dates from 1921, with the bacterium isolated in France by Dumont and Cotoni from a patient with meningitis (159, 604). L. ivanovii (formerly known as L. monocytogenes serotype 5) was first isolated in Bulgaria in 1955 from lambs with congenital listeriosis (299). Human cases of L. ivanovii infection are rare (116), the vast majority of reported isolations of this species being from abortions, stillbirths, and neonatal septicemias in sheep and cattle (4, 90, 134, 529, 610, 693). A third species, L. seeligeri, is considered nonpathogenic (555), although it has been implicated in at least one case of human listeriosis (556).
For many years, clinical Listeria isolates were a mere laboratory rarity, and the epidemiology of the disease was an unresolved mystery (603, 604). However, at the end of the 1970s and the start of the 1980s, the number of reports on Listeria isolations begun to increase, and from 1983 onwards, a series of epidemic outbreaks in humans in North America and Europe clearly established listeriosis as an important food-borne infection (46, 180, 386, 421, 572). The foods most frequently implicated are soft cheeses and dairy products, pâtés and sausages, smoked fish, salads, "delicatessen," and in general industrially produced, refrigerated ready-to-eat products that are eaten without cooking or reheating (176, 425-427, 551, 572). In ruminants, Listeria infection is transmitted by consumption of spoiled silage, in which these bacteria multiply readily, resulting in herd outbreaks (178, 666, 671, 693). Listeria organisms are widely disseminated in the rural environment and, consequently, contaminate the raw materials used in the preparation of industrially processed foods and the production plants as well (237). These bacteria are well equipped to survive food-processing technologies. For example, they tolerate high concentrations of salt and relatively low pHs, and worst of all, they are able to multiply at refrigeration temperatures (145, 362, 393, 426). This makes Listeria microorganisms a serious threat to food safety and ranks them among the microorganisms that most concern the food industry.
Researchers in immunology were interested in L. monocytogenes long before its importance as a risk to public health and food safety was recognized, because an infection highly reminiscent of human listeriosis was easily reproducible in laboratory rodents and protection could be transferred in syngeneic mice through spleen cells. Since the pioneering work of Mackaness in the early 1960s, which demonstrated that L. monocytogenes is able to survive and multiply in macrophages, this bacterium has been used in immunological research as a prototype intracellular parasite (401). For decades, the experimental model of Listeria infection in the mouse has made a significant contribution to our understanding of the cellular immune response (615). For example, key concepts such as the inability of antibodies to protect against infections produced by intracellular pathogens, the importance of activated macrophages in the elimination of intracellular parasites, and that the T cell is the macrophage-activating element required for cell-mediated immunity were established based on studies with the murine model of listeriosis (405, 406, 443, 478, 479).
In addition to the emergence of L. monocytogenes as a major food-borne pathogen, the 1980s also marked the start of investigations into the molecular mechanisms underlying Listeria virulence. The attention of researchers was first drawn to hemolytic activity, classically considered a virulence marker because it was present in the pathogenic species but not (with the exception of L. seeligeri) in the nonpathogenic species. These studies led between 1986 and 1989 to the discovery of the hemolysin gene, hly, and to elucidation of the key role that hemolysin plays in escape from destruction inside phagosomes, a prerequisite for intracellular bacterial proliferation. So, a decade ago, hemolysin became not only the first Listeria virulence factor to have its gene characterized, but also the first bacterial gene product to which a function critical to the survival of a parasite within the cells of the eukaryote host was attributed.
L. monocytogenes has since become not only an important paradigm for immunological investigation but also an important model system for analysis of the molecular mechanisms of intracellular parasitism (107). The identification of the hly gene was rapidly followed by a succession of discoveries resulting in complete characterization of the genetic locus to which this gene maps. This locus is a 9-kb virulence gene cluster that is involved in functions essential to intracellular survival. The internalin locus, inlAB, was also identified and characterized at this time (193). This locus encodes the first invasin described in a gram-positive bacterium, implicated in internalization by cells that are not usually phagocytic, such as epithelial and endothelial cells and hepatocytes. The progress made in the molecular characterization of listerial virulence factors during this period was summarized in a minireview published in 1992 (517). Many advances have since been made that have significantly increased our understanding of the molecular mechanisms of Listeria intracellular parasitism. The sequencing of the genomes of L. monocytogenes and L. innocua is currently finished (European Listeria Genome Consortium, unpublished data), with the expected outcome that very soon the panorama of research into the molecular pathogenesis of Listeria spp. will change dramatically.
The aim of this article is to review the knowledge gathered during the pregenomic era of Listeria research about the pathogenesis of listeriosis and the molecular virulence determinants involved. Readers interested more specifically in immunopathogenesis and the immune response should consult reference 497a. Those interested in issues related to taxonomy, clinical diagnosis and disease management, molecular typing, epidemiology, ecology, and food safety are also referred to other publications (145, 176, 289, 395, 550, 551, 573, 594, 605). For a historical perspective on Listeria spp. and listeriosis, we recommend the book Listeriosis by the pioneer listeriologist Heinz P. R. Seeliger (602) and the classical review, "Listeria monocytogenes and listeric infections," by Gray and Killinger (238).
PATHOPHYSIOLOGY OF LISTERIA INFECTION
|
|
|---|
Clinical Features
The clinical signs of L. monocytogenes
infection are very similar in all susceptible hosts. Two basic forms of
presentation can be distinguished: perinatal listeriosis and
listeriosis in the adult patient. In both instances, the predominant
clinical forms correspond to disseminated infection or to local
infection in the central nervous system (CNS). Listeriosis is usually a very severe disease
in fact, one of the most deadly bacterial infections currently known
with a mean mortality rate in humans of 20 to 30% or higher despite early antibiotic treatment (422, 423,
554, 594).
Fetomaternal and neonatal listeriosis.
This form of
presentation mainly results from invasion of the fetus via the placenta
and develops as chorioamnionitis. Its consequence is abortion, usually
from 5 months of gestation onwards, or the birth of a baby or stillborn
fetus with generalized infection, a clinical syndrome known as
granulomatosis infantiseptica and characterized by the presence of
pyogranulomatous microabscesses disseminated over the body and a high
mortality (336a) (Fig. 1). The infection is usually asymptomatic in the mother or may present as a
mild flu-like syndrome with chills, fatigue, headache, and muscular and
joint pain about 2 to 14 days before miscarriage. Less frequently (10 to 15% of perinatal cases), late neonatal listeriosis is observed. It
generally occurs 1 to 8 weeks postpartum and involves a febrile
syndrome accompanied by meningitis and, in some cases, gastroenteritis
and pneumonia. It presumably results from aspiration of contaminated
maternal exudates during delivery, although hospital-acquired cases
involving horizontal transmission by fomites or medical personnel in
neonatal units have been reported (177, 554, 628). The
mortality of late-onset neonatal listeriosis is lower (10 to 20%), but
like early-onset neonatal listeriosis, it may have sequelae such as
hydrocephalus or psychomotor retardation (173). L. monocytogenes is one of the three principal causes of bacterial
meningitis in neonates (391, 554, 594, 645).
|
Listeriosis in adults. The listerial infection most frequently reported in nonpregnant adults is that affecting the CNS (55 to 70% of cases). Pure meningeal forms are observed in some cases, but infection normally develops as a meningoencephalitis accompanied by severe changes in consciousness, movement disorders, and, in some cases, paralysis of the cranial nerves (Fig. 1). The encephalitic form, in which Listeria organisms are isolated with difficulty from the cerebrospinal fluid (CSF), is common in animals (Fig. 1A to D) but rare in humans (see below). Its course is usually biphasic, with an initial subfebrile phase lasting 3 to 10 days in which there may be headache, vomiting, visual disorders, and general malaise, followed in a second phase by the onset of severe signs of rhombencephalitis. The mortality rate for CNS infection is around 20% but may be as high as 40 to 60% if associated with concurrent, underlying debilitating disease. It has been estimated that L. monocytogenes accounts for 10% of community-acquired bacterial meningitis. Due to effective vaccination against Haemophilus influenzae, L. monocytogenes is now the fourth most common cause of meningeal infection in adults after Streptococcus pneumoniae, Neisseria meningitidis, and group B streptococci. However, in certain high-risk groups, such as cancer patients, L. monocytogenes is the most common cause of bacterial meningitis (391, 473, 593). Another frequent form of listeriosis (in some series of patients reported, even more frequent than CNS infection) is bacteremia or septicemia (15 to 50% of cases), with a high mortality rate (up to 70%) if it is associated with severe underlying debilitating conditions (391) (see below). There are other atypical clinical forms (5 to 10% of cases), such as endocarditis (the third most frequent form), myocarditis, arteritis, pneumonia, pleuritis, hepatitis, colecystitis, peritonitis, localized abscesses (e.g., brain abscess, which accounts for about 10% of CNS infections by Listeria spp.), arthritis, osteomyelitis, sinusitis, otitis, conjunctivitis, ophthalmitis, and, in cows, mastitis (48, 176, 199, 201, 390, 391, 395, 422-424, 550, 628).
An association between clinical episodes of invasive listeriosis and a history of gastrointestinal symptoms, including diarrhea, vomiting, and fever, was noticed some time ago (286, 542, 599). Investigations of recent food-borne outbreaks have provided compelling evidence that a febrile gastroenteritis syndrome may indeed be the main clinical manifestation of L. monocytogenes infection (19, 118, 442, 577, 628). The lesson to be learned from these epidemics is that L. monocytogenes should be sought as a possible etiologic agent in cases of diarrheagenic disease in humans. The potential enteropathogenicity of L. monocytogenes has also been recognized in animals, with outbreaks of diarrhea and gastroenteritis having been reported in sheep (52, 219, 395). There is also a primary cutaneous form of Listeria infection characterized by a pyogranulomatous rash. This form occurs sporadically among farmers and veterinarians and is contracted by direct contact with the genital tract or placenta from cows having had a miscarriage due to Listeria infection (6, 428).Pathogenesis
The pathophysiology of Listeria infection in humans and animals is still poorly understood. Most of the available information is derived from interpretation of epidemiological, clinical, and histopathological findings and observations made in experimental infections in animals, particularly in the murine model. As contaminated food is the major source of infection in both epidemic and sporadic cases (176, 512), the gastrointestinal tract is thought to be the primary site of entry of pathogenic Listeria organisms into the host. The clinical course of infection usually begins about 20 h after the ingestion of heavily contaminated food in cases of gastroenteritis (118), whereas the incubation period for the invasive illness is generally much longer, around 20 to 30 days (386, 542). Similar incubation periods have been reported in animals for both gastroenteric and invasive disease (138, 219, 671).
Ingestion of L. monocytogenes is likely to be a very common event, given the ubiquitous distribution of these bacteria and the high frequency of contamination of raw and industrially processed foods. However, the incidence of human listeriosis is very low, normally around 2 to 8 sporadic cases annually per million population in Europe and the United States (176, 301, 554, 649). Higher incidence rates have been reported for sporadic listeriosis (for example, 10.9 cases per million population per year in Barcelona, Spain [476], and 14.7 in France [234]), but these are exceptional. In epidemic situations, the incidence in the target population increases by a factor of 3 to 10 (46, 386, 587, 599). Thus, L. monocytogenes seems to have a lower pathogenic potential than other food-borne pathogens. This is consistent with the relatively high 50% lethal dose (LD50) values reported for mice infected experimentally by the oral (109 [18, 485]) or parenteral (105 to 106 [18, 333, 553]) routes. The minimum dose required to cause clinical infection in humans has not been determined, but the large numbers of L. monocytogenes bacteria detected in foods responsible for epidemic and sporadic cases of listeriosis (typically 106) suggest that it is high. However, these data should be interpreted with caution, given the long incubation period of invasive listeriosis and the time normally elapsed between diagnosis and analysis of the food eaten, during which Listeria organisms can have multiplied in the patient's refrigerator. It therefore cannot be excluded that low doses may be able to cause infection, at least in immunosuppressed persons, old people, and pregnant women. Indeed, levels of contamination as low as 102 to 104 L. monocytogenes cells per g of food have been associated with listeriosis in humans (176, 425). Obviously, the infectious dose may vary depending upon the pathogenicity and virulence of the L. monocytogenes strain involved and the host risk factors.
Pathogenicity of L. monocytogenes. Heterogeneity in the virulence of L. monocytogenes has been observed in several in vivo (mice) and in vitro (cell culture) studies (68, 129, 550, 663), but in most cases a clear correlation between the level of virulence and the origin or type characteristics of the strain could not be established. However, a recent study has found statistically significant differences in virulence between strains of food and clinical origin, the latter having slightly lower lethal doses (477). On the other hand, there is ample circumstantial evidence for an association between antigenic composition and pathogenicity in Listeria spp. The clearest example is provided by the L. ivanovii-specific serovar 5, which is recovered almost exclusively from ruminants, especially sheep. In these animals, serovar 5 strains cause perinatal infections but not encephalitis, the most typical clinical manifestations of ovine listeriosis (134, 397, 606, 610, 693) (Fig. 1A to D). Further evidence comes from the fact that only 3 of the 12 known serovars of L. monocytogenes, 1/2a, 1/2b, and 4b, account for more than 90% of human and animal cases of listeriosis (176, 397, 594), although other serovars, such as 1/2c, are often found as food contaminants (172, 176). Among the listeriosis-associated serovars, 4b strains cause over 50% of listeriosis cases worldwide, but strains of antigenic group 1/2 (1/2a, 1/2b, and 1/2c) predominate in food isolates (52, 172, 550, 557, 591). This suggests that serovar 4b strains are more adapted to mammalian host tissues than strains from serogroup 1/2. A phenotypically and genomically closely related group of serovar 4b isolates was found to be responsible for major outbreaks of food-borne human listeriosis in California in 1985 (386), Switzerland from 1983 to 1987 (46), Denmark from 1985 to 1987 (580), and France in 1992 (233), supporting the notion that some clones of L. monocytogenes may be particularly pathogenic (302, 510).
A number of observations suggest that there may be differences in pathogenic tropism between L. monocytogenes' strains. In humans, for example, serovar 4b strains have been found to occur more frequently in fetomaternal cases than in cases not associated with pregnancy (424). In sheep, the two major clinical forms of L. monocytogenes infection, meningoencephalitis and abortion, do not tend to occur simultaneously in the same flock (13, 397, 671). Molecular epidemiological evidence for such pathogenic tropism has been presented recently by Wiedman et al. (696). These authors found a correlation between the three serovar-related evolutionary branches into which L. monocytogenes isolates can be grouped (44, 510, 531, 678) and the pathogenic potential for humans and animals. Thus, one group of strains (serovars 1/2b and 4b) contained all isolates from human food-borne epidemics and isolates from sporadic cases in humans and animals, another (serovars 1/2a, 1/2c, and 3a) contained strains from both human and animal cases but no isolates from human food-borne epidemics, while a third group (serovar 4a) contained only animal isolates. A specific ribotype in the first group comprised all the serovar 4b strains associated with human food-borne epidemics but less than 10% of the ruminant isolates, suggesting a possible pathogenic tropism for humans (696). This possible tropism for humans of certain clones of L. monocytogenes serovar 4b may explain, for example, the observations made in Scotland, where during the same time period serovar 4b was most commonly isolated from human cases, whereas most ruminant cases were due to serovar 1/2a strains (397). There are also indications of adaptation to cause a particular clinical form in L. monocytogenes serovar 4b strains, as deduced from the analysis of two food-borne outbreaks of human listeriosis in France in 1992 and 1993, each associated with a different phage type of this serovar. In these outbreaks, the target population was similar but there was a significant difference in the percentage of fetomaternal cases (33 versus 80%) (557, 558).Host risk factors. Host susceptibility plays a major role in the presentation of clinical disease upon exposure to L. monocytogenes. Thus, most listeriosis patients have a physiological or pathological defect that affects T-cell-mediated immunity. This justifies the classification of L. monocytogenes as an opportunisitic pathogen. The groups at risk for listeriosis are pregnant women and neonates, the elderly (55 to 60 years and older), and immunocompromised or debilitated adults with underlying diseases. Listeriosis in nonpregnant adults is associated in most cases (>75%) with at least one of the following conditions: malignancies (leukemia, lymphoma, or sarcoma) and antineoplastic chemotherapy, immunosuppresant therapy (organ transplantation or corticosteroid use), chronic liver disease (cirrhosis or alcoholism), kidney disease, diabetes, and collagen disease (lupus) (176, 423, 551, 554, 594).
Human immunodeficiency virus (HIV) infection is also a significant risk factor for listeriosis. AIDS is the underlying predisposing condition in 5 to 20% of listeriosis cases in nonpregnant adults. It has been estimated that the risk of contracting listeriosis is 300 to 1,000 times higher for AIDS patients than for the general population. Nevertheless, listeriosis remains a relatively rare AIDS-associated infection, probably due to the preventive dietary measures taken by HIV-infected patients (avoidance of high-risk foods), the antimicrobial treatments that they receive regularly to treat or prevent opportunistic infections, and the fact that HIV infection does not significantly reduce the activity of the major effectors of immunity of Listeria spp. (innate immune mechanisms and the CD8+ T-cell subset [266]) (35, 306, 316, 592). The health status of the patient greatly influences the outcome of listeriosis. Immunocompetent patients usually survive listeriosis, whereas those with underlying debilitating diseases often succumb to the infection (mean mortality rate for this group, >30 to 40%) (235, 627). Although most listeriosis cases are associated with underlying risk factors, there are also a few adult patients for whom no obvious predisposing condition can be identified (177, 233, 235). This shows that L. monocytogenes has the potential to infect immunocompetent individuals. In some epidemics, all the nonpregnant adult patients had preexisting illnesses or immunosuppresive conditions (180, 386), whereas in others no such predisposing factors were found in any of the nonperinatal cases (587). This may be due to differences in the bacterial load present in the contaminated food involved or to the degree of virulence of the corresponding strains of L. monocytogenes.Entry and colonization of host tissues.
(i) Crossing
the intestinal barrier.
Before reaching the intestine, the
ingested Listeria organisms must withstand the adverse
environment of the stomach (Fig. 2). Oral
infective doses are lower for cimetidine-treated experimental animals
than for untreated animals (586a), and the use of antacids and H2-blocking agents has been reported to be a risk factor for listeriosis (286, 592). This indicates that gastric
acidity may destroy a significant number of the Listeria
organisms ingested with contaminated food.
|
B and the
subsequent upregulation of interleukin-15 (IL-15), and that at early
stages of an oral infection with L. monocytogenes in mice
and rats, intestinal intraepithelial lymphocytes become activated and
produce Th1-type cytokines. This suggests that the interaction between
intestinal epithelial and lymphoid cells may be relevant in the local
host defence against listerial infection in the gut (706).
Experimental observations made with the mouse and rat models of
intestinal translocation do not, however, explain how L. monocytogenes causes enteritis. The association of gastroenteric
symptoms with fever is consistent with invasive intestinal disease, as
observed by Racz in the guinea pig model (526). Pathogenic
Listeria organisms pass directly from cell to cell by a
mechanism involving host cell actin polymerization (see below).
Therefore, regardless of the mechanism of entry used, the bacteria that
penetrate the intestinal wall might then invade neighboring enterocytes
by basolateral spread, leading to enteritis. This is consistent with in
vitro experimental data showing that L. monocytogenes enters
polarized Caco-2 cells predominantly via the basolateral surface
(196). Gross intestinal lesions develop in experimental
animals only if large oral doses of L. monocytogenes are
given (400, 523). Similarly, episodes of listerial
gastroenteritis in humans occur in the form of outbreaks with very
short incubation periods and high attack rates among immunocompetent
adults (118, 577), consistent with the ingestion of a very
high dose of bacteria (as high as 2.9 × 1011, as
estimated for one of these oubreaks, caused by the consumption of
heavily contaminated chocolate milk [118]). Thus,
intestinal invasion and the ensuing febrile gastroenteritis syndrome
probably result from extensive exposure of the intestine to pathogenic Listeria organisms. However, the possibility that some
L. monocytogenes strains have a greater enteropathogenic
potential and cause intestinal damage at a lower dose cannot be ruled out.
(ii) Multiplication in the liver. The Listeria organisms that cross the intestinal barrier are carried by the lymph or blood to the mesenteric lymph nodes, the spleen, and the liver (411, 523) (Fig. 2). As stated above, this initial step of host tissue colonization by L. monocytogenes is rapid. The unusually long incubation period required by L. monocytogenes for the development of symptomatic systemic infection after oral exposure in relation to that for other food-borne pathogens is therefore puzzling and indicates that listerial colonization of host tissues involves a silent, subclinical phase, many of the events and underlying mechanisms of which are unknown.
Experimental infections of mice via the intravenous route have shown that L. monocytogenes bacteria are rapidly cleared from the bloodstream by resident macrophages in the spleen and liver (99, 112a, 405). Most (90%) of the bacterial load accumulates in the liver, presumably captured by the Kupffer cells that line the sinusoids. These resident macrophages kill most of the ingested bacteria, as shown by in vivo depletion experiments (161), resulting in a decrease in the size of the viable bacterial population in the liver during the first 6 h after infection. Kupffer cells are believed to initiate the development of antilisterial immunity by inducing the antigen-dependent proliferation of T lymphocytes and the secretion of cytokines (243). Not all Listeria cells are destroyed by tissue macrophages, and the surviving bacteria start to grow, increasing in numbers for 2 to 5 days in mouse organs (93, 99, 128, 181, 381, 408, 448). The principal site of bacterial multiplication in the liver is the hepatocyte (100, 112a, 197, 241, 241a, 563). This finding has led to the dismissal of the long-held idea that the major host niche for the parasitic life of L. monocytogenes is the macrophage population. There are two possible ways for L. monocytogenes to gain access to the liver parenchyma after its intestinal translocation and carriage by the portal or arterial bloodstream: via Kupffer cells, by cell to cell spread, or by the direct invasion of hepatocytes from the Disse space after crossing the fenestrated endothelial barrier lining the sinusoids. L. monocytogenes has been shown to efficiently invade hepatocytes in vitro (149, 701). Electron microscopy of hepatic tissue from infected mice suggests that L. monocytogenes goes through the complete intracellular infectious cycle in hepatocytes (197, 621), including actin-based intercellular spread (see below). Direct passage from hepatocyte to hepatocyte would lead to the formation of infectious foci in which L. monocytogenes disseminates through the liver parenchyma without coming into contact with the humoral effectors of the immune system. This may explain why antibodies play no major role in anti-Listeria immunity (516). During the early steps of liver colonization, polymorphonuclear neutrophils are recruited at the sites of infection, forming discrete microabscesses. Neutrophils have been shown to play an important role in controlling the acute phase of Listeria infection (561) and in mediating the destruction of Listeria-infected hepatocytes in vivo (99). Hepatocytes respond to Listeria infection by releasing neutrophil chemoattractants and exhibiting an increase in adhesion to neutrophils, resulting in microabscess formation (560). They also respond by initiating an apoptosis program that may be critical for removing Listeria-infected cells from the liver tissue at early stages of infection (448a, 560). Using transgenic mice expressing a degradation-resistant I
B transgene, it
has been shown recently that NF-
B activation in mouse hepatocytes is
essential to clear L. monocytogenes from the liver, possibly
by coordinating local innate immune response (368). Two to
four days after infection, neutrophils are gradually replaced by
blood-derived mononuclear cells together with lymphocytes to form the
characteristic granulomas (283, 408) (Fig. 1G and H).
These granulomas are the histomorphological correlate of cell-mediated
immunity and presumably act as true physical barriers that confine the
infectious foci, impeding further bacterial dissemination by direct
cell-to-cell passage (516).
Between days 5 and 7 postinfection, L. monocytogenes
bacteria start to disappear from mouse organs until their complete
clearance as a result of gamma interferon (IFN-
)-mediated macrophage
activation and the induction of an acquired immune response primarily
mediated by CD8+ lymphocytes, which together destroy
Listeria-infected cells (241a, 268, 328, 441).
These cytotoxic T lymphocytes (CTL) are directed against listerial
epitopes present in secreted virulence-associated proteins, such as Hly
(59, 71, 266, 281, 625, 677), the metalloprotease Mpl
(79), and the surface protein p60 (203, 204, 267,
624), and possibly also in somatic housekeeping proteins such as
superoxide dismutase (280). Protection against L. monocytogenes also involves a vigorous Th1-biased CD4+
T-cell response (125, 203) and innate mechanisms such as
the activation of IFN-
-producing natural killer (NK) cells in
response to IL-12 and tumor necrosis factor alpha (TNF-
) secretion
by infected macrophages (125, 166, 268, 290). Hepatocytes
may contribute to protection by becoming less permissive to
intracellular proliferation of Listeria organisms upon
exposure to IFN-
(244), especially if costimulated with
other cytokines (646).
The above course of events is accelerated in immune animals, resulting
in rapid elimination of L. monocytogenes from the liver (Fig. 2). This is probably the most common outcome of L. monocytogenes infection in humans and animals in normal
conditions, given the potentially high frequency of exposure to the
pathogen via contaminated food and the relatively rare occurrence of
clinical disease. Indeed, T lymphocytes directed against
Listeria antigens are commonly found in healthy individuals
(457), probably due to chronic stimulation of the immune
system by L. monocytogenes antigens that are presumably continuously delivered to the immune system via food. A recent study
has shown that the nonpathogenic species L. innocua can enhance a previously established L. monocytogenes-specific
T-cell memory via recognition of cross-reactive p60 epitopes shared by the two species (204). L. innocua is commonly
found in food (573), and as stated above, it is translocated to the
deep organs of mice as efficiently as L. monocytogenes.
Therefore, repeated contact with L. innocua may boost
protective immunity against pathogenic Listeria spp.,
possibly explaining in part the rare occurrence of listeriosis in the
general population.
If the infection is not controlled by an adequate immune response in
the liver, as may occur in immunocompromised individuals, unlimited
proliferation of L. monocytogenes in the liver parenchyma may result in the release of bacteria into the circulation (Fig. 2).
L. monocytogenes is a multisystemic pathogen that can infect a wide range of host tissues, as indicated by its capacity to cause
septicemia involving multiple organs and by the variety of potential
sites of localized Listeria infection (see above). However,
the principal clinical forms of listeriosis clearly show that L. monocytogenes has a pathogenic tropism towards the gravid uterus
and the CNS (Fig. 2).
(iii) Colonization of gravid uterus and fetus. Abortion and stillbirth due to Listeria spp. have been reproduced experimentally by intravenous, oral, and respiratory inoculation in naturally susceptible gestating animal hosts, such as sheep, cattle, rabbits, and guinea pigs, as well in pregnant mice and rats (1, 238, 239, 329, 450, 487, 488, 586). This shows that L. monocytogenes gains access to the fetus by hematogenous penetration of the placental barrier (Fig. 2). In pregnant mice, the blood-borne bacteria first invade the decidua basalis and then progress to the placental villi, where they cause diffuse inflammatory infiltration and necrosis (1, 535, 536). Macrophages appear to be excluded from the murine placenta, neutrophils acting as the main antilisterial effector cell population (251a). Using homozygous mutant mice, it has been shown recently that colony-stimulating factor-1 is required for the recruitment of neutrophils to the infectious foci in the decidua basalis. This occurs via induction of neutrophil chemoattractant synthesis by the trophoblast (251a). In humans, placental infection is characterized by numerous microabscesses and focal necrotizing villitis (502, 582). Colonization of the trophoblast layer followed by translocation across the endothelial barrier would enable the bacteria to reach the fetal bloodstream, leading to generalized infection and subsequent death of the fetus in utero or to premature birth of a severely infected neonate with miliary pyogranulomatous lesions (the above-mentioned granulomatosis infantiseptica) (Fig. 1E and F).
The depression of cell-mediated immunity during pregnancy (686) presumably plays an important role in the development of listeriosis. In laboratory rodents, pregnancy reduces resistance to L. monocytogenes (58, 399) and significantly prolongs the course of primary infection in the liver (1). The T-cell-dependent elimination of L. monocytogenes from the organs of pregnant mice is delayed in late pregnancy. This correlates with a failure in the production of IFN-
and results in listerial invasion of placental and fetal tissues
(463). Abnormally high physiological levels of estrogenic
hormones, such as those that occur during late pregnancy, may account
for the disruption of T-cell-mediated resistance to infection, as
treatment of mice with steroids inhibits the proliferative response to
L. monocytogenes of splenic T cells and increases susceptibility to Listeria infection (524).
This correlates with a decrease in the production of IL-2
(524), a cytokine that stimulates resistance to
Listeria spp. in mice (255). The intracellular killing function of macrophages has also been shown to be decreased by
-estradiol, which is associated with inhibition of both IL-12 and
TNF-
secretion in vivo (578). Local depression in the
cellular immune response in the placenta, which physiologically is
important for preventing rejection of the fetus, may also contribute to the higher susceptibility to uterine infection by L. monocytogenes (398, 535, 536). It is not known why
mothers suffering Listeria-induced miscarriage never develop
CNS infection or overt septicemic disease.
(iv) Invasion of the brain. In humans, CNS infection by Listeria spp. presents primarily in the form of meningitis. This meningitis, however, is often associated with the presence of infectious foci in the brain parenchyma, especially in the brain stem (391, 473), suggesting L. monocytogenes has a tropism for nerve tissue. The neurotropism and special predilection of L. monocytogenes for the rhombencephalon are shown most clearly in ruminants, in which listerial CNS infection, in contrast to the situation in humans, develops mainly as primary encephalitis. In these animals, infectious foci are restricted to the pons, medulla oblongata, and spinal cord (Fig. 1C). Although there is inflammatory lymphocyte or mononuclear cell infiltration of the meninges, this condition occurs as an extension of the brain process, and macroscopic lesions may not even be evident or may be restricted to basal areas, midbrain, and cerebellum. Unilateral cranial nerve paralysis is a characteristic of listerial rhombencephalitis in ruminants, leading to the well-known circling disease syndrome (92, 103, 215, 216, 312, 534, 666, 693) (Fig. 1A and B). In humans, primary nonmeningeal brain infection is seldom observed. However, as in ruminants, it develops as cerebritis involving the rhombencephalon (15, 20, 69, 390, 391, 473).
Brain lesions in listerial meningoencephalitis are typical and very similar in humans and animals. They consist of perivascular cuffs of inflammatory infiltrates composed of mononuclear cells and scattered neutrophils and lymphocytes (Fig. 1D). Bacteria are generally absent from these perivascular areas of inflammation. Parenchymal microabscesses and foci of necrosis and malacia are also typically present (Fig. 1D). Bacteria are relatively abundant in these lesions, within phagocytes or free in the brain parenchyma around the necrotic areas (92, 103, 312, 315, 412, 489). Depletion experiments in mice using a neutrophil-specific monoclonal antibody have shown that neutrophils play a critical role in eliminating L. monocytogenes from infectious foci in the brain (389a). Less commonly, bacteria are observed within neurons in both natural (412, 489) and experimentally induced (588) infections. This is consistent with in vitro data showing that the invasion of cultured neurons is a relatively rare event (151, 505). However, neurons are efficiently invaded in vitro by direct cell-to-cell spread from infected macrophages or microgial cells (151). A recent study (146) has shown that L. monocytogenes can efficiently invade sensory neurons of rat dorsal root ganglia but not hippocampal neurons, suggesting that there may be differences in the susceptibility to infection among different types of neurons. The relevance of neuronal invasion to the pathogenesis of Listeria encephalitis is subject to speculation, as discussed below. The mechanisms by which L. monocytogenes infects the CNS are still largely unknown. Numerous attempts have been made to reproduce listerial meningoencephalitis in susceptible animal hosts and laboratory rodents using various routes of inoculation, with variable success. Intravenous delivery of the inoculum does not usually result in CNS infection in sheep (103). This, and the usual absence of visceral involvement in natural cases of ovine listerial encephalitis, seems to argue against a hematogenous route of infection. The topographic distribution of the lesions in sheep, strictly confined to the brainstem, and the frequent unilateral involvement of the trigeminal nerve, with neuritis affecting distal portions of a single or a few fasciculi in only one of the nerve branches, led to the hypothesis that L. monocytogenes invades the brain by centripetal migration along cranial nerves (17, 92, 661). To test this hypothesis, Asahi and coworkers (17) scarified oral, nasal, and labial mucosae of mice with L. monocytogenes. Most mice developed neurological signs, such as torticollis, rolling movements, and paralysis of the hindlegs, 5 days after infection. These signs correlated with the presence of mononuclear and round cell infiltrations along the trigeminal nerve, in the corresponding nerve ganglion, and in the medulla oblongata, suggesting retrograde bacterial ascension along the cranial nerve to the brainstem. In another experiment, 4 of 11 goats inoculated in the lip developed listerial encephalitis 17 to 28 days after inoculation, with microscopic lesions identical to those found in natural cases of listeriosis, with ganglioneuritis of the trigeminal nerve (17). In spontaneous cases of ovine listerial encephalits, bacteria have been observed in linear arrays in individual nerve fibers, inside axons, and with actin tails (91, 92, 489), suggesting active intra-axonal movement. Experiments using a double-chamber cell culture system and dorsal root ganglia neurons provided evidence that L. monocytogenes can infect axons and spread along them towards the nerve cell body (146). Experimental evidence has been obtained that intra-axonal bacterial transport may indeed occur in vivo. Otter and Blakemore (489) developed a mouse model in which L. monocytogenes was injected distally into the sciatic nerve. Paralysis of the leg into which the bacteria were injected occurred 7 to 12 days later, and examination of the spinal cord revealed lesions very similar to those found in the brains of naturally affected sheep. Bacteria were seen in these lesions in neutrophils and, in some cases, in axons (489). The feasibility of ascending intra-axonal transport via the termini of the trigeminal nerve was tested by experimentally injecting L. monocytogenes directly into the dental pulp of sheep through a hole drilled in the tooth crown (22). Six of 21 sheep developed neurological signs 20 to 40 days after challenge, and most animals showed histological encephalitis and trigeminal ganglioneuritis on the side of inoculation. These observations favor the view that L. monocytogenes may directly invade exposed sensory terminal ramifications of the cranial nerve in the mouth and reach the brain by centripetal spread. They also demonstrate that cases of mild CNS invasion by Listeria organisms may occur without overt clinical signs. This is important because it provides one possible explanation for the relatively small number of cases with neurological manifestations that are observed among animals exposed to contaminated silage in a herd affected by listerial encephalitis (and, by extension, to humans exposed to Listeria-contaminated food). However, in another study in which brains from natural cases of sheep with meningoencephalitis were analyzed, inflammatory infiltration was observed only in the intracranial portion of the trigeminal tract, always associated with meningitis adjacent to proximal parts of cranial nerves. The authors were of the opinion that cranial nerve invasion was only secondary to a hematogenous brain infection and occurred by centrifugal spread from the brainstem (103). The above-mentioned experiments with the two-chamber model (146) suggested that both retrograde and anterograde transport of L. monocytogenes may occur inside infected neurons. Although intravenous inoculation only occasionally gives positive results, intracarotid inoculation consistently results in encephalitis in sheep (103, 314, 486). This supports the notion that L. monocytogtenes may indeed reach the brain via the blood. Strong evidence that meningoencephalitis in ruminants has a vascular basis is provided by the nature of the brain lesions themselves, with extensive perivascular infiltrates and mononuclear microabscesses and necrotic foci developing in close proximity to brain capillaries (103) (Fig. 1D). In contrast to intravenous inoculation, intracarotid delivery provides the inoculum direct access to the vascular system of the brain, enabling bacteria to bypass the clearance mechanisms of organs such as the spleen and liver. In an immunocompetent host, these clearance mechanisms should be sufficient to eliminate rapidly a single-dose intravenous inoculum, preventing the bacteria from invading the brain. Intracarotid inoculation in sheep causes CNS lesions involving the choroid plexus and the ependyma of the cerebral ventricles and aqueduct, resulting in primary meningitis and secondary lesions in the adjoining cerebral tissues (17). These brain structures are only rarely affected in natural cases of listerial meningoencephalitis in ruminants (103). The reason for these differences between natural and experimental lesion patterns probably resides in the concentration of bacteria in the blood, as this is an important factor affecting the mode by which bacterial pathogens gain access to the CNS (659, 660). This concentration would reach an extraordinarily high peak in the brain after intracarotid delivery, and high-grade bacteremia is more likely to cause meningitis due to massive bacterial penetration across the epithelium lining the choroid plexus, which has an exceptionally high rate of blood flow. In contrast, low-grade bacteremia, such as that resulting from the release of bacteria into the blood from infectious foci located in distant organs (e.g., the liver), tends to be associated with multiple foci in the brain parenchyma due to individual penetrations along the extensive microvascular endothelial bed (660). Experimental infections in small laboratory animals also provide evidence for a hematogenous route of CNS invasion for L. monocytogenes. Intravenous inoculation in mice results in meningoencephalitis in a significant proportion of animals that survive the initial systemic phase of infection. Lesions include choroiditis, meningitis, and the characteristic perivascular cuffing and parenchymal pyogranulomatous foci in the brainstem (31, 103). No brain invasion is detected in mice challenged with low infective doses that induce only transient bacteremia, even if there is significant bacterial multiplication in the spleen and liver. However, brain invasion is achieved with high infective doses causing severe systemic disease and prolonged bacteremia (31). This suggests that the persistence of large numbers of bacteria in the blood is essential for the induction of meningoencephalitis by L. monocytogenes. This conclusion is consistent with a recent study by Blanot and coworkers (47), who adapted a model of otitis media in gerbils to study listerial CNS invasion. With a low infective dose of L. monocytogenes (103/ear), these authors induced persistent low-level bacteremia (102 bacteria/ml) which was associated with the development of rhombencephalitis in gerbils mimicking that observed during human listerial meningoencephalitis, with leptomeningitis, parenchymal foci, and perivascular sheaths. The number of bacteria in the liver and spleen of gerbils decreased by day 5 postinoculation, but growth in brain tissue was unrestricted (47), suggesting that nerve tissue is a privileged niche for the multiplication of L. monocytogenes. CNS invasion was also regularly observed in mice after oral or subcutaneous inoculation (9, 17, 522). These infection routes imply systemic involvement and, clearly, also lymphohematogenous dissemination of bacteria to the brain. In experiments with orally or subcutaneously infected mice, parenchymal brain lesions are irregularly observed, but marked inflammatory lesions in the meninges and ventricular system (choroid plexus, lateral, third and fourth ventricles, and aqueduct) are consistently recorded (9, 522). This striking affinity of L. monocytogenes for mouse ventricular structures was also noted after direct intracerebral inoculation (588), which prevents primary blood-borne exposure of the ependyma via the choroid plexus. In contrast, no involvement of the ventricular system was noticed in the gerbil model (47). These observations suggest that there may be anatomical and physiological differences in the brains of the various animal species that affect L. monocytogenes neuropathogenesis. Indeed, this may account for the differential characteristics of listerial CNS infection in humans and ruminants. However, it cannot be excluded that the peculiar characteristics of listerial meningoencephalitis in ruminants result from the fact that an alternative primary nonvascular mechanism of CNS invasion, which may perfectly coexist with hematogenous dissemination, has specifically evolved in these animals. Ruminants eat plant material, the physical characteristics of which may lead to small breaches of the oral mucosa. If animals are fed contaminated silage, these small wounds are repeatedly exposed to L. monocytogenes during rumination, favoring invasion of the trigeminal nerve terminals and subsequent intraneural, direct spread to the brain stem. Bacterial pathogens such as H. influenzae, N. meningitidis, S. pneumoniae, and Streptococcus suis cross the blood-brain barrier (BBB) primarily via the choroid plexus. This enables them to reach the CSF and create purulent meningitis by spreading through the subarachnoid space (525, 659, 660, 697). Although in human listerial infections of the CNS, purulent meningitis also occurs and bacteria may also be detected in the CSF, it is clear that L. monocytogenes, unlike other meningitis-causing bacterial pathogens, tends to affect brain parenchymal tissue. This may reflect a tropism for the microvascular endothelium, in particular that lining the capillary bed of the rhombencephalon, resulting in significant or preferential (in ruminants) crossing of the BBB at this point. Direct uptake by endothelial cells of bacteria circulating free in the blood is one possible mechanism by which L. monocytogenes may cross the microvascular BBB. Evidence for this mechanism is provided by an electron microscopic study of human brainstem tissue, in which bacteria have been observed within endothelial cells or adhering to the luminal face of the microvascular endothelium (335). This mechanism is also consistent with in vitro data showing that L. monocytogenes is able to invade cultured human brain microvascular endothelial cells (BMEC) (245, 246). The listerial surface protein InlB, of the internalin family (see below), has been shown to be required for invasion of endothelial cells in vitro (246, 498), indicating that specific bacterial molecules are actively involved in the interaction with the BBB. L. monocytogenes efficiently replicates for long periods of time within brain microvascular cells without causing any evident damage, creating heavily infected foci from which bacteria spread to neighboring cells by actin-based motility (246). In this way, L. monocytogenes may reach and disseminate easily into the protected spaces of the CNS. L. monocytogenes infection induces a potent response in cultured endothelial cells which is accompanied by the upregulation of endothelial adhesion molecules (P- and E-selectin, ICAM-1, and VCAM-1) (see below), leading to an increase in the binding of polymorphonuclear leukocytes to infected endothelial cells (152, 247, 330, 600, 618). Heterologous plaque assays using infected macrophages as vectors have demonstrated that L. monocytogenes can spread efficiently from macrophages into endothelial cells (157, 246). Therefore, the recruitment of phagocytes to the infected endothelium, primarily a host defense response, may also be used by L. monocytogenes, in addition to direct invasion, to cross the BBB. Evidence for a significant role in vivo for such a Trojan horse mechanism of CNS invasion, presumably involving direct bacterial cell-to-cell spread from infected phagocytes carried by the blood after adhesion to endothelial cells, has been provided recently by Drevets (154). This author showed that phagocyte-associated L. monocytogenes accounted for 30% of the total bacterial population circulating in the bloodstream after intravenous inoculation. These entrapped bacteria spread to endothelial cells in vitro, and Listeria-infected peripheral blood leukocytes successfully established brain colonization in vivo (154). It is unknown whether trafficking of infected phagocytes across the BBB, as part of the inflammatory influx induced by endothelial and underlying brain tissue infection, occurs in vivo during CNS invasion by L. monocytogenes.Hypothetical scenario. From the information presented above, the following hypothetical scenario for the pathogenesis of listeriosis can be proposed. Clinical outcome of Listeria infection depends on three major variables: (i) the number of bacteria ingested with food, (ii) the pathogenic properties of the strain, and (iii) the immunological status of the host. In immunocompetent individuals with no predisposing conditions, ingestion of low doses of L. monocytogenes will probably have no effect other than the development or boosting of antilisterial protective immunity. In contrast, oral exposure to large doses is likely to result in an episode of gastroenteritis and fever and, depending on the virulence of the strain, possible invasive disease. Immunocompromised and debilitated individuals, however, cannot mount an immune response strong enough to control bacterial proliferation in the liver, the primary target organ of L. monocytogenes, and are therefore susceptible to invasive disease following the ingestion of a lower inoculum. Inefficiently restricted growth of L. monocytogenes in the hepatocytes in these individuals is likely to result in an increase in the critical mass of bacteria and their release into the bloodstream. The ensuing prolonged bacteremia will result in local infections in secondary target organs (particularly the brain and placenta) or in septicemic disease in severely immunocompromised hosts. Figure 2 summarizes the key steps of the pathophysiology of Listeria infection.
INTRACELLULAR INFECTIOUS CYCLE
|
|
|---|
In addition to multiplying within macrophages, Listeria
organisms are invasive pathogens that can induce their own
internalization in various types of cell that are not normally
phagocytic. These include epithelial cells (194, 435,
518), fibroblasts (359, 641), hepatocytes
(149, 242, 701), endothelial cells (157, 245,
498), and various types of nerve cell, including neurons (151). Listeria organisms have been also shown
to be taken up by and survive within dentritic cells (253,
345). In the interior of all cells that L. monocytogenes is able to penetrate, whether macrophages or
nonprofessional phagocytes, it
develops
an intracellular life cycle with common characteristics (Fig. 3).
|
Internalization
The cycle begins with adhesion to the surface of the eukaryote cell and subsequent penetration of the bacterium into the host cell. The invasion of nonphagocytic cells involves a zipper-type mechanism, in that the bacterium gradually sinks into diplike structures of the host cell surface until it is finally engulfed. During this process, the target cell membrane closely surrounds the bacterial cell and does not form the spectacular local processes or membrane ruffles characteristic of invasion by Salmonella and Shigella spp. (147, 322, 358, 435, 642) (Fig. 3B and C). The structures, mechanisms, and signal transduction cascades involved in the interaction between the bacterium and the cell during phagocytosis are only beginning to be elucidated.
The multisystemic nature of listerial infection indicates that L. monocytogenes probably recognizes a number of different eukaryotic
receptors. The C3bi and C1q complement receptors have been reported to
be involved in L. monocytogenes uptake by phagocytic cells
(10, 115, 155, 156). L. monocytogenes is also
efficiently internalized in the absence of serum, indicating that
nonopsonic receptor-ligand interactions are also involved in host cell
recognition by Listeria spp. (509). The
eukaryote cell receptors used by Listeria spp. include the
transmembrane glycoprotein E-cadherin (435), the C1q
complement fraction receptor (61), the Met receptor for
hepatocyte growth factor (HGF) (615a), and components of
the extracellular matrix (ECM) such as heparan sulfate proteoglycans (HSPG) (12) and fibronectin (217). The
macrophage scavenger receptor was shown to bind L. monocytogenes lipoteichoic acids and hence may also be involved in
Listeria-macrophage interactions (160, 240).
The bacterial ligands identified to date are all surface proteins, such
as the internalins InlA and InlB, the actin-polymerizing protein ActA,
and p60 (see below). Recently, several putative adhesion factors of
L. monocytogenes have been identified by screening transposon mutants for defective attachment to eukaryotic cells. Among
these putative adhesins are the surface protein Ami, an autolysin with
a C-terminal cell wall-anchoring domain similar to InlB (60,
429, 445) (see below), and Lap, a 104-kDa surface protein
involved in attachment to Caco-2 cells (581a). Also
recently, a 24.6-kDa fibronectin-binding protein has been identified in L. monocytogenes by screening a genomic library in
Escherichia coli for fibronectin binding (215).
Bacterium-host cell interactions involving lectins (482)
may also be involved in L. monocytogenes adhesion to
eukaryotic cells (174). Indirect evidence has been obtained for an L. monocytogenes adhesin containing
-D-galactose, involved in uptake by mouse CB1 dendritic
cells (253) and human HepG22 hepatocarcinoma cells
(114) upon recognition of a carbohydrate receptor at the
eukaryotic cell surface. The presence in L. monocytogenes of
lectin-like ligands mediating binding to D-glucosamine,
L-fucosylamine, and
p-aminophenyl-
-D-mannopyranoside moieties has
also been indirectly demonstrated (110).
Intracellular Proliferation and Intercellular Spread
During invasion, Listeria bacteria become engulfed within a phagocytic vacuole (194) (Fig. 3D). Little is known about the characteristics of the Listeria-containing vacuolar compartment, but the vacuoles become acidified soon after uptake (25). There is evidence that L. monocytogenes ensures its intravacuolar viability by preventing phagosome maturation to the phagolysosomal stage (11). Thirty minutes after entry, the bacteria begin to disrupt the phagosome membrane (194), and within 2 h, about 50% of the intracellular bacterial population is free in the cytoplasm (655) (Fig. 3E). This membrane disruption step is essential for listerial intracellular survival and proliferation (220) and is mediated by the hemolysin in combination with phospholipases (see below).
Once in the cytosol, bacteria multiply (Fig. 3E), with a doubling time of approximately 1 h (194, 518), i.e., approximately three times slower than in rich medium. In L. monocytogenes, intracellular growth does not involve the upregulation of known stress proteins (261) (see below), and auxotrophic mutants requiring aromatic amino acids or purines for growth in minimal medium grow inside cells at rates similar to those of the wild-type parent strain (413). This indicates that the cytoplasmic compartment is permissive for Listeria proliferation. However, three metabolic genes (purH, purD, and pyrE, involved in purine and pyrimidine biosynthesis) and an arginine ABC transporter (arpJ) have been shown to be induced within cells (336). Mutation of these genes had no major effect on intracellular proliferation and virulence (336), which can mean that certain nutrients are present in the host cell cytoplasm at concentrations that, although not limiting, are sufficiently low that L. monocytogenes has to upregulate certain metabolic genes to grow efficiently within cells. Recent experimental evidence indicates that pathogenic Listeria spp. may exploit hexose phosphates from the host cell cytoplasm for efficient intracellular growth (543) (see below). Evidence has also been recently presented that antimicrobial peptides from the host cell cytosol, such as ubiquicidin found in macrophages (283a), may play a role in restraining intracellular proliferation of L. monocytogenes. Nothing is known about the listerial mechanisms counteracting these inhibitory peptides.
Intracytoplasmic bacteria are immediately surrounded by a cloud of a fine, fuzzy, fibrillar material composed of actin filaments, which later (around 2 h postinfection) rearranges to form an actin tail of up to 40 µm at one of the poles of the bacterium (see Fig. 6B). This actin tail consists of two populations of cross-linked actin filaments, one formed by relatively long, axially arranged actin bundles and the other by shorter, randomly arranged filaments. The polar assembly of actin filaments propels the bacterial cell in the cytoplasm with a mean speed of 0.3 µm/s, in a fashion reminiscent of the "action-reaction" principle that governs rocket movement. Moving Listeria cells leave an evanescent trail of F-actin undergoing depolymerization at the distal end, the steady-state length of which is proportional to the speed of bacterial movement. This movement is random, so some bacteria eventually reach the cell periphery, come into contact with the membrane, and push it, leading to the formation of finger-like protrusions with a bacterium at the tip (Fig. 3F and G). These pseudopods penetrate uninfected neighboring cells and are in turn engulfed by phagocytosis, resulting in the formation of a secondary phagosome delimited by a double membrane (Fig. 3H), with the inner membrane originating from the donor cell (Fig. 3G). Bacteria escape rapidly (within 5 min) from the newly formed vacuole by dissolving its double membrane, reach the cytoplasm, and initiate a new round of intracellular proliferation and direct intercellular spread (117, 453, 549, 601, 652, 654-656) (Fig. 3A). In tissue culture, this infectious cycle is reflected in the formation of plaques in the cell monolayer (641, 672). Actin-based intracytoplasmic movement and cell-to-cell spread are mediated by the listerial surface protein ActA (see below).
VIRULENCE FACTORS
|
|
|---|
Hemolysin
The hemolysin gene, hly, was the first virulence determinant to be identified and sequenced in Listeria spp. Subsequent characterization of the hly locus led to discovery of the chromosomal virulence gene cluster in which most of the genetic determinants required for the intracellular life cycle of pathogenic Listeria spp. reside (see below). The hly product, Hly, was also the first virulence factor for which a precise role in the pathogenesis of Listeria infection was demonstrated. Hly is a key virulence factor essential for pathogenicity, having a vital role not only in intracellular parasitism but also in several other functions in the interaction of listeriae with their vertebrate host.
Characterization and role in escape from phagosome. In 1941, Harvey and Faber (269) demonstrated for the first time the production of a soluble hemolysin by L. monocytogenes. During the 1960s and 1970s, various researchers tried to purify this hemolysin and characterize its biochemical and toxic properties (218, 303, 305, 475, 620, 683). Jenkins et al. (303) were the first to provide evidence that the Listeria hemolysin is similar in function and antigenicity to streptolysin O (SLO) from Streptococcus pyogenes. Kingdon and Sword (334) showed that the hemolysin was inhibited by cholesterol, that its optimum pH was below 7, and that it had cytotoxic properties in phagocytic cells. They were also the first to suggest that the hemolysin might be involved in the disruption of phagosomal membranes (15, 334). In 1985, Vicente et al. (676) reported the molecular cloning of a chromosomal fragment from L. monocytogenes that conferred hemolytic activity on E. coli. These authors were the first to use molecular genetics in the study of listerial virulence factors. Finally, in 1987, Geoffroy et al. (207) provided the first unambiguous evidence that the hemolysin of L. monocytogenes is an SLO-related cytolysin belonging to the family of cholesterol-dependent, pore-forming toxins (CDTX). This toxin was given the name listeriolysin O (LLO), and one of its key characteristics was determined, its low optimum pH (5.5) and the narrow pH range at which it is active (4.5 to 6.5) (207). Later, the 58-kDa CDTX hemolysin of L. ivanovii, ivanolysin O (ILO), was purified and characterized (669), and it was also shown that the weakly hemolytic but nonpathogenic species L. seeligeri produces, albeit in small amounts, an LLO-related CDTX (208, 376).
The strong correlation between hemolytic activity and pathogenicity in the genus Listeria (the pathogenic species L. monocytogenes and L. ivanovii are hemolytic [see Fig. 5], whereas the nonpathogenic species are not; the exceptional case of L. seeligeri will be discussed below) (250, 605, 626) and the observation that the spontaneous loss of hemolysin production results in avirulence (288) led Gaillard et al. (195) and various other groups to generate isogenic hemolysin mutants of L. monocytogenes by transposon mutagenesis (108, 323, 518). These mutants were much less virulent in mice (increase of >4 log units in the LD50). Spontaneous revertants from which the transposon was lost recovered both hemolytic activity and pathogenicity, and reintroduction of the hly gene in trans into the nonhemolytic mutants restored virulence to wild-type levels (108, 195, 323, 518). Genetic analysis of the point of insertion for one of these mutants led, in 1987, to the identification and characterization of the hemolysin gene (432, 436). Cell culture studies of the effects of hly inactivation showed that hemolysin is required for the survival and proliferation of L. monocytogenes within macrophages and nonprofessional phagocytes (194, 359, 518). Electron microscopy of L. monocytogenes-infected cultured epithelial cells revealed that hly mutants remained within the vacuolar compartment, whereas hemolytic bacteria were free in the cytoplasm (194). The heterologous expression of hly in Bacillus subtilis conferred on this nonpathogenic bacterium the ability to escape from the phagocytic vacuole and to proliferate within cells (although it did not become pathogenic, indicating that virulence factors other than LLO were required for infection) (45). These studies demonstrated the key role played by LLO in the intracellular infectious cycle of pathogenic Listeria spp., as a mediator of phagosome membrane disruption. LLO not only mediates lysis of the primary phagosomes formed after the uptake of extracellular bacteria but is also required for the efficient escape of L. monocytogenes from the double-membrane vacuole that forms upon cell-to-cell spread (202) (Fig. 3D and H). The pores or membrane lesions caused by LLO (Fig. 4) probably facilitate the access of Listeria phospholipases to their substrates (see following section), leading to total dissolution of the physical barrier that delimits the phagosomal compartment.
|
Structure-function. CDTXs typically have a conserved undecapeptide, ECTGLAWEWWR, in the C-terminal region (7, 8). Single-amino-acid substitutions in this undecapeptide in LLO produce L. monocytogenes strains with various degrees of attenuation, proportional to the loss of cytolytic activity of the respective hemolysin variants (440). Mutational analyses of the undecapeptide in several other CDTXs have also demonstrated the importance of this motif for activity (511, 583, 608). LSO, the L. seeligeri hemolysin, has an Ala-to-Phe substitution in this conserved motif (257), and this may be one of the reasons for the lower hemolytic activity of this species. The undecapeptide contains the Cys residue that confers on CDTXs the characteristic after which this group of toxins was formerly designated (i.e., "thiol activated or oxygen labile"), that is, inhibition by oxidation or thiol-reacting compounds and reactivation by thiol-reducing agents (8, 633). It was formerly assumed that activation by thiol-reducing agents was due to the breakage of an intramolecular bond. However, once the sequences of many of these toxins became available, it was clear that only one Cys residue was present in most of the toxins of the family. It was also thought that this residue was essential for activity, presumably serving as the ligand in the interaction with membrane cholesterol (see below) (8, 633). However, replacement of this residue with Ala in LLO (440) and in other toxins of the family (511, 583) did not significantly affect activity, although it did render the molecule insensitive to inactivation by oxidation or thiol-alkylating agents. Replacement with Gly or bulkier amino acids, however, abolished most of the activity, indicating that the mechanism underlying Cys-mediated reversible inhibition of cytolytic function probably involves steric hindrance due to formation of toxin dimers or heterodimers with other proteins via disulfide bridges. Indeed, ILO copurifies with a major 27-kDa protein from the culture supernatant of L. ivanovii (349, 669) (the small, secreted internalin i-InlE [169]), and this heterodimer is resolved by treatment with thiol-reducing agents (669). Its nonessential role for cytolytic activity in vitro raises the question of why there is such strong selection pressure for conservation of the Cys residue among CDTXs. This residue may have a major role in vivo, for example, as a modulator of toxin activity (activation in low pH, reducing environments) or as a facilitator of host membrane targeting for other virulence-associated proteins (for example, i-InlE) that may associate with the CDTX in a heterodimer.
Cholesterol irreversibly inhibits the cytolytic activity of CDTXs, and these toxins are active only against cholesterol-containing membranes, reflecting that this membrane compound is a key toxin target (8, 633). The observation that soluble CDTXs form highly stable amphiphilic complexes with cholesterol led to the development of a simple one-step method to purify these toxins from the culture supernatant by selective precipitation with cholesterol (669, 670). With this technique, it was shown that a cytolytically inactive, truncated form of LLO lacking the C-terminal region including the undecapeptide was nonetheless able to form cholesterol-toxin complexes. The conclusion was that LLO possesses functional domains for cholesterol binding located outside the C-terminal region and independent from those involved in cytolysis. It also appeared clear that the undecapeptide containing the Cys residue was not essential for interaction of the toxin with cholesterol (670). Unfortunately, the ability of these truncated LLO molecules to bind to membranes was not tested. Such an experiment would have indicated whether cholesterol acts as the primary binding receptor for LLO. If this were so, then prior treatment of the toxin with cholesterol should block the cholesterol-binding sites on the molecule and prevent the interaction of the toxin with the target membrane. However, recent experiments have demonstrated that preincubation with cholesterol does not impede the binding of LLO-cholesterol complexes to target membranes (300). This is consistent with experimental data showing that PFO mutations in critical residues of the undecapeptide resulting in impaired binding to membranes (see below) did not affect binding specificity for cholesterol (608). The mechanism by which CDTXs disrupt membranes involves the transition from monomeric, water-soluble toxin to noncovalently bound oligomeric, insoluble arc- and ring-shaped toxin structures that insert into the membrane, forming large pores about 20 to 30 nm in diameter (8, 41, 42, 452, 609, 633) (Fig. 4). An interesting observation was that although cholesterol-complexed LLO binds to target membranes, the toxin does not oligomerize to form pores (300). All these findings suggest that cholesterol is involved not in the initial binding of soluble toxin monomers to the membrane but at a subsequent stage of membrane-toxin interaction that leads to polymerization and membrane intercalation. Indeed, early observations of CDTX activity, showing that at 4°C cytolysis does not occur although binding is unaffected (8, 633), did already indicate that membrane binding and disruption are independent events in CDTX function. This is consistent with experimental data showing that most of the anti-LLO monoclonal antibodies that neutralize cytolytic activity do not affect binding to target membranes (123, 464). The ability of noncytolytic LLO-cholesterol complexes to bind cell membranes is also consistent with such complexes being able to induce cytokine expression (474), IL-1 release (707), and the induction of lipid second messengers (618), host cell responses that require prior interaction of the toxin with membrane receptors. This observation raises the interesting possibility that LLO released extracellularly and rendered noncytolytic by the formation of complexes with free cholesterol present in body fluids may be targeted to the cell membranes and mediate signaling events upon binding. Membrane binding was not affected in LLO mutants with impaired cytolytic activity due to amino acid substitutions in the ECTGLAWEWWR undecapeptide, including Trp-to-Ala substitutions, which almost totally abolish toxin function (440). These data suggested that the motif itself is not primarily involved in the initial interaction of the toxin monomer with the target membrane. This contrasts with other experimental data showing that weakly hemolytic PFO mutants with Phe replacements in the three Trp residues of the Cys-containing region (Trp436, Trp438, or Trp439) had significantly lower erythrocyte membrane-binding activities (608). Circular dichroism spectral analyses of the membrane-associated form of these PFO mutant toxins suggested that both Trp438 and Trp439 are involved in a conformational change that occurs during oligomerization and pore formation (462). Thus, the impaired interaction of PFO mutant toxins with the membrane may reflect either that the motif is directly involved in the interaction with the membrane or that it is required for correct toxin folding during oligomerization and membrane insertion during pore formation. The latter interpretation is consistent with the observed inhibition of pneumolysin (PLY; the CDTX from Streptococcus pneumoniae) self-interaction by derivatization of the single Cys residue with the thiol-active agent dithio(bis)nitrobenzoic acid (213), suggesting that the domain carrying the undecapeptide is involved in toxin autoaggregation. The precise role of the conserved undecapeptide in CDTX function is still not understood and further research on this aspect is clearly needed. A picture of the possible mechanism underlying membrane disruption and cytolysis by CDTXs has begun to emerge in the last few years from crystallographic studies, functional modeling, and detailed structural analyses performed with SLO, PLY, and, in particular, PFO (214, 461, 493, 494, 566, 611). Given the high degree of sequence similarity between members of this toxin family it can be assumed with a reasonable degree of certainty that most of the predicted functional features are extrapolable to LLO. CDTXs are composed of four domains of which the first three would be involved in toxin oligomerization and membrane disruption and the fourth primarily in binding to the membrane. This is consistent with experimental data showing that the membrane-binding activity is associated with the C-terminal half of the toxin molecule (491) and that neutralizing antibodies that map to domain 4 inhibit binding to cellular membranes (130), whereas neutralizing epitopes that do not inhibit binding to membranes map to domain 1 (123). Membrane contact would facilitate the interaction of toxin molecules with cholesterol, which is buried in the membrane. Binding to cholesterol would then trigger a conformational change in the protein, increasing its hydrophobicity and membrane affinity, favoring a more intimate interaction between toxin monomers and the lipid layer. The resulting hydrophobic monomers would become partially embedded in the membrane, diffuse laterally, and collide with other monomers to form polymeric aggregates. This would explain why initial binding of CDTXs to the membrane is reversible and temperature independent whereas the subsequent steps are irreversible and are blocked at 4°C. At this low temperature, membrane dynamics are presumably restricted, resulting in kinetic energy requirements incompatible with membrane penetration, lateral diffusion, and oligomerization. A region that interacts with the membrane has recently been identified in domain 3. This region contains two transmembrane domains that undergo an
-helix to
-strand transition, creating a pair of hairpin structures that
penetrate the membrane. There is some debate over the extent of
membrane penetration; some studies claim that the pore is not a hole in
the bilayer but instead an unusual phospholipid phase structure
(214), whereas others favor the view that the the two
amphipathic
-hairpins completely span the bilayer, creating a true
pore (611).
Other roles in infection.
Evidence is accumulating
that LLO is a multifunctional virulence factor with many important
roles in the host-parasite interaction other than phagosomal membrane
disruption. Exogenous and endogenous exposure to LLO may induce a
number of host cell responses, such as cell proliferation and focus
formation in transfected fibroblasts (131), activation of
the Raf-Mek-mitogen-activated protein (MAP) kinase pathway in
epithelial cells (647, 647a, 685), mucus exocytosis induction in intestinal cells (97), modulation of
internalization via calcium signaling (680) and cytokine
expression in macrophages (355, 474), degranulation and
leukotriene formation in neutrophils (619), apotosis in
dendritic cells (252), phosphoinositide metabolism (618), lipid mediator generation (618),
NF-
B activation (330), and expression of cell adhesion
molecules in infected endothelial cells (153, 330, 351).
More details of these aspects of LLO can be found below.
Phospholipases
Pathogenic Listeria spp. produce three different enzymes with phospholipase C (PLC) activity that are involved in virulence. Two, PlcA and PlcB, are present in L. monocytogenes and L. ivanovii; the third, SmcL, is specific to L. ivanovii.
Characterization. Production of phospholipase activity by L. monocytogenes was first described in 1962 by Fuzi and Pillis (191), who reported opacity reactions in egg yolk agar that correlated in intensity with the hemolytic activity of the strains tested (see Fig. 12). This activity was detected in hemolytic fractions of L. monocytogenes culture supernatants and was at first wrongly identified as being due to the hemolysin itself (303, 304, 332). However, the application of careful fractionation procedures led to separation of the hemolytic and phospholipase activities (305, 620). The L. monocytogenes phospholipase was characterized as a secreted phosphatidylcholine (PC) cholinephosphohydrolase (PC-PLC;EC 3.1.4.3) similar to that responsible for the lecithinase activities of Bacillus cereus and C. perfringens (375). The purified PC-PLC/lecithinase is a zinc-dependent enzyme with an apparent molecular mass of 29 kDa, active over a wide pH range (5.5 to 8.0), and with a broad substrate spectrum (206, 223). On lipid micellar dispersions, this PLC rapidly hydrolyzes PC, phosphatidylethanolamine (PE), and phosphatidylserine (PS). It also, to a lesser extent, hydrolyzes sphingomyelin (SM) but does not or only very weakly hydrolyzes phosphatidylinositol (PI) (206, 223). However, PI is rapidly hydrolyzed in erythrocyte ghosts and in PI-PC-cholesterol liposomes, leading to the formation of inositol-l-phosphate (223). The purified enzyme is atoxic for mice; it is weakly hemolytic in guinea pig, horse, and human erythrocytes but not in sheep erythrocytes (206).
Lecithinase activity, like hemolytic activity, is an easily recognizable phenotypic marker closely associated with pathogenicity in the genus Listeria (528) (see Fig. 12). As for hly, transposon mutagenesis was used to identify the lecithinase gene. Two types of lecithinase-deficient, attenuated-virulence mutants were isolated. In the first type, the transposon was inserted into mpl (532), which encodes a zinc-metalloprotease (140), and the first gene of a 5.7-kb operon located immediately downstream from hly (434) (see Fig. 8). The second type of lecithinase-deficient mutant resulted from transposon insertion into the actA gene, located downstream from mpl in the operon and encoding the actin nucleator ActA (672) (see following section). Cloning of the DNA region targeted by the transposons in this mutant led to identification of the structural gene encoding the nonspecific listerial PLC, plcB. This gene occupies the third position in the 5.7-kb operon, called the lecithinase operon (see Fig. 8). The sequence of the plcB product, PlcB, is very similar to those of the PC-PLC precursor of B. cereus (38.7% identity over 253 amino acids) and the
-toxin precursor from C. perfringens (22.4% identity
over 223 amino acids) (672). Western immunoblotting of
PlcB in the L. monocytogenes culture supernatant detects two
antigenically related bands of 33 and 29 to 30 kDa (206, 470,
532). This indicates that PlcB, like the B. cereus
and C. perfringens PC-PLCs (309, 657), is secreted as an inactive proenzyme that is processed in the
extracellular medium by proteolytic cleavage. The secreted PlcB
proenzyme contains 264 amino acids, including a 26-residue N-terminal
propeptide of 2.9 kDa, which is cleaved to give the faster-migrating
mature, active enzyme. PlcB must be secreted in an inactive form to
prevent bacterial membrane damage due to degradation of its
phospholipids. The lecithinase-deficient mpl insertion
mutant described above produced only the larger PlcB band corresponding
to the inactive proenzyme (532), and complementation of
this mutant with mpl restored the lecithinase phenotype and
production of the active 29- to 30-kDa PlcB form (520).
Thus, Mpl, which is encoded by the first gene of the lecithinase operon
and, like PlcB, is also a zinc-dependent metalloenzyme, is involved in
processing of the PC-PLC/lecithinase into its mature and active form in
the L. monocytogenes culture supernatant.
The plcA gene, which encodes a PI-specific PLC, was
identified in L. monocytogenes earlier than plcB
by chromosome walking in the region upstream from hly
(82, 377, 431) (see Fig. 8). Its secreted product, PlcA,
is a 33-kDa polypeptide similar to the PI-PLCs from Bacillus
thuringiensis, B. cereus, and Staphylococcus aureus
(around 30% primary sequence identity) and eukaryotic PI-PLCs, such as
that produced by Trypanosoma brucei (431). The
purified PlcA enzyme is highly specific for PI, with a pH optimum
between 5.5 and 6.5 in Triton X-100-mixed micelles, suggesting that,
like LLO, it would be active in acidified phagocytic vesicles. No
hydrolyzing activity was observed with PC, PS, PE, PI 4-phosphate, or
PI 4,5-bisphosphate (222). The enzyme is able to hydrolyze
glycosyl PI (GPI)-anchored eukaryotic membrane proteins (222,
431), although much less efficiently than the orthologous enzyme
from B. thuringiensis (200).
The animal pathogen L. ivanovii produces an additional PLC
that is specific for SM. This SMase was purified from L. ivanovii culture supernatant after selective removal of ILO by
sequestration with cholesterol and shown to contribute to the hemolytic
activity of this species (669). In contrast to L. monocytogenes, which is weakly hemolytic, L. ivanovii
produces a strong bizonal lytic effect on sheep blood agar, with an
inner halo of complete hemolysis surrounded by a ring of incomplete
hemolysis similar to that for
-toxin-producing S. aureus
and B. cereus (546, 607, 669) (Fig. 5). The outer ring of incomplete
hemolysis is completely lysed if erythrocytes are exposed to a soluble
product released by the actinomycete Rhodococcus equi
(546, 626, 667, 668) (a cholesterol oxidase
[467]), giving rise to a characteristic shovel-shaped patch of synergistic hemolysis (Fig. 5). This CAMP-like hemolytic reaction is routinely used for the identification of L. ivanovii (605, 606, 668). The gene encoding the
L. ivanovii SMase, smcL, has recently been
identified and sequenced. Its predicted protein product, SmcL, is
highly similar (around 50% identity) to the known bacterial SMases
from S. aureus (
-toxin), B. cereus, and Leptospira interrogans (226). Gene disruption
and complementation studies have demonstrated that smcL is
the determinant responsible for the differential hemolytic properties
of L. ivanovii (225, 226). SmcL is functionally
very similar to the S. aureus
-toxin in terms of
membrane-damaging activity, as revealed by the similar ability of the
two molecules to elicit shovel-shaped CAMP-like reactions with R. equi and the lytic selectivity for SM-rich membranes (both enzymes
lyse sheep erythrocytes, in which SM accounts for 51% of total
membrane phospholipids, but not horse erythrocytes, in which the SM
content is only 13.5%) (Fig. 5). However, SmcL does not cause the
hot-cold lysis typical of
-toxin (unpublished data), indicating
that, despite their structural and functional similarities, there are
differences in the mechanisms underlying membrane damage between these
two homologous bacterial SMases.
|
Role in virulence.
The observation that
Hly
mutants of L. monocytogenes are able to
escape to the cytosol and grow within certain human epithelial cells
(Henle 407 and HeLa cells) suggested that listerial membrane-active products other than Hly may be involved in phagosome disruption (518). Such a role for a listerial phospholipase was first
shown for PlcB. Sequential insertional mutagenesis of the lecithinase operon of L. monocytogenes revealed that a plcB
mutant formed smaller plaques in infected J774 macrophage monolayers
and accumulated within double-membrane vacuoles (672).
This indicated that the PlcB phospholipase is required for efficient
lysis of the secondary phagosomes formed after listerial cell-to-cell
spread (Fig. 3H). Using in-frame deletion mutants, Hly was shown to be
dispensable for efficient lysis of the primary vacuole of Henle 407 cells as long as PlcB was produced, suggesting that PlcB also mediates escape from primary phagosomes in these cells (414).
Immunofluorescence studies with infected cells showed that PlcB
accumulates in L. monocytogenes-containing vacuoles,
colocalizing with the endosomal-lysosomal marker Lamp1
(415). In the absence of Hly, a
mpl mutation
caused defects in escape from primary phagosomes and cell-to-cell
spread similar to those in a
plcB mutant or a double
mpl
plcB mutant, consistent with Mpl's
being involved in the activation of pro-PlcB (414, 415).
Using the
mpl mutant, it was shown that intracellular activation of proPlcB is mediated not only by Mpl, but also via an
Mpl-independent pathway presumably mediated by a lysosomal cysteine
protease. PlcB activation by both pathways is sensitive to bafilomycin
A1, an inhibitor of the vacuolar proton pump ATPase, indicating that
this activation is, as for LLO, low-pH dependent and hence vacuolar
compartment specific (415). A recent study has shown that
intracellularly multiplying bacteria contain pools of preformed
pro-PlcB. These pools are suddenly secreted when pH decreases below 7.0 by an unknown mechanism involving the Mpl-mediated release of active
enzyme (416). The amount of the processed form of PlcB,
but not that of proPlcB, is significantly lower in cells infected with
an ActA
mutant, indicating that proPlcB proteolytic
activation occurs predominantly in secondary vacuoles
(415). This is consistent with PlcB's playing a key role
in cell-to-cell spread. PlcB has recently been shown to be required for
intercellular spread from macrophages to different types of mammalian
cells, including brain microvascular endothelial cells in vitro
(246), and for spread in murine brain tissue in vivo
(589). This provides experimental evidence for a major
role of PlcB-facilitated cell-to-cell spread in the in vivo
physiopathogenesis of Listeria infection.
plcA
plcB mutant was found to be severely impaired in virulence
(500-fold increase in LD50) and in its ability to escape
from the primary phagosome and to spread from cell to cell
(414). In a
hly background, PlcB was found
to be essential, but PlcA made only a minor contribution to escape from
primary vacuoles (414). Overall, these data indicated that
PlcA has only a minor individual role in virulence but acts synergistically with PlcB and Mpl (which themselves also have an
accessory role in virulence) to achieve, in conjunction with LLO,
optimal levels of escape from primary and secondary phagosomes.
Recent experimental evidence has indicated that the L. ivanovii SMase also plays an accessory role in pathogenesis
similar to that of PlcA and PlcB. A lack of SMase production in
L. ivanovii results in a moderate decrease in virulence
(fourfold increase in mouse LD50) and in intracellular
growth rate in bovine epithelial cells. Complementation with the
smcL gene facilitated intracellular survival of the
nonpathogenic species L. innocua in macrophages and
conferred on an L. monocytogenes mutant devoid of any known membrane-damaging virulence determinant (hly, plcA, and
mpl/plcB) as well as of the actA gene the ability
to proliferate within epithelial cells. Electron microscopy of these
cells showed that SmcL mediates the disruption of primary vacuoles and
the release of bacteria into the cytosol (225, 226).
There are several possible reasons to explain the presence in
pathogenic Listeria spp. of such a panoply of phospholipases with redundant functions in phagocytic vacuole destabilization. First,
the relative amounts of membrane phospholipids differ between cells
(5). Second, in a given cell type, membrane phospholipids are asymmetrically distributed in the lipid bilayer, with some mostly
present in the outer (SM) or inner (PE, PS, and PI) lipid leaflets and
others equally represented in the two lipid layers (PC)
(5). Third, membrane asymmetry is inverted during
phagocytosis, and in double-membrane phagosomes, there is presumably a
mixed situation, with bacteria bound by membranes with normal and
inverted lipid asymmetries. Last, transmembrane asymmetry is also
modified in a number of physiological and pathological conditions, such as during apoptosis or during cellular activation associated with increased levels of intracellular Ca2+ (39,
360), so it is likely that variations in phagosome membrane lipid composition occur during the host cell adaptive response to
infection. Consequently, (i) the contribution of each phospholipase to
phagosome disruption may differ according to cell type and (ii), in the
same cell type, the sequential or combined action of several
phospholipases with different substrate specificities and mechanisms of
action may be important for optimal bacterial escape from phagosomes
with variable membrane lipid bilayer topology and composition. In this
scenario, the PlcB phospholipase, which is able to degrade most
membrane phospholipids, is likely to be a key player in phagosome
disruption whatever the composition and distribution of lipids in the
membrane, leading to complete dissolution of the physical barrier that
separates bacteria from their cytoplasmic niche. The role of PlcA, in
contrast, is more difficult to understand if we consider that PlcB has
been reported to efficiently hydrolyze PI in biological membranes and
liposomes in vitro (see above). PI is moreover a minor lipid in
eukaryotic membranes. However, it is clear that PlcA potentiates the
membrane-damaging activity of PlcB, which may not depend exclusively on
enzymatic activity itself but on particular structural features of the
enzyme molecule affecting its membrane insertion and the accessibility to its specific substrate in natural conditions. The role in
pathogenesis played by the cleavage of GPI-anchored surface proteins by
PlcA is unknown. The production by L. ivanovii of an
additional phospholipase specific for SM is particularly intriguing if
we take into account that plcA and plcB are
sufficient for pathogenesis in L. monocytogenes. It is
possible that the hemolysin and the PlcA/PlcB phospholipase tandem of
L. ivanovii are less efficient in disrupting the phagocytic vacuole and that SmcL is required to facilitate disruption of the
SM-rich luminal leaflet of phagosomes. Another possibility, suggested
by the selective membrane-damaging activity of the enzyme for sheep
erythrocytes, is that SmcL is involved in the pathogenic tropism of
L. ivanovii for ruminants (226). An attractive
hypothesis is that SmcL has specifically evolved in L. ivanovii because some of the ruminant cell types or vacuolar
compartments important in pathogenesis have, like ruminant
erythrocytes, membranes containing large amounts of SM. Consistent with
a role for SmcL in host adaptation, expression of smcL was
shown to promote intracellular growth of the L. monocytogenes mutant devoid of any membrane-damaging factor in
bovine MDBK cells but not in canine MDCK cells, a similar
kidney-derived epithelial cell line from a mammalian species that is
not naturally susceptible to L. ivanovii (225).
Besides their mechanical function in escape from the phagosome,
listerial PLCs may also play an important role in pathogenesis by
subverting the host signaling pathways mediated by phospholipid hydrolysis products such as diacylglycerol (DAG), ceramide (CER), and
inositol phosphates. These lipid metabolites regulate key cell
processes, including cell growth and differentiation, apoptosis, and
the synthesis of cytokines and chemokines (346, 596), and hence their generation during Listeria infection may play an
important role in adapting host cell and tissue inflammatory responses
to the needs for intracellular life and host tissue colonization. Higher levels of lipid turnover with accumulation of DAG and CER have
been shown to occur 3 to 4 h after infection of murine J774 macrophages
by L. monocytogenes. An involvement of bacterial PLCs in
this DAG and CER generation activity was suggested by the fact that
cells infected with a
plcA
plcB mutant
showed a smaller increase in the levels of these mediators
(629). However, this double mutant still induced the
generation of DAG and CER (629), suggesting the
involvement of endogenous phospholipases in this host cell response.
Pathogenic Listeria spp. also induce phosphoinositide metabolism and DAG accumulation in infected human umbilical vein endothelial cells (HUVECs), and this response was shown, using mutant
bacteria and exogenously added purified proteins, to be dependent on
the synergistic interaction between LLO and PlcA (617).
Since prior treatment with LLO was a prerequisite for the observation
of such a response upon external stimulation of the cells, it was
suggested that LLO-induced pores provide PlcA with access to PI in the
inner membrane leaflet (617). Similar LLO-PlcA
cooperation-dependent induction of phosphoinositide hydrolysis and
concomitant cell activation has been observed in neutrophils (619). The listerial phospholipases PlcA and PlcB have
also been shown to be required for persistent NF-
B activation in
P388D1 macrophages (272) and for full induction of CER
generation associated with NF-
B activation and enhanced E-selectin
expression and neutrophil rolling and adhesion in HUVECs
(600). An association between PlcA and PlcB expression,
intracellular Ca2+ signaling, and listerial internalization
has been reported in J774 macrophages during early time points of
infection (680), but the underlying mechanism and true
relevance of these observations are unknown. Recently, using L. ivanovii isogenic mutants and heterologous expression in an
L. monocytogenes double plcA plcB mutant, it has
been shown that the SmcL SMase mediates CER generation in infected host
cells. This required the previous release of bacteria into cytosol and
was associated with increased apoptosis of infected MDBK cells
(González-Zorn et al., unpublished data).
ActA
A great deal of attention has been paid in recent years to the study of the actin-based intracellular motility of pathogenic Listeria spp. (27, 87, 105, 105a, 147, 366a, 401, 402, 515, 581, 630, 636). No classical motor proteins such as myosin have been found to be involved in bacterial intracellular motility, and the actin tail of moving Listeria organisms is functionally similar to the poorly understood actin polymerization process observed in lamellipodia, responsible for the locomotion of eukaryotic cells. Therefore, interest in listerial actin-based motility has transcended microbial pathogenicity, as it provides cell biologists with a relatively simple model for dissecting the molecular mechanisms underlying actin cytoskeleton assembly and function. This model has the enormous advantage that a single bacterial protein is sufficient to promote the actin recruitment and polymerization events responsible for intracellular movement. This protein is ActA (142, 339), the product of the actA gene (672).
The central role of ActA in listerial intracellular motility and
virulence was initially revealed by the unusual phenotype of an
isogenic actA mutant of L. monocytogenes in
infected tissue culture cells (339). After entry, these
bacteria were capable of escaping into the host cytoplasm, but could
not move intracellularly and accumulated as microcolonies in the
perinuclear area of the cell (Fig. 6).
The mutant was unable to recruit actin, as shown by staining with
fluorescein isothiocyanate-labeled phalloidin, a fungal toxin that
binds to F-actin and paralyzes the actin cytoskeleton. In addition, the
actA mutant was highly attenuated in the mouse infection
model (142, 339).
|
The actA gene encodes a secreted 639-amino-acid protein with
a 610-residue mature form that is attached to the bacterial cell wall
via its C-terminal region (Fig. 6). Several lines of experimental evidence have demonstrated the essential role of ActA in actin-based bacterial motility. Transfection experiments in epithelial cells showed
that ActA is targeted to the mitochondrial surface and that these
organelles recruit actin filaments in a way similar to
actA-expressing bacteria (513).
Microfilament-associated proteins such as
-actinin and fimbrin were
also recruited to the ActA-decorated mitochondria in transfected cells.
Thus, ActA, whether anchored to the bacterial or mitochondrial
membrane, can induce the formation of an actin cytoskeleton. Although
transfection experiments conclusively demonstrated that ActA alone was
essential for actin filament recruitment, they did not show how this
protein generates intracellular bacterial motility. This was achieved
by heterologous expression of the actA gene in L. innocua and S. pneumoniae, bacteria that are otherwise
incapable of actin-based motility. This demonstrated that ActA itself
mediates actin polymerization-driven bacterial movement (340,
631).
Mature ActA from L. monocytogenes can be arbitrarily divided into three distinct domains: (i) N-terminal domain (amino acids 1 to 234), which is rich in cationic residues; (ii) central region of proline-rich repeats (amino acids 235 to 394); and (iii) C-terminal domain (amino acids 395 to 610), with a highly hydrophobic stretch spanning residues 585 to 606 that anchors the protein to the bacterial surface (Fig. 6). Early structure-function studies with actA deletion constructs expressed in transfected cells (189, 513) or in a Listeria background and tested in Xenopus egg extracts (365, 409) permitted an initial attribution of specific functions to these domains of the ActA protein. The N-terminal region plays an essential role, as it contains all the information necessary to initiate F-actin assembly and bacterial movement (Fig. 6). A domain rich in positively charged residues (amino acids 129 to 153) in this region was identified as being strictly required for actin assembly. Amino acids 117 to 121 were shown to be critical for filament elongation, and deletion of amino acids 21 to 97 led to discontinuous actin tail formation, suggesting a role in maintenance of the dynamics of actin-based motility for this domain. Interestingly, a synthetic peptide corresponding to part of this domain (residues 33 to 74) was shown to interact with F-actin in vitro (365). In the central region, a domain of proline-rich repeats (amino acids 265 to 396) is required for binding of the focal contact proteins vasodilator-stimulated phosphoprotein (VASP) and Mena (see below). Listeria mutants lacking this region of ActA are still able to recruit actin to the bacterial surface and to move intracellularly, albeit at significantly lower speeds. This indicates that while the VASP and Mena proteins are not essential for the initiation of actin assembly on the bacterial surface, they are important for the efficiency of the process (366, 472, 632). There is significant structural and functional similarity between the C-terminal half of ActA (including the proline-rich repeat region) and zyxin (224), a eukaryotic protein associated with focal adhesions and actin stress fibers that may be considered a eukaryotic homolog of the listerial surface protein.
The mechanism by which ActA induces actin polymerization and bacterial
motility is now beginning to be understood. ActA is not detected in the
actin tail (341, 471), so clearly the listerial surface
protein is not necessary for stabilization of the actin meshwork left
behind by moving Listeria cells. In the proximal region of
this tail, F-actin filaments tend to be unidirectionally polarized,
with barbed ends oriented towards the bacterial cell surface,
indicating that actin nucleation is occurring at this point (655,
656). This suggested that ActA could act as an actin nucleator.
However, globular (G)-actin monomer-binding activity could not be
unequivocally demonstrated in ActA until very recently (96,
708), so the question arose whether ActA must be modified in
vivo in the mammalian cell to have adequate actin-binding function (e.g., by phosphorylation [70]), or whether another host
molecule interacts with ActA and cooperates with it to trigger actin
nucleation. Systematic searches for such a host factor among known
actin cytoskeleton-binding, cross-linking, and regulatory proteins
revealed that many, including
-actinin, tropomyosin, talin,
vinculin, fimbrin (plastin), filamin, villin, gelsolin, ezrin/radixin,
cofilin, profilin, coronin, Rac, CapZ, Arp3, and VASP, colocalize with
Listeria-associated actin filaments (86, 105, 117,
126, 139, 338, 361, 409, 514, 564, 650, 653).
Profilin and VASP were found exclusively at the point of actin assembly, in close association with the bacterial cell (88, 653), suggesting that they are actively involved in initiation of the Listeria-induced actin polymerization process. Profilin is a G-actin-binding protein, and its function in actin assembly is to bring ATP-actin to the barbed end of the filament in a complex that lowers the critical concentration for polymerization. Profilin interacts with polyproline (503), and poly-L-proline beads have been used to deplete profilin from cell extracts, resulting in the abolition of actin tail formation and bacterial motility (653). As profilin colocalizes with ActA at the site of actin polymerization and ActA has four polyproline motifs, it was thought that profilin was involved in actin nucleation by recruiting G-actin to the site of ActA expression on the bacterial surface. However, profilin was shown to associate only with bacteria in cell extracts or within infected cells, and not with ActA-expressing bacteria grown in culture medium, indicating that it requires an additional host factor to interact with ActA (653). VASP, in contrast, was shown to interact directly with ActA in vitro (88). VASP and its homolog Mena, which is also present between the bacterial surface and the growing actin tail (210), normally colocalize with actin filaments in focal contacts and in dynamic membrane processes (515, 538). VASP and Mena belong to the Drosophila Enabled (Ena)/VASP family of proteins, known to be involved in neural development. They are organized into three domains, an EVH1 (Ena-VASP homology 1) domain, a proline-rich central domain, and an EVH2 C-terminal domain. VASP has been shown to act as a ligand for profilin, vinculin, and zyxin (88, 210, 319, 537). Thus, by binding to ActA and profilin, VASP and Mena may establish a direct connection between intracellular Listeria cells and the cytoskeletal components of the host cell (210, 367). The EVH1 domain of the Ena/VASP-like proteins has been shown to bind directly to the proline-rich motif FPPPP, repeated three to four times in ActA, depending on the L. monocytogenes strain. This proline-rich ActA sequence is a novel polyproline motif that mimics the natural interaction between Ena/VASP proteins with their endogenous ligands in the focal adhesion proteins zyxin and vinculin. VASP has also been shown to interact with filamentous (F)-actin via its C-terminal EVH2 domain (85, 367, 472). These data strongly suggest that VASP may act as a bridge between polymerization-competent profilin/actin complexes and ActA and between ActA and the actin tail itself, thereby favoring assembly of the actin network that is used for bacterial propulsion across the cytosol. However, profilin is not essential for listerial actin-based motility (409), and the same is true for Ena/VASP-like proteins because, as indicated above, deletion of their ligand motif on ActA does not prevent (although it does impair) listerial actin-based motility.
A major clue to the mechanism by which ActA induces actin polymerization came from recent experiments showing that the N-terminal 264 amino acids of the protein interact with the Arp2/3 complex, resulting in a dramatic increase in actin nucelation activity (690, 691). First identified in Acanthamoeba, the Arp2/3 complex, which includes two actin-related proteins, Arp2 and Arp3, caps pointed ends, cross-links actin filaments, and has weak actin nucleation activity (403, 456). This complex was shown to initiate actin assembly on the surface of Listeria cells in a reconstituted cell-free system (689). The Arp2/3 complex is activated by proteins of the Wiskott-Aldrich syndrome protein (WASP)/Scar family, which connect the cytoskeleton with the signaling pathways involved in the dynamic remodeling of the actin framework (404, 562, 700, 704). It has been demonstrated that the p21-Arc subunit of the Arp2/3 complex binds to the C-terminal domain of Scar1 and the related WASP. Strikingly, the N-terminal 264 amino acids of ActA, the C-terminal p21-Arc-binding fragment of Scar1, and the C-terminal fragment of WASP are similar in sequence, and all increase the nucleation activity of the purified Arp2/3 complex (404). Indeed, C-terminal fragments of Scar1 that bind Arp2/3 completely block actin tail formation and Listeria motility in cell extracts and in cells overexpressing the corresponding Scar1 constructs, although Listeria organisms are able to initiate actin cloud formation. Motility is restored by adding purified Arp2/3 complex (419). Thus, Arp2/3 is clearly an essential host cell factor for actin-based motility, and the major role of ActA is probably to regulate the activity of this multiprotein complex. Recent studies have demonstrated that the N-terminal region of ActA plays a critical role in binding and stimulating the nucleation activity of the Arp2/3 complex (514a, 626a, 708). Two domains in this ActA region (residues 56 to 76 and 92 to 109), with sequence similarity to WASP homology 2 domains, bind to actin monomers (708) (Fig. 6). A third N-terminal domain (residues 115 to 150, in particular the positively charged motif 117-KKRRK-121), with sequence similarity to the Arp2/3 homology region of WASP family proteins, binds Arp2/3 and competes for this binding with the the WASP family proteins N-WASP and Scar1 (514a, 708) (Fig. 6). It thus appears that ActA uses a mechanism similar to that of the endogenous WASP family proteins to promote Arp2/3-dependent actin nucleation.
However, using pure proteins in solution with assembled F-actin in the presence of ATP (the hydrolysis of which releases free energy for actin assembly), Loisel et al. (389) demonstrated recently that Arp2/3 in combination with VASP or WASP is not sufficient for actin-based motility. Wild-type movement was only reconstituted upon addition of capping protein and actin depolymerizing factor (ADF or cofilin), previously shown to be required for the depolymerization of actin tails (564) and to increase the rate of propulsion of L. monocytogenes in highly diluted, ADF-limited cell extract (86). In accordance with these observations, a cofilin homology sequence similar to that in WASP family proteins has been identified in the N-terminal fragment of ActA and shown to be critical for stimulating actin nucleation with the Arp2/3 complex in vitro and for actin-based motility in cells (626a). These data indicate that adequate turnover and the maintenance of high levels of ATP-G-actin and profilin-actin are essential for elongation of the actin tail and motility (389).
Gelsolin, a protein that caps barbed ends and severs actin filaments
and which concentrates behind motile bacteria, was also shown to
increase the length of actin tails and to support higher intracellular
velocities. However, unlike ADF, gelsolin is not essential for
Listeria motility (361). Loisel et al. (389)
also confirmed that neither profilin nor VASP is essential for
actin-based motility, although their absence causes the rate of
bacterial movement to decrease 3- to 10-fold. Similarly, the actin
filament cross-linking protein
-actinin, which is uniformly
distributed over the actin tail (117), is not required for
movement, but in its absence there is an apparent lack of rigidity in
the actin tail and a greater tendency for bacteria to drift in solution (389). These findings emphasize that while relatively few
proteins are sufficient to build the core of the actin motor of
L. monocytogenes, many other host cell proteins, some with
as-yet-unknown functions, may be involved in the actin cytoskeletal
processes that lead to ActA-mediated listerial intracellular motility.
Among these proteins is LaXp180 (506), recently identified
using the yeast two-hybrid system aproach and shown to colocalize with
intracellular Listeria cells. LaXp180 is a putative binding
partner of the phosphoprotein stathmin, involved in the regulation of
microtubule dynamics. By immunofluorescence it was demonstrated that
stathmin also colocalizes with intracellular ActA-expressing L. monocytogenes (506). The role in infection of these
newly identified proteins that are recruited to the listerial cell
surface remains to be elucidated.
The motile force for intracellular bacterial movement is thought to be provided by the continuous deposition of actin monomers at the interface between the bacterial cell surface and the growing tail of tangled actin filaments immobilized in the cytosol that serves as a support structure for propulsion. To be effective, this motion system requires that actin deposition occur at only one pole of the bacterial cell, pushing it forward. This is indeed the case, as shown by the fact that the actin tail extends only from one end of the bacterium. This unidirectional actin polymerization appears to be related to the asymmetrical distribution of ActA on the bacterial cell. ActA accumulates at one of the bacterial poles and is totally absent from the other (the newly formed pole after bacterial division), which corresponds to the leading edge of movement opposite the place where actin tail formation occurs (341, 656). The basis of this polar ActA expression is not fully understood, but it clearly depends on the bacterial cell cycle and septum formation. Recent experiments with S. pneumoniae cells and polystyrene beads hemispherically decorated with purified ActA have provided convincing evidence that asymmetric distribution of ActA is indeed sufficient for directional actin assembly and movement (81, 631).
Because actin-based intracellular motility and intercellular spread are crucial for Listeria virulence, it is not surprising that the second pathogenic species of the genus, L. ivanovii, also possesses these features (320). The actA gene from L. ivanovii, i-actA, encodes a protein larger than ActA from L. monocytogenes. The similarity between the two proteins is also limited (34% identity) (230, 348). However, ActA and i-ActA have a similar overall structure (charged N-terminal region, central region of polyproline motifs, and C-terminal membrane anchor region), and the functional domains required for actin recruitment and VASP binding are also conserved (209). The two proteins do indeed have the same function, and i-actA restores actin tail formation in an actA mutant of L. monocytogenes (230). Remarkably, the ActA proteins are the only polypeptides encoded by the central virulence gene cluster that have the same function but a high degree of sequence divergence between L. monocytogenes and L. ivanovii (see below). Differences in the interactions of the two species with the eukaryote host may have resulted in different selection pressures for conservation of actA genes in L. monocytogenes and L. ivanovii. Alternatively, actin-based motility may only require a set of conserved functional modules correctly exposed in space, the core protein carrying these modules tolerating significant deviations and even the insertion of other species-specific functional motifs. L. seeligeri has also been shown to contain actA-homologous sequences (232). However, this species cannot induce actin polymerization in mammalian cells even if it is manipulated so that it can escape from the phagosomes of infected cells (321). The avirulence of this strain may have led to the mutational corruption of a protein with a function that is no longer required.
Two other intracellular bacteria, Shigella flexneri and Rickettsia spp., and vaccinia virus have similar mechanisms of intracellular movement and cell-to-cell spread by continuous polar actin assembly (38, 190, 231, 278, 389). Bacterially induced actin polymerization has also been studied in great detail in S. flexneri, and interestingly, the bacterial protein involved in this process, IcsA, has no sequence similarity to ActA. IcsA also has a polar distribution on the bacterial surface and induces polar actin deposition but uses a different mechanism of actin nucleation, involving activation of the Cdc42 effector WASP to form a ternary IcsA-WASP-Arp2/3 complex (105a, 164). Thus, it appears that ActA and IcsA have evolved convergently, with both subverting the signaling pathway that controls actin cytoskeletal dynamics but by different strategies, accounting for their structural differences.
Recently, evidence has been presented that ActA may also be involved in
the entry of L. monocytogenes into eukaryotic cells, probably by recognition of an HSPG receptor (12). Indeed,
putative heparan sulfate (HS)-binding motifs, typically consisting of
clusters of positively charged amino acids with interdispersed
hydrophobic residues, have been identified in the N-terminal region of
ActA. One such motif is very similar to the HS ligand of the
Plasmodium circumsporozoite protein, and treatment of target
cells with a synthetic peptide containing this malarial HS-binding
motif significantly inhibited listerial attachment. In addition, by
using CHO cells deficient in HS synthesis, it was shown that the
absence of ActA reduced the binding and uptake of L. monocytogenes only in cells containing this glycosaminoglycan. A
family of HSPGs, the syndecans, are bound to cell membranes via a
membrane-spanning core protein, colocalize with actin bundles at the
eukaryotic cell surface, and are thought to act as bridges between the
ECM and the cortical cytoskeleton (530, 710). It therefore
seems plausible that the interaction of ActA with an HSPG receptor
induces transmembrane signaling events leading to cytoskeletal
rearrangements and phagocytosis. Definitive confirmation that ActA
plays a major role in L. monocytogenes internalization by
host cells has recently been obtained by using an in-frame
actA mutant. Loss of ActA production in this mutant resulted in a decrease in invasiveness of up to a factor of 60 to 70 in
epithelial cells, which was fully recovered upon complementation with
the actA gene (Suárez et al., submitted for publication).
Although it is a major surface-exposed virulence factor, ActA is not presented by either MHC class I or class II molecules. This is only achieved if ActA is manipulated so that it is delivered in soluble form to the cytosolic MHC class I-processing compartment. However, the CD8+ CTLs so elicited against the listerial surface protein are not protective in vivo (120).
Internalins
Internalins are the protein products of a family of
virulence-associated genes found in pathogenic Listeria spp.
The first members of this family to be characterized, InlA and InlB,
encoded by the inlAB operon, were identified in L. monocytogenes by screening a bank of transposon-induced mutants
for impaired invasiveness in Caco-2 cell monolayers. InlA was shown to
function as an invasin, mediating bacterial internalization by these
normally nonphagocytic epithelial cells, and was therefore named
internalin (193). A large number of internalin homologs
have since been identified in both L. monocytogenes and
L. ivanovii (150, 168, 169, 527) (Fig.
7). An element common to all internalins
is a leucine-rich repeat (LRR) domain consisting of a tandem repeat
arrangement of an amino acid sequence with leucine residues in fixed
positions (317). The typical LRR unit of internalins
consists of 22 amino acids, with leucine or isoleucine residues at
positions 3, 6, 9, 11, 16, 19, and 22 (
L
L
L
L
N
I
I/L
L). This sequence forms a novel, right-handed helix
designated parallel
-helix, with a turn after every LRR unit, first
identified in the pectate lyase of Erwinia chrysanthemi
(277, 705). The LRR domain is thought to be involved in
specific protein-protein interactions. LRR domain proteins are numerous
among eukaryotes, in which they are involved in a variety of functions,
such as cell adhesion, as is the case for decorin, fibromodulin, and
the glycoprotein Ibg, or receptor-ligand interactions and signal
transduction pathways, as is the case for Trk, CD14, and the adenylate
cyclase of Saccharomyces cerevisiae (337). LRR
proteins are less frequent among prokaryotes and most are virulence
factors, like YopM of Yersinia pestis and Yersinia
pseudotuberculosis, IpaH of Shigella flexneri, and the filamentous hemagglutinin of Bordetella pertussis (55,
264, 407). The occurrence in pathogenic Listeria spp.
of a multigene family of LRR-containing proteins is unusual among
prokaryotes.
|
The internalins best characterized in terms of structure and function are InlA and InlB. InlA comprises 800 amino acids, which can be subdivided into two functional regions. The N-terminal half of InlA contains, in addition to a signal peptide (a feature common to all internalins), 15 LRR units (A repeats), whereas the C-terminal half contains three longer repeat sequences (B repeats) and a cell wall anchor comprising the sorting motif LPXTG followed by a hydrophobic membrane-spanning region of approximately 20 amino acids and a few positively charged amino acids (Fig. 7). This distal LPTXG motif, like similar motifs in other surface proteins covalently linked to the peptidoglycan in gram-positive bacteria, has been shown to be responsible for the attachment of InlA to the bacterial cell envelope in a process mediated by the enzyme sortase (105b, 135, 179, 371, 465, 466, 590). InlB comprises 630 amino acids with seven LRR units in the N-terminal part (149). The LPXTG motif and the hydrophobic tail are absent from the C-terminal part of InlB. Instead, InlB has a 232-amino-acid region consisting of tandemly arranged repeats about 80 amino acids long, each starting with the sequence GW. This domain, known as the cell surface anchor (Csa) domain, is responsible for the attachment of InlB to the bacterial surface (60). The Csa domain mediates a novel mechanism of protein-bacterial surface association in which InlB is partially buried in the cell wall, interacts with the cytoplasmic membrane, and uses lipoteichoic acid as a ligand (313). This type of association appears to be relatively weak, as significant amounts of InlB are found in the supernatant of L. monocytogenes cultures and InlB is released from the bacterial surface upon incubation in buffers with high Tris-HCl concentrations (60, 455). Another surface protein of L. monocytogenes, the putative autolysin/adhesin Ami, also associates with the bacterial cell wall via a Csa domain (313).
inlAB mutants are severely impaired in host cell invasion, and both InlA and InlB have been shown to be required for entry of L. monocytogenes into normally susceptible nonphagocytic cells in vitro (143, 149, 193, 196, 197, 242, 246, 385). The invasion processes mediated by InlA and InlB are apparently similar from a mechanistic point of view (of the zipper type [417, 642]), but the two proteins follow different signaling pathways to achieve entry (see below). InlA and InlB are sufficient to trigger internalization by appropriate host cells, as shown by their ability to confer invasiveness on normally noninvasive bacteria, such as L. innocua and Streptococcus faecalis, and to induce the internalization of latex beads coated with the purified proteins (62, 63, 373, 455).
Functional analysis of InlA has shown that the N-terminal region
encompassing the LRR domain and the interrepeat region is necessary and
sufficient for bacterial entry into permissive cells (373). Monoclonal antibodies directed against the LRR
domain block InlA-mediated entry, indicating that this structure is
essential in the entry process (435). The host cell
receptor for InlA is E-cadherin, a calcium-dependent intercellular
adhesion glycoprotein composed of five extracellular domains and a
cytoplasmic tail (205, 703). This receptor was identified
by affinity chromatography on a column with covalently coupled InlA
onto which a Caco-2 cell extract was loaded. Definitive evidence that
E-cadherin is a principal receptor for InlA was obtained by
transfection experiments using fibroblasts nonpermissive for invasion
by L. monocytogenes; expression of the gene of the chicken
homolog of E-cadherin, L-CAM, made these fibroblasts fully susceptible
to invasion by recombinant L. innocua expressing the
inlA gene but not to invasion by wild-type L. innocua or by a
inlA mutant of L. monocytogenes (435). E-cadherin accumulates at the
gap junctions between intestinal epithelial cells but is also present
over the entire basolateral face of these cells, consistent with
experimental data showing that L. monocytogenes
preferentially penetrates polarized intestinal Caco-2 cells via their
basolateral surface (196, 650). E-cadherin is also present
on the surface of hepatocytes, dendritic cells, brain microvascular
endothelial cells, and the epithelial cells lining the choroid plexus
and placental chorionic villi, all of which are potential targets
during Listeria infection. The cadherin specific to the
nervous system, N-cadherin, does not promote InlA-mediated entry
(435), which correlates with the observation that direct invasion of neurons by L. monocytogenes is not efficient
(151). However, certain sensory neurons seem to be
permissive for InlA-mediated internalization of L. monocytogenes because they may express E-cadherin (146). InlA presumably interacts, via its LRR region, with
the first extracellular domain of E-cadherin (372). This
interaction leads to bacterial adherence, but entry is mediated by the
intracytoplasmic domain of E-cadherin, which presumably leads to actin
cytoskeleton rearrangement via
- and
-catenins
(372a).
Upon contact with susceptible eukaryotic cells, InlB induces membrane
ruffling and tyrosine phosphorylation of several proteins, including
Gabl. Cbl, and Shc, implicated in membrane localization and activation
of the phosphatidylinositol 3-kinase (PI3K) p85/p110. This PI3K, known
to be involved in the control of the actin cytoskeleton, is stimulated
by InlB, resulting in activation of PLC-
1 and in increased levels of
phosphoinositide second messengers. Inhibition studies have shown that
p85/p110 PI3K does not participate in InlA-mediated uptake but is
indispensable for InlB-mediated phagocytosis (45a, 296, 297). Met, a
receptor tyrosine kinase which physiologically serves as ligand for
hepatocyte growth factor (HGF), has been recently identified as a
signaling receptor for InlB. Interaction with InlB tyrosine
phosphorylates the 145-kDa subunit of Met, a binding partner of PI3K.
Met-deficient cell lines are unable to mediate InlB-dependent entry,
suggesting a major role for this receptor in L. monocytogenes invasion (615a). Using affinity
chromatography, a second receptor for InlB has been identified in
gC1q-R, the cellular ligand of the globular part of the C1q complement
fraction. Pretreatment of target cells with soluble C1q or anti-gC1q-R
antibodies impaired InlB-mediated entry, and transfection of the gC1q-R
gene in nonpermissive cells promoted internalization of InlB-coated beads (61). However, gC1q-R lacks a transmembrane domain,
suggesting that it may function as a coreceptor rather than a signaling
receptor. As for InlA, the LRR region of InlB is sufficient for entry
into mammalian cells (62, 297). The X-ray crystal
structure of the InlB LRR domain has been recently determined: it
consists of an elongated structure resembling a bowed tube with an
extensive solvent-exposed surface area. Three regions were identified
as potential candidates for mediating protein-protein interaction: two
were in the concave face of the tube, consisting, respectively, of
clusters of hydrophobic and negatively charged amino acids; the other
was at the tip and contained two calcium ions, which may serve as
bridging molecules in the interaction with host cell receptors
(412a).
Evidence indicates that InlA and InlB have different cell specificities and may therefore play an important role in cell and host tropism. Dramsi et al. (149) analyzed in detail the effect of in-frame inlA and inlB deletions and corresponding gene complementations in an internalin double mutant on L. monocytogenes entry into various cell types. They showed that InlA but not InlB mediates entry into human Caco-2 intestinal cells and that InlB is necessary for invasion of murine TIB73 hepatocytes, whereas InlA is not. However, in the human hepatocyte cell line HepG-2, both InlA and InlB were required for internalization. More recently, the entry of L. monocytogenes into HUVECs and brain microvascular endothelial cells has been shown to be dependent on InlB but not on InlA (157, 246, 247, 498). The available data indicate that the role of InlA in invasion is restricted to E-cadherin-expressing cells, whereas InlB mediates entry into a wider range of cell types from various animal species, including certain epithelial and fibroblast cell lines, such as Vero, HEp-2, HeLa, CHO, L2, and S180 cells, as well as hepatocytes and endothelial cells (150, 246, 435, 455, 498). InlA has also been shown to contribute to at least 50% of serum-independent phagocytosis by macrophages (584), indicating that at least one macrophage receptor recognizes this listerial surface protein.
A major breakthrough in our understanding of InlA function has been the
recent discovery by Lecuit et al. (372) that a Pro residue
at position 16 in the first extracellular domain of E-cadherin is
critical for this interaction with InlA. The presence of a Pro residue
at position 16 of E-cadherin correlated with permissivity to invasion
of the host cell. Thus, cells expressing mouse and rat E-cadherin, both
of which have a Glu residue at this position, do not allow
InlA-dependent entry, whereas cells expressing human E-cadherin, L-CAM,
and guinea pig E-cadherin, with Pro16, are totally permissive to
invasion by InlA-expressing bacteria. A Pro16
Glu substitution in
human E-cadherin abolished interaction with InlA, whereas replacement
of the Glu16 residue with a Pro in mouse E-cadherin resulted in a gain
of function (372). These findings are important in that
they are the first to identify a possible molecular basis for host
specificity in a bacterial pathogen. They also make necessary
reevaluation of the available experimental information on the role of
InlA and InlB in virulence, in particular, data obtained from in vivo
studies in mice and rats, in which no clear pathophysiological role of
the inlAB determinant could be identified despite its proven
involvement in cell invasion in vitro. In such in vivo studies, for
example, the inlAB locus has been shown to affect only very
slightly the persistence of L. monocytogenes in mouse liver
and not to be essential for the invasion of hepatocytes in vivo
(14, 149, 150, 197, 242, 385). Similarly, no role for the
inlAB-encoded internalins was detected in intestinal
invasion and translocation in mouse and rat ligated ileal loop models
(119, 523) or in the development of murine cerebral
listeriosis (589). Despite the different cell specificities of InlA and InlB, a double
inlAB mutant was
10 times less invasive than a single inlA mutant in Caco-2
cells, indicating that the two internalins synergize to optimize
invasiveness. Such synergistic activity of InlA and InlB is also
evident in human hepatocytes, with
inlA,
inlB, and
inlAB mutations reducing the rate of entry by factors of
2 to 5, 10, and 100, respectively (149). However, the
heterologous expression of inlB did not confer on L. innocua the ability to invade murine hepatocytes
(149). It is therefore possible that the absence of InlA
recognition by E-cadherin in mouse tissues impairs the targetting of
L. monocytogenes to certain critical cell types in vivo,
thereby preventing the appropriate interaction of InlB with host cell
surface receptors.
The study of Lecuit et al. (372) raises important questions about the usefulness of the widely used mouse model, at least for those aspects in which InlA and InlB are potentially involved. Indeed, as described above, oral infection with L. monocytogenes leads to invasion of the intestinal epithelium in guinea pigs, which have the permissive type of E-cadherin, but not in mice and rats, which express a Listeria-nonpermissive isoform of the intercellular adhesion molecule.
The observation that InlB alone is not sufficient to mediate entry of
L. innocua into murine hepatocytes whereas complementation with the inlB gene restores full invasiveness to a
inlAB
mutant (149) clearly shows that other L. monocytogenes-specific products are involved in the interaction
with host cells. This is also indicated by the significant level of
residual invasiveness of inlAB mutants both in vitro
(143, 150, 157, 196, 197, 247, 253, 385, 435) and,
especially, in vivo (14, 149, 196, 242, 385, 589). It
seems very likely that other members of the Inl repertoire play a role
similar to that of InlA and InlB in the interaction with the eukaryotic
cell surface. In addition to the inlAB operon, six other
genes encoding putative surface-associated internalins (inlC2,
inlD, inlE, inlF, inlG, and inlH) have been identified
in L. monocytogenes. These internalin genes are distributed in three loci, two of which contain three internalin genes each and
correspond to a single internalin islet that has presumably evolved
differently in two isolates of L. monocytogenes serovar 1/2a
(150, 527) (see Fig. 7 and below). All these newly
identified internalins have signal peptides and LRR domains with
various numbers of repeat units in their N-terminal halves and, like
InlA, an LPXTG motif at their C-terminal ends, suggesting that they are
covalently bound to the bacterial cell wall. Deletion of the inlGHE gene cluster did not affect entry into a number of
mammalian cell lines, suggesting that these internalins, unlike InlA
and InlB, are not involved in invasion. However, counts of the
inlGHE mutant in the liver and spleen were 3 and 2.5 log10 units below those of the wild-type parental strain,
indicating that the missing internalins are somehow important for host
tissue colonization in vivo (527). Deletion of the
inlGHE-homologous inlC2DE gene cluster and of the
additional inlF gene identified in the other strain also had
no effect on entry into various cell types; however, here the absence
of these internalin loci did not affect the bacterial counts in mouse
organs (150). This, together with evidence indicating that
internalin gene homologs are also present in the nonpathogenic species
L. innocua (193), suggests that members of this
multigene family may have biological functions not exclusively related
to virulence.
All the above-mentioned internalins are large, cell wall-associated
proteins which, until very recently (see below), had been found
exclusively in L. monocytogenes. Their genes are
preferentially expressed extracellularly and, with the exception of the
inlAB operon, are independent of the listerial virulence
regulator PrfA (75, 527). A new group of LRR proteins has
recently been identified in both L. monocytogenes and
L. ivanovii. Structurally, they are very similar to the
large internalins but lack the C-terminal (B) repeat region, the LPXTG
motif, and the membrane anchor (Fig. 7). The internalin proteins of
this class are therefore generally smaller (around 30 kDa versus the 80 and 71 kDa of InlA and InlB, respectively) and are released in soluble
form into the culture supernatant. InlC (167), also called
IrpA (143), is the prototype of this group of small,
secreted internalins (167) and is the only secreted
internalin detected to date in L. monocytogenes. Unlike the
genes encoding the large, cell wall-associated internalins, all the
genes encoding these secreted internalins are PrfA dependent. Indeed,
this property was fundamental to the discovery of this subfamily of
internalins: InlC was identified in the culture supernatant as a major
30-kDa protein that was overproduced in L. monocytogenes after complementation with the prfA gene in multicopy, which
results in the artificial upregulation of PrfA-dependent proteins
(143, 167, 384). In L. ivanovii, five
PrfA-dependent secreted internalins (i-InlC, i-InlD, i-InlE, i-InlF,
and i-InlG) have been reported (168, 169, 350), three of
which (i-InlE, i-InlF, and i-InlG) are encoded in a large virulence
gene cluster containing additional genes encoding secreted internalins
(225; Dominguez-Bernal et al., unpublished; see also below).
Internalization and intracellular growth were found to be similar for
an L. monocytogenes inlC deletion mutant and the parental
wild-type strain when tested in several cell types in vitro. The
inlC mutation, however, resulted in significantly lower
virulence in mice (decrease in 1 log10 in the bacterial load in organs) after infection by the intravenous or oral route (143, 167). A significant loss of virulence in mice has
also been observed for the
i-inlE and
i-inlF mutants of L. ivanovii (169). Like most
PrfA-dependent genes (see below), inlC is preferentially expressed in the cytoplasm, especially at late stages of infection, when bacteria are in the process of active intercellular spread (75, 167). This suggests that InlC may be involved in the
dissemination of infection. However, cell-to-cell spread was found not
to be affected in an inlC mutant (143, 167,
246). No intracellular target has yet been identified for InlC,
and the role in virulence of the small, secreted internalins remains unknown.
Other Virulence Factors
The listerial proteins reviewed so far are true virulence factors because they primarily accomplish tasks specifically required for parasitization of the vertebrate host and have evolved exclusively in pathogenic Listeria species. In addition to these virulence factors, other listerial products have been identified that also contribute to survival within the host. Although some of them have a major influence on the outcome of the host-parasite interaction, their participation in pathogenesis is more indirect, as they are probably involved in general houskeeping functions also necessary for saprophytic life. This does not exclude the possibility that some of these bacterial products may have evolved specific characteristics and differ in certain aspects from their counterparts in nonpathogenic Listeria spp. as a result of adaption to the lifestyle of a facultative intracellular pathogen.
p60 (iap). On agar plates, L. monocytogenes gives rise spontaneously to colonies with an altered, stable, rough phenotype. These bacteria form long filamentous structures composed of chains of individual cells (354). Although these rough mutants produce wild-type levels of Hly, their virulence is attenuated (288). This lack of virulence correlates with impaired invasiveness, particularly in fibroblasts (354). This invasion deficit results from a defect in the production of a major 60-kDa extracellular protein, p60, that is found both in the culture supernatant (354) and associated with the cell wall (570) and which, when added exogenously, disaggregates the bacterial chains and restores invasiveness (354). The p60 protein is encoded by the iap (for invasion-associated protein) gene, which in L. monocytogenes encodes a 484-residue polypeptide containing a central repeat region of Thr-Asn units (343). The expression of iap is independent of PrfA (72, 75) and is controlled at the posttranscriptional level (342). p60-homologous proteins are synthesized by all Listeria spp., but in each species there are specific differences in amino acid sequence that can be used for identification purposes in PCR-based and immunological assays (74, 77). Only the L. monocytogenes protein is able to restore invasiveness to p60-defective rough mutants (73). There is some experimental evidence supporting a role of p60 in intestinal invasion and in vivo survival (279, 282). A recent study using recombinant p60 from L. monocytogenes has shown that the protein binds specifically to Caco-2 intestinal cells (499). The p60 protein has a murein hydrolase activity required for normal septum formation and essential for cell viability (702), which makes it difficult to determine the precise role of p60 in virulence because iap mutations are lethal. It has recently been shown that p60 is a major antigen in the protective response against L. monocytogenes (203, 204, 267).
Antioxidant factors.
Macrophages become listericidal
after their immunological activation by cytokines such as IFN-
or by
engagement of complement receptor 3 during C3b-facilitated opsonic
phagocytosis of L. monocytogenes (84, 115, 146,
181). Although it is unclear how macrophages kill intracellular
parasites such as L. monocytogenes, it is thought that the
generation during the oxidative burst of reactive oxygen intermediates
(ROI) and, via interaction of the superoxide anion with nitric oxide
(NO), reactive nitrogen intermediates (RNI) plays a key role. In vitro
experimental data indeed suggest that ROI and RNI contribute
significantly to the macrophage-mediated killing of L. monocytogenes (28, 37, 57, 294, 483, 484). Some
studies suggest a major involvement of ROI (294, 454,
484), whereas others indicate that both ROI and RNI are required
and may even act in synergy (3, 490). Iron is required for
the catalytic reactions leading to the generation of ROI and RNI, and
the correct intracellular homeostasis of this element has been reported
to be essential for adequate macrophage listericidal activity
(181). In vivo, inducible NO synthase (NOS) has been shown
to be expressed during listerial encephalitis by macrophages in
microabscesses at the sites of active bacterial multiplication (315). Inhibition of NO synthesis by a specific NOS
inhibitor was also found to exacerbate listerial infection in mice
(28, 56).
Metal ion uptake. Iron is a key element for all living cells, including prokaryotic cells, serving as cofactor for a large number of enzymes and essential proteins involved in electron transport processes. In animal host tissues, iron is not freely available because it is sequestered by ferric transferrin in serum and by ferritin and heme compounds within cells. Thus, bacterial pathogens have evolved specialized mechanisms to capture iron for growth in host tissues, and these mechanisms play an important role in virulence (502a). In L. monocytogenes, iron not only stimulates growth in synthetic medium but, if administered to infected mice in salt form, also increases bacterial proliferation rates in the liver and spleen and decreases the LD50 (639, 644). In humans, hypersideremia after massive blood transfusions has been identified as an important risk factor for listeriosis (594). Unlike many other bacteria, Listeria does not seem to secrete extracellular iron scavengers (siderophores).
Three different iron uptake systems have been described in L. monocytogenes. One involves the direct transport of ferric citrate to the bacterial cell by a citrate-inducible system (2). Another system involves an extracellular ferric iron reductase, which uses as a substrate naturally occurring iron-loaded catecholamines and siderophores (2, 21, 111, 112, 133). The third system may involve a bacterial cell surface-located transferrin-binding protein (263), although the existence of such a mechanism has been questioned (43). No experimental evidence is currently available on the contribution of these iron uptake systems to the pathogenesis of L. monocytogenes infection. In addition to its role as an essential nutrient, iron is also used by pathogenic bacteria as a signal molecule for the regulation of virulence gene expression. This sensory system is based on the marked differences in free iron concentrations between the environment and intestinal lumen (high) and host tissues (low) (387). Expression of hly has been shown to be induced in conditions of iron limitation, indicating that this metal ion plays a role in the regulation of virulence gene expression in L. monocytogenes (see below). Recently, a P-type ATPase involved in copper transport, CtpA, has been identified in L. monocytogenes. A ctpA knockout mutant was impaired in in vivo survival in tissues of infected mice but had normal intracellular growth in HeLa and J774 cell monolayers (182). Copper is a cofactor in a variety of redox enzymes, such as SOD, that are involved in the disposal by bacteria of toxic ROI generated during the oxidative burst of macrophages (2a). However, the marginal implication of SOD in L. monocytogenes virulence (see above) indicates that the involvement of CtpA in pathogenesis may be more indirect and related to the regulation of metal ion homeostasis.Stress response mediators. As indicated above, a small proportion of L. monocytogenes cells survive the stressful, hostile conditions of the phagocytic vacuole and reach the cytoplasm, where they proliferate, leading to the spread of the infection (128). Survival under stress involves an adaptive response mediated by a set of conserved proteins that are upregulated in vitro upon exposure to heat shock, low pH, oxidative agents, toxic chemical compounds, starvation, and, in general, any situation in which bacterial growth is arrested. These proteins may be chaperones that assist in the proper refolding or assembly of stress-damaged proteins or proteases that degrade damaged proteins, ensuring that essential physiological pathways function correctly in stressed cells (229).
Analysis of the stress response of L. monocytogenes, including that to heat and cold shock conditions, has revealed similarities to that of other prokaryotes (24, 261, 507, 508). In facultative intracellular pathogenic bacteria, for example, Salmonella, general stress proteins have been shown to be induced upon infection of macrophages (78, 95). In L. monocytogenes, in contrast, stress proteins appear not to be required for intracellular proliferation. This has been shown by Hanawa et al. (261), who found that none of the 32 listerial proteins selectively induced in J774 macrophages infected for 5 h were the same as any of the stress proteins produced when bacteria were subjected to various environemental stresses. It has also been shown that the alternative sigma factor
B is not
involved in L. monocytogenes virulence, although its
expression is activated in stress conditions and is required for
osmotolerance (26, 695). This may be explained by the
particular characteristics of L. monocytogenes intracellular
parasitism, which develops mainly in a nonaggressive environment, the
host cell cytoplasm, much less hostile than that of the phagolysosome
in which Salmonella bacteria proliferate. However,
adaptation to sublethal environmental stresses has been shown to
protect L. monocytogenes against the lethal action of toxic
compounds (392), indicating that in this bacterium there
is a "stress-hardening" adaptive response that may be important for
survival in hostile conditions. There is evidence that the adaptive
response of L. monocytogenes to acidic conditions, such as
those encountered in the stomach and in certain foods, may be relevant
to pathogenesis. Thus, development of acid tolerance results in
increased internalization by Caco-2 cells and higher survival rates in
lipopolysaccharide-activated macrophages (101a). Acid
adaptation also results in higher loads of L. monocytogenes bacteria in the intestine and the mesenteric lymph nodes after oral
infection in mice (576a). Stressful conditions are also
likely to be encountered during the transient residence in the
phagolysosome. Consistent with this, the stress response of L. monocytogenes involves the induction of hly, which
encodes the principal factor involved in escape from the phagocytic
vacuole (634, 635) (see below).
Recently, a group of virulence-associated stress mediators involved in
intravacuolar survival and subsequent escape to the cytoplasm have been
identified in L. monocytogenes. All these stress proteins
have highly conserved counterparts in B. subtilis, in which
they have stress tolerance-related functions and are involved in the
signaling cascade of sporulation. One of these stress proteins is ClpC,
an ATPase belonging to the heat shock protein-100 (HSP-100)/Clp family,
a class of highly conserved proteins involved in stress tolerance in
many prokaryotic and eukaryotic organisms (585, 638, 684).
The locus encoding this protein, clpC, was identified by
Rouquette et al. (569) by transposon mutagenesis and
selection for iron-dependent growth in synthetic medium. The original
intention was to identify genes involved in iron uptake
(567). However, the phenotype of the mutants isolated, the
mutations of which all mapped to the clpC locus, had nothing to do with iron metabolism but was instead related to a defect in
resistance to the nutritional stress caused by iron deprivation (569). clpC is upregulated in heat shock
conditions (42°C) and preferentially expressed during stationary
phase, a pattern consistent with this gene's being induced by general
stress conditions. The clpC mutants were found to be highly
susceptible to several stresses, including high temperature and high
osmolarity in addition to iron limitation. Their growth in bone marrow
macrophages and in vivo survival in the organs of infected mice were
also severely impaired, resulting in a substantial loss of virulence
(decrease of 3 log10 units in bacterial counts) (568,
569). Electron microscopy showed that clpC mutants
remained confined to the phagocytic vacuole, indicating either that
ClpC is involved in lysis of the phagosomal membrane (568)
or, more probably, that the loss of ClpC reduces bacterial fitness to
the extent that L. monocytogenes is no longer capable of
surviving within the phagosome or producing sufficient quantities of
active membrane-damaging virulence factors.
Expression of clpC was found to be almost abolished in an
L. monocytogenes prfA* mutant, in which the PrfA
regulon is constitutively overexpressed (see below), and in culture
conditions that trigger the activation of PrfA. This suggests that the
listerial virulence gene transcriptional activator protein negatively
controls ClpC. This repressor effect is apparently released as L. monocytogenes enters the stationary phase, indicating that the
stress-induced clpC-activating regulatory pathways prevail
over PrfA (548). No canonical PrfA boxes (the binding site
for PrfA in PrfA-regulated promoters) were identified in the promoter
region controlling the expression of clpC, suggesting that
expressional crosstalk between PrfA and ClpC is mediated by an
intermediary negative regulator activated by PrfA. Expressional
interplay between a true virulence determinant and a stress mediator
has been described in other facultative intracellular pathogens, such
as Salmonella spp. In these bacteria, the stress response
mediator RpoS induces the synthesis of the positive transcriptional
regulator SpvR, which controls spv plasmid virulence genes
important for intracellular survival and the development of systemic
infection (95, 251). In L. monocytogenes the
situation appears to be the converse, because activation of the central
virulence regulator PrfA triggers the downregulation of a general
stress response effector. As discussed above, these differences
probably stem from the differences in intracellular behavior of the two
bacteria. Thus, Salmonella organisms proliferate within a
vacuole, presumably a hostile environment in which stress proteins
and virulence factors involved in intraphagolysosomal survival
would be simultaneously required. In contrast, Listeria cells rapidly escape from the phagosome and actively multiply in the
more permissive environment of the host cell cytoplasm. The repression
of clpC by PrfA is entirely consistent with the observed
activation of the PrfA system when bacteria enter the cytoplasm (see
below) and with the nonrequirement for stress proteins for the
proliferation of L. monocytogenes in this cellular
compartment (see above). The coupling of PrfA activation with ClpC
downregulation in L. monocytogenes is a good example of the
clever strategies that facultative intracellular pathogens have evolved
to coordinate gene expression and to ensure that genes encoding factors
superfluous at a given step of the infectious cycle are appropriately
turned off. It has been recently shown that ClpC is required for
adhesion and invasion of L. monocytogenes, possibly by
modulating the expression of InlA, InlB, and ActA (460a).
ClpE is, like ClpC, a member of the Clp family of HSP-100 stress
proteins and is also required for prolonged survival at 42°C and
involved in the virulence of L. monocytogenes
(460). A double clpC clpE mutant was found to
be totally avirulent in the mouse model and was readily eliminated from
liver tissue. clpE expression was found to be upregulated in
a clpC mutant, suggesting that ClpC and ClpE have redundant
roles in stress tolerance and that the absence of one is compensated
for by upregulation of the other (460).
ClpP is a 22-kDa protein belonging to a family of stress proteases
highly conserved in prokaryotes and eukaryotes (198). Deletion of clpP showed that ClpP is required for growth
under stress conditions and for survival in macrophages in vitro and in
mouse tissues in vivo. In the clpP mutant, LLO production
was low under stress conditions, and virulence and hemolytic activity were totally restored by complementation with clpP. This
suggests that the ClpP protease is important for the observed
stress-induced upregulation of Hly (see above).
ClpC, ClpE, and ClpP are regulated by CtsR, the first gene of the
operon including clpC (459). L. monocytogenes CtsR is a homolog of the B. subtilis CtsR
repressor of stress response genes. A ctsR deletion mutant
of L. monocytogenes displayed enhanced survival under stress
conditions and normal virulence in mice, whereas a wild-type strain
engineered to overexpress ctsR had significantly attenuated
virulence, presumably due to a restricted stress response
(459). This is consistent with CtsR being a negative regulator of Clp proteins. It would be interesting to investigate whether repression of clpC is due to PrfA-mediated
activation of ctsR, resulting in silencing of the
CtsR-controlled stress response regulon.
Another locus that may be involved in stress tolerance and virulence in
L. monocytogenes has recently been identified. This locus,
lisRK, encodes a two-component system and was identified in
an acid-tolerant transposon-induced mutant of L. monocytogenes. Deletion of the gene encoding the histidine kinase
component of this LisRK system, lisK, resulted in greater
resistance to acid and high ethanol concentrations in the stationary
phase and, apparently, also in lower virulence (109). The
mechanism underlying the phenotype of the mutant is unclear.
GENETIC ORGANIZATION AND EVOLUTION OF VIRULENCE
DETERMINANTS
|
|
|---|
Although plasmids have been reported in Listeria spp. (370, 504, 521), all the listerial virulence determinants identified to date are chromosomally encoded. The virulence genes of Listeria spp., as in other pathogenic bacteria, are mostly organized into discrete genetic units known as pathogenicity islands (PAIs). PAIs are presumably acquired by bacteria via horizontal gene transfer, sometimes as part of mobile genetic elements, and consequently play a key role in the evolution of bacterial virulence (49, 249, 259, 260).
Central Virulencee Gene Cluster
Six of the virulence factors responsible for key steps of L. monocytogenes intracellular parasitism (prfA, plcA, hly,
mpl, actA, and plcB) are physically linked in a 9-kb
chromosomal island formerly known as the hly or
PrfA-dependent virulence gene cluster (88a, 350) and now
referred to as LIPI-1 (for Listeria pathogenicity island 1)
(670a). Figure 8 shows the
physical and transcriptional organization of this "intracellular
life" gene cassette. The hly monocistron, encoding LLO,
occupies the central position in this locus. Downstream from
hly and transcribed in the same orientation is the
lecithinase operon, comprising the mpl, actA, and
plcB genes (434, 672). These genes are
transcribed either as a single 5.7-kb mRNA under control of the
mpl promoter or as shorter transcripts, one specific for
mpl and the other starting at a promoter immediately upstream from actA and covering the actA and
plcB genes and three additional small open reading frames
(ORFs). The plcA-prfA operon is located upstream from
hly and is transcribed in the opposite orientation, either
as a bicistronic mRNA of 2.1 kb or in monocistronic transcripts of 1.2 and 0.8 to 0.9 kb, respectively (187, 188, 433).
|
Phylogenetic analyses based on the sequence of the 16S and 23S rRNA
have revealed that the genus Listeria comprises two
evolutionary branches, one relatively distant, corresponding to
L. grayi, and the other containing the remaining species.
The latter are in turn divided into two sublines of descent, one
comprising L. monocytogenes and the closely related
nonpathogenic species L. innocua, and the other containing
L. ivanovii and the nonpathogenic species L. seeligeri and L. welshimeri (98, 579)
(Fig. 9). L. ivanovii, which
has an intracellular life cycle similar to that of L. monocytogenes (320), carries a copy of LIPI-1
(232, 350, 670a) (Fig. 8). The genetic structures of
LIPI-1 from L. monocytogenes and L. ivanovii are
identical, but the corresponding DNA sequences exhibit only 73 to 78%
similarity (350, 670a), a degree of divergence compatible
with the genetic distance that separates the two species. One gene of
LIPI-1, actA, is specially dissimilar, reflecting a
divergent evolution in these two Listeria spp. This lack of similarity is also reflected at the amino acid level (34% identity) even though the corresponding ActA proteins have similar functions in
actin-based motility (230, 348). LIPI-1 is absent from the genomes of the nonpathogenic Listeria spp. with one
exception, L. seeligeri (88a, 350, 670a).
Although in this species LIPI-1 genes are present in a structurally
intact form (232, 257), they are not expressed correctly
due to the insertion of a divergently transcribed ORF (orfE)
between plcA and prfA, disrupting the positive autoregulatory loop crucial for adequate PrfA-dependent virulence gene
activation (321, 350) (Fig. 8) (see below). The L. seeligeri LIPI-1 contains additional ORFs (orfCD) and
duplications of the plcA and plcB genes
(350, 670a). In L. monocytogenes, L. ivanovii, and L. seeligeri, LIPI-1 is stably inserted at the same
chromosomal position (Fig. 8), has a DNA composition similar to that of
the core genome, lacks any obvious traces of mobility factors
(integrases, transposases, or insertion sequences [IS]), and its
insertion point is devoid of typical integration signals (direct
repeats or tRNA genes) (88a, 350, 670a). These data are
consistent with LIPI-1's having been acquired a long time ago by a
common listerial ancestor (350, 670a).
|
It is clear that LIPI-1 provides the host bacterium with access to a new niche, animal host tissues, which imposes selection pressures totally different from those encountered in the environment. The evolutionary history of the genus Listeria can thus be interpreted such that the acquisition of LIPI-1 by a clone of the primordial listerial ancestor was a crucial event that led to separation of the genus into two different phylogenetic branches, one corresponding to bacteria that remained saprophytic, resulting in the current species L. grayi, and the other to bacteria which, by virtue of the intracellular life cassette, became parasitic (350, 670a) (Fig. 9). It is reasonable to assume that the outcome of LIPI-1 in each of the two lines of descent of the parasitic branch also played a key role in the further diversification of the genus, as follows: (i) stabilization, in L. monocytogenes and L. ivanovii; (ii) early deletion (possibly when LIPI-1 still had its original mobility functions), in L. innocua and L. welshimeri; and (iii) functional inactivation, in L. seeligeri (Fig. 9). The persistence of the LIPI-1 genes in intact form in L. seeligeri is intriguing. Because these genes no longer confer any virulence properties on the host bacterium, one would expect them to be eliminated or corrupted during evolution. One explanation for their conservation is that the prfA-inactivating insertion was a relatively recent event in the evolution of L. seeligeri, the additional ORFs present in LIPI-1 of this species representing subsequent gene insertions that were tolerated by the afunctional PAI. Alternatively, the gene cluster present in L. seeligeri may represent an ancestral form of LIPI-1 which is still evolving and which, in its present form, provides an advantage in a specific natural habitat other than the mammalian host but which also requires phagosome escape functions for survival (e.g., in protists that take up bacteria from soil) (350).
Two virulence determinants present in LIPI-1, hly and plcB, have homologs which are exclusively present in low-G+C gram-positive bacteria closely related to Listeria, such as Bacillus and Clostridium. Homologs of two other LIPI-1 genes, plcA and the thermolysin-related zinc-metalloprotease gene mpl, are also common in this branch of gram-positive bacteria. This clearly suggests that the source of LIPI-1 genes is within the same phylogenetic division to which the genus Listeria belongs. PrfA, a member of the Crp/Fnr superfamily of transcription factors, is widespread in both gram-negative and gram-positive bacteria (221). ActA is the only LIPI-1-encoded protein for which no obvious structural homolog has been identified yet in prokaryotes. ActA carries functional domains present in eukaryotic proteins involved in the assembly of the actin cytoskeleton, such as vinculin, zyxin, and the WASP family of proteins (see above). It remains to be determined whether this reflects convergent evolution or indicates horizontal gene transfer between Listeria and eukaryotic cells. Whether LIPI-1 was acquired in a single recombinational event or whether it specifically evolved in the Listeria ancestor by a stepwise assembly process also remains unclear. Recent sequence analyses of the prs-ldh intergenic region of L. innocua and L. welshimeri have provided evidence that LIPI-1 was indeed once present in the chromosome of these species and that it became entirely excised, possibly in a single event, from the chromosome of these bacteria. Consistent with this, two small ORFs at the right end of LIPI-1 have been shown to exhibit significant similarity to bacteriophage or viral proteins, suggesting that the gene cluster (or at least part of it) was originally mobilizable by phage transduction (88a, 670a) (Fig. 8).
Internalin Islands
Internalins belong to a multigene family exclusive to
Listeria. Except for the inlC and inlF
genes of L. monocytogenes, the members of this family are
always found in clusters of two to several genes, all oriented in the
same direction (Fig. 10). The largest
of the known internalin islands is LIPI-2, a chromosomal locus specific
to L. ivanovii which contains 10 inl genes (see below). All inl genes have very similar sequences and encode
highly homologous proteins with variable numbers of LRR repeats and, in
the case of the large, surface-associated internalins, B and Csa (or
GW) repeats. These repetitive DNA sequences are naturally prone to
recombination, suggesting that the diversity of inl genes on
the listerial chromosome is the result of gene duplications and intra-
and intergenic rearrangements. There is evidence for such recombination
events in inl genes. Comparison of the same internalin locus
in two different L. monocytogenes strains revealed a
different gene organization. The two strains shared only two structurally identical inl genes (inlG and E),
and two internalin genes present in one isolate (inlC2 and
inlD) (150) presumably recombined to generate a
new internalin gene in the other (inlH) (527)
(Fig. 10). In L. ivanovii, a tandem fusion of two small, secreted internalin genes in LIPI-2 has led to the generation of a
hybrid gene encoding a larger, secreted internalin, i-inlG (Dominguez-Bernal et al., unpublished). (Fig. 7).
|
The origin of the inl genes is intriguing. LRR domains are widespread in eukaryotic proteins but rare in bacterial proteins, suggesting that they are a relatively recent acquisition by prokaryotes. inl genes are also found in the nonpathogenic species L. innocua (193; European Listeria Genome Consortium, unpublished). The presence of members of the internalin multigene family in Listeria spp. representing distinct phylogenetic branches of the genus suggests that inl genes were already present in the common listerial ancestor and, consequently, that evolutionarily they are probably as old as LIPI-1. However, inl loci have a different distribution, gene organization, and location in the different Listeria spp. The inlG(C2D/H)H internalin islet of L. monocytogenes is present between two housekeeping genes (ascB and dapE) that are contiguous in L. ivanovii and other Listeria spp. (350). Also, inlC of L. monocytogenes is inserted alone, whereas its counterpart in L. ivanovii, i-inlC, is adjacent to another inl gene (i-inlD), and both are inserted at a different place of the chromosome (168). Another example is the large internalin island LIPI-2 of L. ivanovii, which is inserted between two housekeeping genes that are otherwise contiguous in L. monocytogenes. The analysis of the insertion points of i-inlCD and LIPI-2 revealed that these two loci are associated with tRNA genes (168, 225). tRNA loci are commonly used as a target for integration of lysogenic phages and other mobile elements (539) and are frequently found at the insertion sites of PAIs in gram-negative bacteria (259, 260). Consequently, inl genes have probably been not only transmitted vertically during evolution but also exchanged by horizontal transfer within the genus Listeria, possibly carried by phages, which in these bacteria are abundant, have interspecies infectivity, and are capable of DNA transduction (287, 338).
The conservation of such a repertoire of inl homologs in the genome of pathogenic Listeria spp. must necessarily reflect that each of the individual internalins plays a role in the biology of these bacteria. It has been suggested that variability in the exposed face of internalin LRR motifs is important to create a variety of specific protein-protein interactions (412b). Consistent with this notion, a direct involvement in receptor-facilitated invasion of permissive host cells has been demonstrated for the LRR domains of InlA and InlB (62, 373) and a role in cell and host tropism has been demonstrated for these internalins (149, 372) (see above). In L. monocytogenes, genes encoding large, surface-anchored internalins are abundant (150, 193, 527), whereas there seem to be very few genes encoding small, secreted internalins (only one, inlC, has been identified to date) (167). In L. ivanovii, the reverse seems to be true, with many genes encoding small, secreted internalins and no genes encoding large, surface-associated internalins (168, 169, 226; Dominguez-Bernal et al., unpublished). It is therefore possible that the different gene complements in these two Listeria spp. and the structural diversity of the internalins they encode facilitate the recognition of a variety of host receptors and are thus at least partly responsible for their different pathogenic characteristics.
In line with this assumption is the recent discovery in L. ivanovii of LIPI-2, a large (22 kb) gene cluster composed of many small, secreted internalin genes and the smcL gene, encoding
the L. ivanovii SMase (225). LIPI-2 is
specifically present in L. ivanovii within the genus
Listeria and may play a significant role in the pathogenic
tropism of this species for ruminants. At least for the smcL
product, there are indications for such a role in host tropism, as it
selectively lyses sphingomyelin-rich membranes (e.g., those from sheep
erythrocytes) (226) and promotes intracellular
proliferation in bovine MDBK cells but not in canine MDCK cells
(225). Most of the LIPI-2 inl genes are PrfA
dependent, whereas smcL is absolutely independent of PrfA
and is transcribed in the opposite orientation (226). This
suggests that LIPI-2 was formed by the insertion of smcL
into a preexisting core of inl genes. The
smcL-encoded enzyme is homologous to the S. aureus
-toxin and the B. cereus SMase
(226), suggesting that the gene was acquired by L. ivanovii via horizontal transfer from either of these two low-G+C
gram-positive bacteria. LIPI-2 has a DNA composition significantly
different from that of the genome of L. ivanovii and is
unstable, leading to a 17-kb deletion that affects the right part of
the PAI. These characteristics, together with the expressional
subordination of most of its genes to the LIPI-1-encoded PrfA protein,
indicate that LIPI-2 is a more recent development that LIPI-1 in the
evolutionary history of the genus Listeria. Spontaneous
LIPI-2 deletion mutants are significantly impaired in virulence for
mice and sheep and exhibit altered organ tropism in the latter animals
(Dominguez-Bernal et al., unpublished).
REGULATION OF VIRULENCE GENE EXPRESSION
|
|
|---|
Evidence for coordinate regulation of virulence genes in L. monocytogenes was first provided by the analysis of spontaneous and transposon-induced mutants that were noninvasive and had a combined
deficiency in hemolysin (Hly) and lecithinase (PlcB) production
(325). Genetic analysis of these mutants revealed that
they were affected in the expression of the prfA gene,
located immediately downstream from plcA in LIPI-1 (Fig. 8)
(228, 379, 433). Trans-complementation
experiments in these mutants and in a heterologous host, B. subtilis, confirmed that the prfA gene product, a
27-kDa protein called PrfA (for positive regulatory factor A), was
required for the expression of hly and the other genes of
LIPI-1 (89, 188, 380, 433). Accordingly,
PrfA
mutants had a markedly higher LD50 in
mice (around 3 log units) and were unable to grow in host tissues
(89, 433, 613). Spontaneous prfA deletion
mutants arise frequently in L. monocytogenes strains kept in
laboratory conditions. Indeed, the current type strain of the species,
SLCC 53T (also called CIP 82110T and ATCC
15313), one of the original strains isolated by Murray et al. in 1926 (458) (see Introduction), is one such mutant (324, 380, 433).
PrfA, Master Regulator of Virulence
PrfA is the only regulator identified to date in Listeria spp. which is directly involved in the control of virulence gene expression. This protein is the main switch of a regulon including the majority of the known listerial virulence genes. Some of the members of the regulon, including LIPI-1 genes (with prfA itself; see below) and several genes of the subfamily of secreted internalins (e.g., inlC of L. monocytogenes and i-inlE of L. ivanovii), are tighly regulated by PrfA; others, such as the inlAB operon, are only partially regulated by PrfA (148, 167, 350, 385, 433, 544). However, the expression of some listerial virulence genes is totally independent of PrfA, as is the case for the SMase gene of L. ivanovii, smcL (226), and the inlGHE internalin locus of L. monocytogenes (527). There is evidence that PrfA also negatively regulates some L. monocytogenes genes, such as the stress response mediator gene clpC (548) and the motility-associated genes motA (439) and flaA (544). This suggests that PrfA has a more global regulatory role in L. monocytogenes.
The deduced amino acid sequence of the PrfA protein shows similarities
(20% overall identity) to that of the cyclic AMP (cAMP) receptor
protein of E. coli (Crp, also known as CAP), on the basis of
which the listerial regulator has been included in the Crp/Fnr family
of bacterial transcription factors (347, 364).
Crp/Fnr-like proteins have a role in virulence gene regulation in other
mammalian and plant pathogens (221, 347, 694). Although
most members of the Crp family of transcription factors are from
gram-negative bacteria, Crp/Fnr-related transcriptional regulators have
been also described in gram-positive bacteria (298). The
PrfA homologs encoded by the prfA genes of L. ivanovii and L. seeligeri have a primary structure 80%
identical to that of the L. monocytogenes virulence
regulator protein. In L. ivanovii, PrfA also plays a central
role in the coordinate regulation of virulence gene expression. In
L. seeligeri, virulence genes are not expressed, but
complementation with the plcA-prfA bicistron from L. monocytogenes activates transcription of the seeligerilysin O
(slo) gene, leading to bacterial escape from the phagosome
and intracellular bacterial multiplication (321). This
suggests that the avirulence of this Listeria species is at
least partly due to the insertion of the divergently transcribed orfE between the plcA and prfA genes
(Fig. 8), resulting in a PrfA
phenotype even if
prfA is intact and the corresponding PrfA protein is
potentially active (see preceding section). Whether the complemented L. seeligeri strain is virulent has not yet been tested.
Two structural features that are important for Crp function are also
present at the corresponding positions in PrfA (Fig. 11). One is a
helix-turn-helix (HTH) motif in the C-terminal region (amino acids 171 to 191) which, as in Crp, mediates the interaction of the protein with
specific DNA sequences in target promoters (612). These
target sequences, called PrfA-boxes, are 14-bp palindromes centered on
position
41.5 relative to the transcription start site in
PrfA-dependent promoters (187, 437, 672) (Fig.
11). DNA footprinting experiments have
shown that PrfA binds in vitro to the PrfA-box (136). The
second structural feature of Crp that is shared by PrfA is a series of
short antiparallel
-strands delimited by Gly residues, which form a
-roll structure involving most of the N-terminal half of the protein
(residues 19 to 99) (Fig. 11). In Crp, this structure forms the binding
site for the activating cofactor, cAMP (344). However,
cAMP is not detected and is not known to function as an intracellular
messenger in gram-positive bacteria (291). Accordingly,
most of the Crp residues involved in cAMP binding are not conserved in
PrfA, and the addition of exogenous cAMP to L. monocytogenes
does not lead to PrfA-mediated transcriptional activation
(673). The role of this putative
-roll structure in
PrfA is currently unknown. Two other functionally important regions of
Crp, the D
-helix (amino acids 138 to 155), involved in transmission
of the allosteric effect from the cAMP-binding N-terminal domain to the
DNA-binding C-terminal domain, and activation region 1 (residues 156 to
164), involved in Crp-RNA polymerase interaction with class II
promoters, are also particularly well conserved in PrfA (Fig. 11). PrfA
does have some features that are unique among the members of the
Crp-related family of transcriptional regulators, an additional HTH
motif in the N-terminal region of unknown function, and a 25-amino-acid
extension at its C terminus, which may form a leucine zipper (Fig. 11).
Mutant forms of PrfA lacking this putative leucine zipper motif were
found to be inactive (221).
|
Environmental Control of Virulence Gene Expression
Virulence factors are primarily required to colonize animal tissues and to overcome the host defense mechanisms brought into play during infection. Therefore, their synthesis outside the host may represent a burden compromising the ability of L. monocytogenes to survive in the natural environment and limiting its potential for transmission. Evidence is accumulating that L. monocytogenes has evolved signal-sensing and signal-transducing mechanisms to exploit the diverse physicochemical environments it may encounter to adapt virulence gene expression to the particular needs of saprophytic versus parasitic lifestyles. Temperature is one such environmental variables. Thus, PrfA-dependent transcription is weak below 30°C (environmental temperature) but becomes induced at 37°C (body temperature of warm-blooded animals) (124, 378, 544). The mechanism underlying this thermoregulation is unknown.
An increase in temperature is, however, not sufficient for maximal levels of transcriptional activation of prfA and the genes of the PrfA-dependent regulon to be reached in L. monocytogenes. Wild-type strains express PrfA-regulated genes very weakly in rich media (e.g., brain heart infusion [BHI]) at 37°C, but transcription of these genes is strongly activated if the bacteria are cultured in BHI supplemented with activated charcoal (543-545, 548). The presence of this absorbent does not affect bacterial growth, indicating that the effect on virulence gene transcription involves a signal-sensing regulatory mechanism rather than a nutritional stress response due to sequestration of essential nutrients (545). One possible explanation for the "charcoal effect" is that activated charcoal absorbs a substance that is present in BHI but not in infected tissues and that allows L. monocytogenes to detect that it is growing outside an adequate host compartment. One such substance might be iron, because low free iron availability defines the environment of host tissues (387) and there is evidence that hly expression is activated in conditions of iron limitation (101, 113, 207). The specific binding of PrfA to target sequences in the hly and actA promoters is also strongly inhibited under high-iron conditions (51). However, charcoal-treated BHI does not retain its virulence-activating properties after removal of the charcoal by filtration (Novella et al., unpublished data), suggesting that the mechanism responsible is not related to the sequestration of a component of the culture medium.
Although the mechanism of charcoal-mediated activation of virulence genes remains unknown, the charcoal effect clearly demonstrates that signals from the growth medium play a critical role in regulating the expression of the PrfA regulon. It also shows that L. monocytogenes needs to sense a suitable combination of environmental signals of physical and, possibly, chemical nature to upregulate the PrfA regulon. This may represent a fail-safe mechanism by which Listeria bacteria prevent the expression of virulence genes in situations in which they are not required even if the temperature rises above the critical activation threshold. An induction of prfA and PrfA-dependent virulence genes similar to that observed with charcoal takes place when L. monocytogenes bacteria growing in BHI are transferred to minimal essential medium (MEM) (54, 635). MEM does not support normal growth of L. monocytogenes (635), so it is unclear whether the virulence gene-activating effect is due to a sensory mechanism involving chemical signals, a stress response to starvation, or both.
L. monocytogenes has been shown to respond to various stresses, such as exposure to high temperature (42°C) and oxidants or entry into stationary phase, by increasing, via induction of prfA, the expression of a set of genes including hly (634, 635). The upstream mediator involved in the activation of prfA under stress conditions is unknown. Detailed transcriptional analysis of the genes of LIPI-1 at 42°C revealed selective induction of hly and plcA, transcription of the genes of the lecithinase operon (mpl, actA, and plcB) remaining at basal levels (Ripio et al., unpublished). This expression pattern is identical to that observed if bacteria are confined within a phagocytic vacuole (75). It is therefore possible that a transient stress response involving the transcriptional activation of some genes of the PrfA regulon (those requiring lysis of the phagocytic vacuole) takes place when Listeria cells are still confined within the acidified phagosome, during the early stages of cell infection after invasion (see below). A simple decrease in pH to between 5.0 and 6.0 (i.e., the pH of acidified phagosomes) reduces hly expression in vitro (30, 124), indicating that other growth-arresting stress conditions found within phagosomes may be required for the induction of hly and the synergistic phagosome-disrupting virulence determinant plcA. It is also possible that de novo synthesis of hly plays a lesser role in phagosome disruption than acid-induced release of preformed intracellular stocks of the toxin, as postulated for PlcB (416).
Although wild-type L. monocytogenes cells produce low to
undetectable levels of virulence factors in BHI, they are as virulent in mice as prfA* strains (545), which
overexpress virulence genes constitutively in vitro (see below). As
described above, wild-type strains can strongly induce PrfA-dependent
virulence genes, up to expression levels similar to those in
constitutive prfA* mutants, if grown with charcoal or in
MEM. These observations led to the suggestion that the high levels of
virulence gene induction reached by wild-type strains in vitro upon
exposure to charcoal or MEM may correspond to the levels of expression
required in vivo by L. monocytogenes to survive and
proliferate in infected host tissues (545). A recent study
has provided support to this hypothesis by showing that, despite their
differences in spontaneous levels of expression in vitro, there is no
significant difference in intracellular virulence gene activation
between a wild-type strain and a prfA* mutant
(75). Indeed, several PrfA-dependent virulence genes, such
as plcA (336), actA (54, 137,
451), and inlC (167), and PrfA synthesis
itself (540), have been shown to be highly induced
intracellularly. Investigation of L. monocytogenes intracellular gene expression using the green fluorescent protein as a
reporter revealed that the actA promoter is activated within 30 min to 1 h of infection. This activation depended upon the ability of L. monocytogenes to reach the host cytosol, as it
was not observed in a
hly mutant unable to escape from
the phagocytic vacuole (185). All these findings indicate
that the expression of prfA and PrfA-dependent genes is
upregulated if L. monocytogenes senses activatory signals
specific to the host cytosolic compartment.
Carbon Source Regulation of Virulence Genes
Fermentable carbohydrates cause a strong repression of virulence genes in L. monocytogenes (30, 67, 124, 444, 543). This downregulation occurs only if the carbohydrate is added in amounts sufficient to promote bacterial growth, suggesting that the underlying regulatory mechanism is related to catabolite repression (CR) (444). However, an L. monocytogenes mutant lacking CcpA, a central mediator of CR in gram-positive bacteria, did not show any alteration in carbon source regulation of virulence genes (29). Sugar-mediated repression affects not only the divergently transcribed virulence genes, plcA and hly, which have overlapping promoters, but also plcB, belonging to another transcriptional unit with no immediate physical link to plcA and hly and the promoter of which (PactA) is strictly dependent on PrfA (50, 67, 544) (Fig. 8). This suggests that repression is mediated by a trans-acting pleiotropic factor and somehow involves PrfA. Fermentable sugars such as cellobiose (336, 444, 541) and glucose (unpublished data) reduce PrfA-dependent virulence gene expression without affecting the levels of PrfA protein, indicating that this regulation is mediated by a repressor mechanism that either reduces the activity of the PrfA protein or blocks the binding of PrfA to its target promoters. The repressor mechanism appears to be situated hierarchically over the positive control pathway that activates the PrfA virulence regulon (see below), because fermentable carbohydrates annulate the induction of virulence genes by charcoal treatment (67, 543). Control of the synthesis of virulence-associated products by carbon source has also been reported for other pathogenic bacteria, such as E. coli (STb heat stable enterotoxin) (80), Actinobacillus actinomycetemcomitans (leukotoxin) (449), and Pseudomonas aeruginosa (PlcH hemolytic phospholipase) (575). Such a CR-like regulatory mechanism therefore seems to be widespread among pathogenic bacteria, suggesting that it may be important for the coordinate control of bacterial virulence. The actual relevance of this regulatory mechanism to the modulation of virulence expression in vivo is presently unknown.
An interesting observation is that in strain NCTC 7973 of L. monocytogenes, virulence gene expression was downregulated by the
-glucosides cellobiose and arbutin but not by common sugars, such as
glucose, mannose, or fructose (67, 500, 501). Although the
behavior of NCTC 7973 is anomalous and there is evidence that this
strain has accumulated several regulatory mutations (30, 67,
543), it suggests that sugars may use two independent mechanisms to bring about virulence gene repression in L. monocytogenes, one responding to any carbon source and another
specific for
-glucosides. This is also suggested by the recent
characterization of a mutant derived from the wild-type strain EGD, in
which a clear uncoupling between glucose- and
-glucoside-induced
PrfA-dependent virulence factor expression was observed
(67). In addition, PlcB production is inhibited in NCTC
7973 by cellobiose and arbutin, but not by salicin (67),
indicating that repression by
-glucosides is a complex phenomenon in
which various sugar-sensing mechanisms, with different substrate
specificities, may be involved. Recently, a 4-kb operon specific to
L. monocytogenes, bvrABC, encoding a putative
-glucoside-specific phosphoenolpyruvate-sugar phosphotransferase system similar to that of the bgl and arb operons
of E. coli and Erwinia chrysanthemi and the
bgl regulon of B. subtilis, has been reported to
be involved in virulence gene repression by cellobiose and salicin
(67). Transcription of the enzyme II permease gene, bvrB, was found to be induced by cellobiose and salicin but
not arbutin, and a bvrAB knockout mutation abolished the
repression exerted by cellobiose and salicin.
-Glucosides are unique
to the plant kingdom and are presumably abundant in decaying
vegetation. Thus, Bvr-mediated sensing of
-glucosides may allow
L. monocytogenes to recognize its presence in a soil
environment and consequently switch off virulence genes. It is
presently unknown how the the bvr locus triggers repression
of PrfA-dependent genes. Another locus possibly involved in regulation
of hly expression by cellobiose has also recently been
identified by transposon mutagenesis (292).
In contrast to glucose and other common fermentable carbohydrates, glucose-1-phosphate (G1P) (in general, any hexose phosphate) efficiently stimulates the growth of L. monocytogenes without causing virulence gene repression (543). Sugar phosphate utilization is not constitutive in L. monocytogenes; it is a strictly PrfA-dependent phenotype that is coexpressed with other virulence factors (e.g., Hly, ActA, and PlcB), suggesting a role in pathogenesis. Consistent with this, the capacity to grow on hexose phosphate as a sole carbon source is also present in the pathogenic species L. ivanovi (as a PrfA-dependent phenotype as well) but absent from nonpathogenic Listeria spp. As previously mentioned, PrfA-dependent genes become selectively activated in the cytoplasm of the host cell. In this compartment, the sugar phosphates G1P and glucose 6-phosphate are available as exogenous carbon sources for bacterial growth as a result of glycogen mentabolism. A role of hexose phosphate uptake in Listeria intracellular proliferation has recently been confirmed with the identification and mutagenesis of the PrfA-dependent gene hpt, encoding a sugar phosphate transporter (Chico-Calero et al., submitted for publication). The lack of repression of virulence genes observed with hexose phosphates indicates that uptake of these sugars bypasses the regulatory circuit responsible for triggering the CR response.
Regulatory Mechanism of PrfA
The clearest evidence that PrfA is a functional homolog of Crp was
provided by the characterization of prfA* mutants of
L. monocytogenes (544). These mutants were
first identified by Ripio et al. (545) when testing a
panel of L. monocytogenes strains for Hly and PlcB
production as markers of PrfA-dependent virulence gene expression.
Three different phenotypes were observed (Fig. 12). Phenotype 1 was exhibited by most
of the strains tested and was characterized by low to undetectable
levels of virulence factor production in BHI and the capacity to
substantially (by 10- to 25-fold) increase this production upon culture
medium supplementation with charcoal. Phenotype 2 was exhibited by only
a few strains and was characterized by spontaneously high levels of
virulence factor production and by unresponsiveness to charcoal, the
levels of virulence factor production already being maximal. The third phenotype was exhibited by only one strain (LO28) and was characterized by intermediate levels of spontaneous Hly and PlcB production on BHI
and responsiveness to charcoal. It was concluded that phenotype 1 corresponded to the wild type of L. monocytogenes and that
phenotypes 2 and 3 represented mutant or variant phenotypes
(545) (Fig. 12).
|
All phenotype 2 variants were strains that had been kept under
laboratory conditions for a long time. Some were well-known collection
strains widely used in research on listerial virulence, such as NCTC
7973 (Fig. 12) and the EGD Mackaness strain used in the laboratory of
one of us (P.B.), originally obtained from R. J. North at the
Trudeau Institute and thereafter renamed EGD-A to prevent confusion
with the wild-type EGD strain currently used as a reference strain by
the European Listeria Genome Consortium (545).
Phenotype 2 variants were probably introduced inadvertently into
research as model strains because their conspicuous hyperhemolytic phenotype facilitated the selection of Hly
mutants during
early studies on the role of hemolysin in Listeria virulence. Phenotype 2 variants arise spontaneously at a very low
frequency from wild-type strains during subculture in the laboratory
and may be induced by chemical mutagenesis (171, 326, 545). The prfA genes in all phenotype 2 strains
tested to date have a point mutation at codon 145, leading to an amino
acid substitution (Gly
Ser) in the PrfA protein. Complementation
studies have shown that this mutation is responsible for the
constitutive overexpression of virulence genes exhibited by phenotype 2 strains (544).
A PrfA protein with the Gly145Ser substitution renders the virulence regulon insensitive to a variety of environmental repressor signals, such as growth in rich medium, low temperature, and the presence of readily fermentable carbon sources (30, 543, 544). Gly-145 of PrfA aligns with Ala-144 of Crp (544, 673), a position at which any bulkier substitution (e.g., Ala144Thr) results in a mutant Crp* protein that no longer requires the cofactor cAMP to become transcriptionally active (344) (Fig. 11). Like Crp* mutant forms, the Gly145Ser PrfA protein has greater binding affinity for the specific target DNA sequence (673). The Gly145Ser mutation also increases the capacity of the PrfA-RNA polymerase complex to initiate transcription in vitro (Vega et al., unpublished data). From these observations, it has been suggested that PrfA functions via a cofactor-mediated allosteric transition mechanism similar to that of Crp and that the Gly145Ser mutation represents a cofactor-independent PrfA* form that is "frozen" in an active conformation (544, 673).
The regulatory model currently proposed for PrfA is depicted in Fig.
13. This model is based on two
premises. The first is that PrfA has two functional states, inactive
and active, and shifts from one to the other upon binding of a
low-molecular-weight cofactor, not yet identified, that
transduces the stimulatory environmental signals to the PrfA
transcriptional machinery (544, 673). Evidence for the
existence of this PrfA-activating cofactor has been obtained by the
fractionation of bacterial extracts on sucrose gradients, in which a
low-molecular-weight component seems to stimulate PrfA-target DNA
complex formation (221). The second premise is that PrfA
is always present, at least in minimal amounts, in the bacterial
cytoplasm, which is also the case. prfA is expressed in two
ways: (i) under the control of growth-regulated promoters in the
plcA-prfA intergenic region, generating a monocistronic transcript from which PrfA is synthesized in low but detectable amounts
even if bacteria are exposed to PrfA regulon-nonactivating conditions
(186, 187, 433, 540, 541, 673); and (ii) under the control
of a PrfA-dependent promoter in front of the plcA gene,
which generates a plcA-prfA bicistronic transcript
(83, 186, 187, 433) (Fig. 13; see also Fig. 8), creating
an autoregulatory loop which is critical for the adequate activation of
prfA (378, 433, 541, 543, 544, 673). In the
model proposed, the levels of virulence gene expression depend
primarily on the functional status of the PrfA protein. This in turn
controls the levels of prfA expression via positive
feedback, resulting in strong PrfA-dependent transcriptional activation
due to a rapid increase in PrfA in the active conformation, provided
that the intracellular levels of the environmentally regulated
stimulatory cofactor remain high (see the legend to Fig. 13). This
positive-control model is highly versatile and makes possible a
fine-tuned adaptive response to rapidly changing environmental
conditions, such as would be encountered by L. monocytogenes
during its transition from free to parasitic life and during passage
across the various physiological barriers, tissues, and compartments of
the infected host. The model provides a coherent explanation of all the
available experimental data on PrfA regulation and is also compatible
with the possible existence of additional regulatory elements
modulating the activity of PrfA or its interaction with the target DNA.
These elements include the so-called PrfA-activating factor (Paf), a
proteinaceous substance that may be a fraction of the RNA polymerase
and that facilitates the formation of the PrfA/RNA polymerase/target
DNA complex (50, 51, 136, 221), and the putative mediators
of carbon source regulation of virulence gene expression (see above).
|
Fine Regulation of Virulence Determinants
A second level of regulation is provided by the differential response of PrfA-dependent promoters according to the structure of their PrfA-boxes (Fig. 11). Binding affinity to PrfA-boxes is affected by the number of nucleotide mismatches they carry, becoming weaker as the sequence diverges from the perfect inverted repeat. Promoters with perfectly symmetrical palindromes (e.g., Phly and PplcA) are more sensitive and respond more efficiently to activation by PrfA than those with nucleotide mismatches (e.g., Pmpl, PactA/plcB, and PinlA) (Fig. 11), which require larger amounts of the regulatory protein for full activation (53, 72, 186, 187, 544, 613, 698). This complementary cis-acting regulatory mechanism appears to be critical for the temporal and spatial expression of virulence genes and consequently for the correct development of the intracellular infectious cycle of L. monocytogenes. Early work by Freitag et al. (186, 187) and Camilli et al. (83) using different combinations of mutants affected in the monocistronic or bicistronic expression of prfA demonstrated that transcription of prfA from its own promoters in the plcA-prfA intergenic region was sufficient to mediate escape from the phagocytic vacuole and subsequent intracellular proliferation, but not to mediate cell-to-cell spread, which required a functional autoregulatory loop. These observations suggested that small amounts of PrfA synthesized during the early stages of bacterium-cell interaction are sufficient to activate rapidly and fully the high-affinity promoters of the hly and plcA genes, the products of which are involved in phagosome disruption. In contrast, activation of the low-affinity actA promoter, which directs the expression of the actA and plcB determinants involved in cell-to-cell spread, requires higher levels of PrfA, as provided by induction of the bicistronic transcript in the cytoplasm. Consistent with this, a recent study comparing wild-type bacteria with hly and actA mutants (which are confined in the phagosome and host cell cytoplasm, respectively) has shown that the PrfA-dependent membrane-damaging determinants hly and plcA are predominantly expressed in the phagosomal compartment, whereas the actA and mpl genes are selectively induced in the cytoplasm of the infected host cell (75).
As described above, experimental evidence has recently been obtained
that PrfA synthesis is indeed activated in the host cell cytoplasm,
correlating with higher activity of the PrfA-dependent plcA
promoter that directs the expression of the plcA-prfA
bicistron (540). However, prfA* mutants, in
which PrfA-dependent expression is constitutively activated, are highly
cytotoxic for the host cell (unpublished data). This may result from
excess, unrestricted production of toxic virulence factors such as Hly
and the phospholipases. In other words, activation of the PrfA system
in the cytoplasm may be deleterious and incompatible with intracellular
parasitism unless modulated by additional regulatory mechanisms
(especially when L. monocytogenes reaches high intracellular
population densities after multiplication). prfA transcript
levels are surprisingly low within host cells (75),
suggesting that a high turnover of prfA mRNA may be a
mechanism that helps limit PrfA synthesis within host cells. The
reported short half-life of Hly (127a, 311, 677) and PlcB
(415) in the host cell cytoplasm may also play an
important role in posttranslationally regulating the intracellular levels of cytotoxic virulence factors. This is clearly suggested by the
observation that, whereas the levels of actA transcription in the host cell cytoplasm are only three times higher than those of
hly, the amounts of the corresponding proteins are very
different, with 70 times more ActA than Hly (451).
Additional negative control mechanisms acting at the transcriptional
level may also contribute to modulate prfA expression within
the host cell. For example, uptake of glucose from the host cell
cytoplasm may counteract, by carbon source-mediated repression (see
above), the stimulatory effect of the intracellular environment on PrfA
function. Freitag et al. (186, 187) reported that in the
absence of PrfA, transcription from the two promoters immediately
upstream from prfA is increased, and deletion of the
35
region of one of these two promoters (P2) (see Fig. 11 and 13), with a
structure reminiscent of a PrfA-box, leads to higher levels of
prfA transcription. This suggests that, by binding to the
plcA-prfA intergenic region, PrfA may short-circuit the
autoamplification loop, thereby downregulating its own expression. One
study did not confirm the existence of such a PrfA-mediated negative
autoregulatory mechanism (613), but a more recent study has shown that the transcription of a reporter gene under the control
of the P2prfA promoter is significantly repressed by PrfA (72).
Some L. monocytogenes virulence genes, although part of the PrfA regulon, can also be expressed independently of PrfA. This may provide additional expressional characteristics important for the specific role of individual virulence factors in pathogenesis. A clear example is the internalin operon, inlAB, which is expressed from three promoters, two of which are PrfA independent. The third promoter is PrfA dependent, but its PrfA-box has two substitutions, resulting in a low binding affinity and inefficient induction by the listerial virulence regulator (53, 136, 148, 613). This promoter configuration is obviously responsible for the peculiar expression characteristics of the inlAB operon, which, in contrast to other PrfA-regulated loci, is significantly expressed during extracellular growth in broth medium at 37°C and positively regulated by elevated iron concentrations (i.e., PrfA-downregulating conditions) but poorly expressed within the cell cytoplasm or in MEM (i.e., PrfA-activating conditions) (53, 75, 101, 167). This is consistent with the role of the products of this operon, the internalins InlA and InlB, as invasins mediating internalization from the extracellular space and with no known involvement in intracellular proliferation.
The hly gene, which is primarily PrfA dependent, has an alternative means of expression via a weak PrfA-independent promoter (141). This explains why L. monocytogenes prfA deletion mutants have weak hemolytic activity (141, 544) and low-level expression of hly is detectable in L. monocytogenes in conditions of PrfA downregulation, such as extracellular growth in broth culture. As discussed earlier (617, 619), low concentrations of exogenous Hly released by extracellular bacteria may contribute to pathogenesis by triggering cell responses, and the PrfA-independent promoter of the hly gene may be important in this respect.
HOST CELL RESPONSES TO INFECTION
|
|
|---|
Signal Transduction Pathways Associated with Epithelial Cell Invasion
Little is known about the signaling cascades triggered by Listeria organisms during entry into cells that are normally nonphagocytic. InlB has been shown to be an agonist of the lipid kinase p85/p110 (PI 3-kinase [PI3K], and the InlB-mediated uptake of L. monocytogenes by Vero cells has been shown to be associated with activation of the PI3K (296, 297). In addition to InlB, this activation also requires tyrosine phosphorylation in the host cell, because uptake is inhibited by genistein treatment, which blocks tyrosine-specific protein kinases. The mechanism by which the PI-3 kinase mediates uptake is unknown. However, the products of the reaction catalyzed by PI3K, phosphoinositide-3,4-bisphosphate and phosphoinositide-3,4,5-triphosphate, may directly interfere with the actin cytoskeleton by uncapping the barbed ends of actin filaments, thereby affecting cytoskeleton dynamics. In addition to phosphoinositide-phosphates, leukotrienes are also thought to be involved in L. monocytogenes signaling during the invasion of epithelial cells. Nordihydroguaretic acid, an inhibitor of 5-lipooxygenase activity, which generates leukotrienes from arachidonic acid, also inhibits the invasion by L. monocytogenes of Hep-2 cells (430). However, it is not yet known at which step of the putative signaling cascade leukotrienes are involved, or whether the leukotriene signal is initiated by InlA- or InlB-receptor interactions.
The treatment of various types of cell with the protein kinase C (PKC) inhibitor genistein (or staurosporine) inhibits invasion by L. monocytogenes, suggesting that PKC activity is critical for regulating the cytoskeletal changes necessary for listerial uptake (253, 353, 648, 675). It has recently been reported (648) that the invasion of HeLa cells by L. monocytogenes activates not only ERK-1 and ERK-2, but also two other MAP kinases (p38 and JNK) and the MAP kinase kinase MEK-1. ERK-2 is also phosphorylated upon invasion by LLO-negative mutants and is a downstream target of MEK-1. These data suggest that MEK-1/ERK-2 activation is one step in the signaling cascade leading to L. monocytogenes uptake by host epithelial cells. ERK-2 activation is not sensitive to wortmannin treatment, showing that it is not a downstream event of PI3K activation. Obviously, the PI3K and MEK-1/ERK-2 pathways may form two components of converging or independent signal transduction systems required for L. monocytogenes invasion. Another protein tyrosine kinase, pp60c-src, is clearly activated during the entry of L. monocytogenes into epithelial cells because specific inhibition of pp60c-src by herbimycin blocks inlAB-dependent entry (664). Treatment of host cells with TcdB toxins led to a dramatic breakdown of the normal actin cytoskeleton but did not abrogate L. monocytogenes invasion (or actin-based motility), indicating that the small GTP-binding proteins of the Rho and Ras subfamilies are not involved in the entry process (162).
The L. monocytogenes invasion process has been found to be sensitive to treatment with cytochalasin D for all cell types tested, demonstrating the importance of microfilaments for internalization (194, 359). Several recent reports have demonstrated that microtubules also play some role in invasion. The uptake of L. monocytogenes by mouse dendritic cells, mouse bone marrow-derived macrophages, and human brain endothelial cells is sensitive to nocodazole treatment, which disrupts microtubules (246, 253, 352).
Activation of NF-
B and Modulation of Host Gene
Expression in Macrophages
Differential gene expression in eukaryotic cells depends largely
on modification of the transactivating activity of inducible transcription factors. NF-
B, which is involved in regulation of the
expression of many immunologically important genes (622), is the prototype of a family of transcription factors. NF-
B
DNA-binding activity in response to L. monocytogenes
infection has been studied in the macrophage-like cell line
P388D1 (272, 273), endothelial cells
(330, 600), and epithelial cells (271). A
rapid invasion-independent increase of the NF-
B RelA/p50 DNA-binding
activity is observed in macrophages within 10 to 20 min of addition of
the bacteria. Studies with in-frame deletion mutants have shown that
NF-
B is induced with biphasic kinetics upon L. monocytogenes infection. The first transient induction of NF-
B
requires only the adhesion of L. monocytogenes to the
P388D1 cells. This induction also occurs upon infection
with mutants of L. monocytogenes that have lost one or more
of the known virulence genes and involves lipoteichoic acid, a cell
surface component of L. monocytogenes. A second, permanent
induction of NF-
B is detectable after release of the Listeria bacteria into the cytoplasm of the host cell. This
occurs exclusively with virulent L. monocytogenes strains
and requires the synthesis of the bacterial phospholipases PlcA and
PlcB in the infected host cell. It has been speculated that DAG and
CER, likely products of the two enzymes (see above), act as second messengers in the induction of persistent NF-
B activation.
The expression of cytokines upon treatment of mammalian cells with L. monocytogenes or L. monocytogenes-derived products has been analyzed in many different cell systems. Infections were performed with defined cell populations, such as mouse bone marrow-derived macrophages (BMM), macrophage-like cell lines, and complex mixtures of cells, like spleen cell preparations (356, 357). We will briefly review some of the studies and focus on those in which defined cell types were used as hosts for L. monocytogenes.
Early studies by E. A. Havell (274-276) showed that
murine fibroblasts infected with L. monocytogenes produce
significant amounts of alpha/beta interferon (IFN-
/
) and IL-6 and
that mouse alveolar macrophages respond to L. monocytogenes
infection by producing IL-6 and TNF-
. Differences in the induction
of cytokine expression were assessed for macrophages infected with live
and killed L. monocytogenes-infected macrophages. Live and
killed bacteria differ in IL-1, IL-6, and TNF-
production
(447, 709), whereas IL-12 is induced in vitro by live and
killed Listeria cells (94).
Using various well-defined mutants of L. monocytogenes, it
has been shown that viable bacteria rapidly induce IL-1
, IL-1
, IL-6, and TNF-
mRNAs in the mouse macrophage-like cell line
P388D1, whereas killed bacteria induce only IL-1
mRNA
(355). Hly
mutants are unable to induce
IL-1
, IL-6, and TNF-
but do induce IL-1
mRNA. The infection of
BMM with L. monocytogenes also induces the proinflammatory
cytokines (132). However, an Hly
L. monocytogenes mutant was found to induce the same types and amount
of cytokines as the wild-type strain, indicating that intracellular growth is not necessary for the transcriptional induction of these cytokines in BMM.
Not all the bacterial products mediating the induction of cytokines
upon L. monocytogenes infection have been identified. The
bacterial cell wall polymer lipoteichoic acid has been shown to induce
the expression of the proinflammatory cytokines IL-1
/
, IL-6, and
TNF-
in BMM (353) and in human monocytes
(40). Nishibori et al. (474) analyzed
cytokine gene expression upon treatment of spleen cells with purified
LLO. Total spleen cell preparations containing macrophages and NK cells
responded rapidly with increases in the synthesis of IL-1
, IL-6,
IL-10, IL-12, TNF-
, and IFN-
mRNAs. By depleting the cell
preparations of either NK cells or macrophages, the contribution and
interaction of the two cell types to cytokine production were assessed.
It was found that IL-1
, IL-12, and TNF-
were produced mainly by
macrophages, whereas IFN-
was clearly produced by NK cells
stimulated by macrophages, probably via TNF-
and IL-12.
The synthesis of cytokine receptor mRNAs in BMM infected with L. monocytogenes seems to be regulated inversely to the corresponding cytokines (132). TNF receptor type I and IFN-
receptor
are transcriptionally downregulated following the infection of BMM with
L. monocytogenes, whereas IL-1 receptor type II mRNA is
unaffected. In contrast, TNF receptor type II expression is
upregulated. The bacterial requirements for this downregulation of
cytokine receptor expression are unknown, but the downregulation is
specific for infection with L. monocytogenes and was not
found upon infection with nonpathogenic L. innocua strains.
Phagocytosis of L. monocytogenes is required for transcriptional induction of the heat shock protein 70 (hsp70) gene in macrophages. The synthesis of LLO seems to accentuate the hsp70 response (598). In contrast, expression of the gene encoding MHC class II antigen I-Ab is downregulated upon phagocytosis, at a time when the bacteria are still located mainly in the phagosomal compartment (595). Again, LLO seems to be important for this host response. Another important host cell gene that is downregulated on infection of macrophages by L. monocytogenes encodes antigen H-2K, a major component of the class I MHC molecule. Unlike downregulation of the gene encoding antigen I-Ab from the class II MHC, this event requires not only LLO, but also the expression of one or more genes of the listerial lecithinase operon (595).
Host Responses during Infection of Endothelial Cells
Host cell responses elicited in endothelial cells during infection
or by treatment with listerial exotoxins include lipid second-messenger
generation (617, 618), NF-
B activation (330, 600), stimulation of cytokines and chemokines, and induction of
cell adhesion molecule expression (152, 153, 247, 330, 351,
699). HUVECs were shown to respond to L. monocytogenes infection or treatment with purified LLO by
increasing phosphoinositide metabolism and inducing the production of
the vasoactive inflammatory mediators platelet-activating factor and
prostaglandin I2. This LLO-triggered second-messenger
induction is further stimulated by the phospholipase PlcA, which acts
in synergy with LLO (see above). It has been speculated that the
pore-forming activity of LLO might facilitate the uptake of PlcB by the
HUVECs, resulting in DAG and inositol phosphate generation
(617). Listerial phospholipase-mediated increased levels
of CER were also found in HUVECs during L. monocytogenes infection. This increase is followed by an elevation in the activity of
the transcription factor NF-
B (152, 600). The cell
adhesion molecules for which expression was analyzed in L. monocytogenes-infected HUVECs and BMECs include E-selectin,
P-selectin, VCAM-1, and ICAM-1 (152, 153, 351, 699).
P-selectin expression peaked 30 to 60 min after infection, whereas the
induction of E- selectin, ICAM-1, and VCAM-1 started 4 to 8 h
postinfection. Cell adhesion molecule expression is partly
dependent on LLO expression (351). E-selectin expression and the concomitant induced adhesion of polymorphonuclear leukocytes to HUVECs is particularly dependent on PlcA and PlcB synthesis by L. monocytogenes. These data show that the
phospholipases are important virulence factors in the L. monocytogenes-endothelial cell interaction, interfering with
signal transduction pathways mediated by lipid second messengers and
causing changes in gene expression (600). The expression
of IL-6 and IL-8 is also induced during the infection of HUVECs, but no
data are available concerning the bacterial requirements for the
induction of cytokine and chemokine expression upon infection
(247).
Apoptosis
L. monocytogenes has recently been shown to induce apoptosis in hepatocytes (560), Caco-2 epithelial cells (662), and dendritic cells, in which it was also demonstrated that LLO is the bacterial component triggering this event (252). L. monocytogenes-infected hepatocytes undergo apoptosis in vitro and in the infected mouse. It has been suggested that hepatocyte apoptosis, which is linked to neutrophil recruitment, eliminates infected cells rapidly from the tissue. Thus, apoptosis would inhibit the spread of L. monocytogenes to the neighboring cells and simultaneously would make the intracellular Listeria cells accessible to effector cells. In dendritic cells, which are important antigen-presenting cells, LLO-induced apoptosis should result in lower levels of antigen presentation to immune cells, thereby downregulating the immune response.
Figure 14 summarizes the information
available on the signaling cascades involved in the host cell response
to Listeria infection.
|
CONCLUDING REMARKS AND FUTURE PERSPECTIVES
|
|
|---|
In the last 15 years, listeriosis has undergone a transformation from an infectious disease of limited importance to one of the most topical food-borne infections and a source of major concern for health authorities and the food industry alike. In the same period of time, the work of various groups in Europe and the United States has made the causal agent of this disease, L. monocytogenes, one of the best-characterized intracellular parasites at both the molecular and cellular levels. One particular aspect of the interaction between L. monocytogenes and the eukaryotic host cell, the actin-based motility mediated by the surface protein ActA, is today a true paradigm of cell biology. Despite the major progress made towards understanding the mechanisms of virulence of Listeria spp., our current insight into the process of pathogenesis is still very partial and fragmentary. We have unraveled fundamental details of the intracellular parasitism practiced by these bacteria and the molecular determinants responsible for key stages in their life cycle within the cells of the host. However, we know very little about the mechanisms used by pathogenic Listeria spp. to penetrate the organism, to cross the host's physiological barriers, and to interact with the target cells in which they proliferate, causing disease. The same holds true for the strategies used by Listeria spp. to resist and counteract the defense mechanisms of the host for long enough after intestinal translocation to produce invasive disease in the target organs. Only about 15 listerial genetic determinants have been found to date to be associated with pathogenesis, including true virulence genes and housekeeping genes required for survival in the host. This number is very small compared with the nearly 3,000 genes predicted for the 2.9-Mbp genome of L. monocytogenes (438, 679; European Listeria Genome Consortium, unpublished). It is therefore clear that there must be other, as yet unknown loci in the Listeria chromosome that are required for the development of infection.
To date, studies of the molecular determinants of Listeria virulence were mainly based on the analysis of mutants affected in conspicuous phenotypes displayed under in vitro conditions. The clearest illustration of this is the central virulence gene cluster, which was discovered by genetic analysis of transposon mutants affected in hemolytic and lecithinase activities, two phenotypes easily detectable on agar plates. With hindsight, it was a clear stroke of luck that the mutated hly and plcB genes were located in the same chromosomal locus together with other essential virulence genes such as prfA and actA. In other cases, the in vitro phenotype used to identify potential virulence genes during mutagenesis was a priori more directly related to functions relevant to Listeria pathogenesis, such as loss of invasiveness in eukaryotic cells. The extensively studied inlAB operon was identified in this way. However, although the inlAB products have been clearly shown to have an invasin function in cell monolayers in vitro, no clear role for this locus in pathogenesis has been demonstrated yet in infection models in vivo. This illustrates the limitations inherent to the approaches used to date in the molecular analysis of Listeria virulence, particularly when combined with in vitro models of infection that do not necessarily reproduce reliably the natural conditions encountered by L. monocytogenes in the tissues of the host.
This scenario is likely to change radically in the immediate future with the availability of the complete sequence of the genome of L. monocytogenes. This will make it possible to shift from an investigation largely based on reductionist analysis of the role in virulence of individual microbial products in an isolated form, to a holistic approach to Listeria pathogenesis. In conjunction with appropriate in vivo expression technologies, which are beginning to be applied to Listeria spp. with promising results (158, 192), the genomic approach will make it possible to identify systematically the entire set of genes required by L. monocytogenes for its survival and proliferation in the various tissues and compartments of the host. The comparative genomic investigation of pathogenic versus nonpathogenic Listeria species, and of environmental versus epidemic strains of L. monocytogenes, will lead to the discovery of new pathogenicity determinants, providing us at the same time with insight into the evolution of virulence in this bacterial genus. Progress in human genomics will also make it possible to define the host components and processes engaged during Listeria infection, as shown by a recent study in which cellular responses to L. monocytogenes were monitored using oligonucleotide microarrays (97a). Characterization of the expression profiles of both the host cell and the pathogen at various stages of the infection process will undoubtedly represent a quantum leap in our understanding of host-microparasite interaction.
The shift towards genomic technology as the primary approach for analyzing the molecular determinants of Listeria pathogenesis will not make reductionist strategies of investigation less important. Indeed, functional analysis of the genome of L. monocytogenes will bring to light a growing number of potential virulence factors, and the intimate mechanisms of interaction of these factors with the molecules of the host will still require investigation by the classical techniques of molecular and cell biology. The importance of this reductionist approach is illustrated by the recent study by Lecuit et al. (372), suggesting that the host tropism of L. monocytogenes may depend on a single residue of E-cadherin, the cell receptor for InlA. It has required the continuous efforts of various research groups over several years to make the first steps towards elucidating the molecular mechanisms of actin-based motility, which involves only one Listeria protein. This indicates the enormity of the task ahead of us if we are to understand in precise molecular terms the way in which Listeria interacts with its various vertebrate hosts to produce infection.
Fundamental research on Listeria molecular biology and pathogenesis can be exploited in the rational design of novel biotechnological tools to fight disase. The characterization of the listerial intracellular life cycle and of the role that hemolysin plays in it, together with the knowledge accumulated concerning the immunobiology of experimental listeriosis in the mouse, has made L. monocytogenes a most promising candidate as antigen delivery system for the development of novel recombinant oral live vaccines (254). By its phagosome-disrupting activity, Hly permits the antigens secreted by the producer bacteria to be released into the cytoplasm and thus to be presented by MHC class I molecules, inducing a cytotoxic response useful for combating intracellular parasite infections or tumoral disease (327). Indeed, successful vaccination of mice using L. monocytogenes-based recombinant live vaccines has been reported for several viral and tumor model systems (183, 227, 293, 307, 418, 492, 496, 497, 614, 688). Recently, a plasmid containing model antigen genes under the control of a eukaryotic promoter and an endolysin gene from a Listeria phage under the control of the strictly PrfA-dependent promoter of the actA gene (which is selectively activated in the host cell cytoplasm) were introduced into an L. monocytogenes strain attenuated by a deletion in the lecithinase operon. Bacteria lysed upon entry into the cytosol and generated an MHC class I-restricted immune response against the model antigens expressed from the plasmid (137). These and similar experiments (104) show that L. monocytogenes is also a good potential candidate for a vector to transfer DNA into eukaryotic cells, of potential value for DNA vaccines or for gene therapy (637). Increasing our knowledge of the molecular and cellular mechanisms of listerial pathogenesis by genomic research will make it possible to improve these Listeria-based biotechnological tools by endowing them with optimal biosafety and target cell specificity characteristics. Progress in Listeria genomics and comprehensive understanding of the complete physiological pathways of L. monocytogenes may also enable us to identify targets for the development of novel antimicrobial agents to treat listeriosis and other bacterial infections, or of inhibitory substances for selectively controlling the survival and growth of L. monocytogenes in foods.
We are still very far from completely understanding at the molecular level how pathogenic Listeria spp. interact with the host to cause infection. Many questions remain unanswered. For example, what is the true role of the large internalin multigene family in Listeria biology and pathogenesis? Why does L. monocytogenes preferentially infect the CNS and the placenta? Why is it that only certain serovars of L. monocytogenes are associated with listeriosis and certain clones of serovar 4b are associated with epidemic episodes of invasive disease? Why do pregnant women develop neither meningoencephalitis nor septicemic disease while suffering miscarriage due to Listeria infection? What mechanisms are involved in the direct invasion of neighboring cells during cell-to-cell spread? What pathways are involved in transduction of the signals involved in the induction of phagocytosis during cell invasion? In the coming years of the new era of postgenomic Listeria research, we will certainly witness spectacular progress in understanding of the complex molecular mechanisms used by these versatile bacteria to survive as parasites in the tissues and cells of the vertebrate host, and we will no doubt find answers to these and many other questions.
ACKNOWLEDGMENTS
|
|
|---|
This work was supported by the BIOMED 2 program of the European Commission (grant BMH4-CT96-0659). J.-A.V.-B. thanks the Complutense University of Madrid for the sabbatical leave awarded, which has been critical for the completion of this review.
FOOTNOTES
* Corresponding author. Mailing address: Grupo de Patogénesis Molecular Bacteriana, Unidad de Microbiología e Inmunología, Departamento de Patología Animal I, Facultad de Veterinaria, Universidad Complutense, 28040 Madrid, Spain. Phone: 34-91.394.37.04. Fax: 34-91-394.39.08. E-mail: vazquez{at}eucmax.sim.ucm.es.
REFERENCES
|
|
|---|
| 1. | Abram, M., and M. Doric. 1997. Primary Listeria monocytogenes infection in gestating mice. Folia Microbiol. 42:65-71. |
| 2. |
Adams, T. J.,
S. Vartivarian, and R. E. Cowart.
1990.
Iron acquisition systems of Listeria monocytogenes.
Infect. Immun.
58:2715-2718 |
| 2a. | Agranof, D. D., and S. Krishna. 1998. Metal ion homeostasis and intracellular parasitism. Mol. Microbiol. 28:403-412[CrossRef][Medline]. |
| 3. | Akaki, T., K. Sato, T. Shimizu, C. Sano, H. Kajitani, S. Dekio, and H. Tomioka. 1997. Effector molecules in expression of the antimicrobial activity of macrophages against Mycobacterium avium complex: roles of reactive nitrogen intermediates, reactive oxygen intermediates, and free fatty acids. J. Leukocyte Biol. 62:795-804[Abstract]. |
| 4. | Alexander, A. V., R. L. Walker, B. J. Johnson, B. R. Charlton, and L. W. Woods. 1992. Bovine abortions attributable to Listeria ivanovii: four cases (1988-1990). J. Am. Vet. Med. Assoc. 200:711-714[Medline]. |
| 5. | Allan, D. 1996. Mapping the lipid distribution in the membranes of BHK cells. Mol. Membr. Biol. 13:81-84[Medline]. |
| 6. | Allcock, J. 1992. Cutaneous listeriosis. Vet. Rec. 130:18-19[Medline]. |
| 7. | Alouf, J. E. 1999. Introduction to the family of the structurally related cholesterol-binding cytolysins ("sulfhydryl-activated" toxins), p. 443-456. In J. E. Alouf, and J. H. Freer (ed.), The comprehensive sourcebook of bacterial protein toxins, 2nd ed. Academic Press, San Diego, Calif. |
| 8. | Alouf, J. E., and C. Geoffroy. 1991. The family of the antigenically-related, cholesterol-binding (`sulfhydryl-activated') cytolytic toxins, p. 147-186. In J. E. Alouf, and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press, London, U.K. |
| 9. | Altimira, J., N. Prats, S. López, M. Domíngo, V. Briones, L. Domínguez, and A. Marco. 1999. Repeated oral dosing with Listeria monocytogenes in mice as a model of central nervous system listeriosis in man. J. Comp. Pathol. 121:117-125[CrossRef][Medline]. |
| 10. |
Alvarez-Domínguez, C.,
E. Carrasco-Marín, and F. Leyva-Cobián.
1993.
Role of complement component C1q in phagocytosis of Listeria monocytogenes by murine macrophage-like cell lines.
Infect. Immun.
61:3664-3672 |
| 11. | Alvarez-Domínguez, C., R. Roberts, and P. D. Stahl. 1997. Internalized Listeria monocytogenes modulates intracellular trafficking and delays maturation of the phagosome. J. Cell Sci. 110:731-743[Abstract]. |
| 12. | Alvarez-Domínguez, C., J. A. Vázquez-Boland, E. Carrasco-Marín, P. López-Mato, and F. Leyva-Cobián. 1997. Host cell heparan sulfate proteoglycans mediate attachment and entry of Listeria monocytogenes, and the listerial surface protein ActA is involved in heparan sulfate receptor recognition. Infect. Immun. 65:78-88[Abstract]. |
| 13. | Anonymous. 1983. Listeria infections in farm animals. Vet. Rec. 112:314. |
| 14. |
Appelberg, R., and I. S. Leal.
2000.
Mutants of Listeria monocytogenes defective in in vitro invasion and cell-to-cell spreading still invade and proliferate in hepatocytes of neutropenic mice.
Infect. Immun.
68:912-914 |
| 15. |
Armstrong, B. A., and C. P. Sword.
1966.
Electron microscopy of Listeria monocytogenes-infected mouse spleen.
J. Bacteriol.
91:1346-1355 |
| 16. | Armstrong, R. W., and P. C. Fung. 1993. Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes: case report and review of the literature. Clin. Infect. Dis. 16:689-702[Medline]. |
| 17. | Asahi, O., T. Hosoda, and Y. Akiyama. 1957. Studies on the mechanism of infection of the brain with Listeria monocytogenes. Am. J. Vet. Res. 18:147-157. |
| 18. | Audurier, A., P. Pardon, J. Marly, and F. Lantier. 1980. Experimental infection of mice with Listeria monocytogenes and L. innocua. Ann. Microbiol. 131B:47-57. |
| 19. |
Aureli, P.,
G. C. Fioruci,
D. Caroli,
G. Marchiaro,
O. Novara,
L. Leone, and S. Salmaso.
2000.
An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes.
N. Engl. J. Med.
342:1236-1241 |
| 20. | Bach, M. C., and K. M. Davis. 1987. Listeria rhombencephalitis mimicking tuberculous meningitis. Rev. Infect. Dis. 9:130-133[Medline]. |
| 21. | Barchini, E., and R. E. Cowart. 1996. Extracellular iron reductase activity produced by Listeria monocytogenes. Arch. Microbiol. 166:51-57[CrossRef][Medline]. |
| 22. | Barlow, R. M., and B. McGorum. 1985. Ovine listerial encephalitis: analysis, hypotheses and synthesis. Vet. Rec. 116:233-236[Abstract]. |
| 23. |
Barry, R. A.,
H. G. A. Bouwer,
D. A. Portnoy, and D. J. Hinrichs.
1992.
Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread.
Infect. Immun.
60:1625-1632 |
| 24. | Bayles, D. O., B. A. Annous, and B. J. Wilkinson. 1996. Cold stress proteins induced in Listeria monocytogenes in response to temperature downshock and growth at low temperatures. Appl. Environ. Microbiol. 62:1116-1119[Abstract]. |
| 25. |
Beauregard, K. E.,
K. D. Lee,
R. J. Collier, and J. A. Swanson.
1997.
pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes.
J. Exp. Med.
186:1159-1163 |
| 26. |
Becker, L. A.,
M. S. Çetin,
R. W. Hutkins, and A. W. Benson.
1998.
Identification of the gene encoding the alternative sigma factor B from Listeria monocytogenes and its role in osmotolerance.
J. Bacteriol.
180:4547-4554 |
| 27. | Beckerle, M. C. 1998. Spatial control of actin filament assembly: lessons from Listeria. Cell 95:741-748[CrossRef][Medline]. |
| 28. | Beckerman, K. P., H. W. Rogers, J. A. Corbett, R. D. Schreiber, M. L. Daniel, and E. R. Unanue. 1993. Release of nitric oxide during T-cell independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J. Immunol. 150:888-895[Abstract]. |
| 29. |
Behari, J., and P. Youngman.
1998.
A homolog of CcpA mediates catabolite control in Listeria monocytogenes but not carbon source regulation of virulence genes.
J. Bacteriol.
180:6316-6324 |
| 30. |
Behari, J., and P. Youngman.
1998.
Regulation of hly expression in Listeria monocytogenes by carbon sources and pH occurs through separate mechanisms mediated by PrfA.
Infect. Immun.
66:3635-3642 |
| 31. | Berche, P. 1995. Bacteriemia is required for invasion of the murine central nervous system by Listeria monocytogenes. Microb. Pathog. 18:323-336[CrossRef][Medline]. |
| 32. | Berche, P., J.-L. Gaillard, C. Geoffroy, and J. E. Alouf. 1987. T cell recognition of listeriolysin O is induced during infection with Listeria monocytogenes. J. Immunol. 139:3813-3821[Abstract]. |
| 33. | Berche, P., J.-L. Gaillard, and P. Sansonetti. 1987. Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J. Immunol. 138:2266-2271[Abstract]. |
| 34. | Berche, P., K. A. Reich, M. Bonnichon, J.-L. Beretti, C. Geoffroy, J. Ravenau, P. Cossart, J.-L. Gaillard, P. Geslin, H. Kreis, and M. Veron. 1990. Detection of anti-listeriolysin O for serodiagnosis of human listeriosis. Lancet 335:624-627[CrossRef][Medline]. |
| 35. | Berenguer, J., J. Solera, M. D. Díaz, S. Moreno, J. A. López-Herce, and E. Bouza. 1991. Listeriosis in patients infected with human immunodeficiency virus. Rev. Infect. Dis. 13:115-119[Medline]. |
| 36. | Berg, R. D. 1995. Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 3:149-154[CrossRef][Medline]. |
| 37. | Bermudez, L. E. 1993. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages: the role of nitric oxide. Clin. Exp. Immunol. 91:277-281[Medline]. |
| 38. |
Bernardini, M. L.,
J. Mounier,
H. d'Hauteville,
M. Coquis-Rondon, and P. J. Sansonetti.
1989.
Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin.
Proc. Natl. Acad. Sci. USA
86:3867-3871 |
| 39. | Bevers, E. M., P. Comfurius, D. W. Dekkers, M. Harmsma, and R. F. Zwaal. 1998. Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling. Lupus 7:S126-S131. |
| 40. |
Bhakdi, S.,
T. Klonisch,
P. Nuber, and W. Fischer.
1991.
Stimulation of monokine production by lipoteichoic acids.
Infect. Immun.
59:4614-4620 |
| 41. | Bhakdi, S., and J. Tranum-Jensen. 1987. Damage to mammalian cells by proteins that form transmembrane pores. Rev. Physiol. Biochem. Pharmacol. 107:147-233[Medline]. |
| 42. |
Bhakdi, S.,
J. Tranum-Jensen, and A. Sziegoleit.
1985.
Mechanism of membrane damage by streptolysin O.
Infect. Immun.
47:52-60 |
| 43. | Bhatt, R., D. A. Ala'Aldeen, T. Baldwin, and S. P. Boriello. 1994. The 126 kDa iron-regulated protein of Listeria monocytogenes is not a transferrin binding protein. FEMS Microbiol. Lett. 123:119-123[CrossRef][Medline]. |
| 44. |
Bibb, W. F.,
B. G. Gellin,
R. Weaver,
B. Schwartz,
B. D. Plikaytis,
M. W. Reeves,
R. W. Pinner, and C. V. Broome.
1990.
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiological investigations.
Appl. Environ. Microbiol.
56:2133-2141 |
| 45. | Bielecki, J., P. Youngman, P. Connelly, and D. A. Portnoy. 1990. Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 345:175-176[CrossRef][Medline]. |
| 45a. |
Bierne, H.,
S. Dramsi,
M. P. Gratacap,
C. Randriamampita,
G. Carpenter,
B. Payrastre, and P. Cossart.
2000.
The invasion protein InlB from Listeria monocytogenes activates PLC- 1 downstream from PI 3-kinase.
Cell. Microbiol.
2:465-476[CrossRef][Medline].
|
| 46. | Bille, J. 1990. Epidemiology of human listeriosis in Europe, whith special reference to the Swiss outbreak, p. 71-74. In A. J. Miller, J. L. Smith, and G. A. Somkuti (ed.), Foodborne listeriosis. Elsevier, New York, N.Y. |
| 47. | Blanot, S., M. Muffat Joly, F. Vilde, F. Jaubert, O. Clement, G. Frija, and P. Berche. 1997. A gerbil model for rhombencephalitis due to Listeria monocytogenes. Microb. Pathog. 23:39-48[CrossRef][Medline]. |
| 48. | Blenden, D. C., E. H. Kampelmacher, and M. J. Torres-Anjel. 1987. Listeriosis. J. Am. Vet. Med. Assoc. 191:1546-1551[Medline]. |
| 49. |
Blum, G.,
M. Ott,
A. Lischewski,
A. Ritter,
H. Imrich,
H. Tschäpe, and J. Hacker.
1994.
Excission of large DNA-regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen.
Infect. Immun.
62:606-614 |
| 50. | Böckmann, R., C. Dickneite, W. Goebel, and J. Bohne. 2000. PrfA mediates specific binding to RNA polymerase of Listeria monocytogenes to PrfA-dependent viruelence gene promoters resulting in a transcriptionally active complex. Mol. Microbiol. 36:487-497[CrossRef][Medline]. |
| 51. | Böckmann, R., C. Dickneite, B. Middendorf, W. Goebel, and Z. Sokolovic. 1996. Specific binding of the Listeria monocytogenes transcriptional regulator protein PrfA to target sequences requires additional factor(s) and is influenced by iron. Mol. Microbiol. 22:643-653[CrossRef][Medline]. |
| 52. |
Boerlin, P., and J.-C. Piffaretti.
1991.
Typing of human, animal, food and environmental isolates of Listeria monocytogenes by multilocus enzyme electrophoresis.
Appl. Environ. Microbiol.
57:1624-1629 |
| 53. | Bohne, J., H. Kestler, C. Uebele, Z. Sokolovic, and W. Goebel. 1996. Differential regulation of the virulence genes of Listeria monocytogenes. Mol. Microbiol. 20:1189-1198[CrossRef][Medline]. |
| 54. | Bohne, J., Z. Sokolovic, and W. Goebel. 1994. Transcriptional regulation of prfA and PrfA-regulated virulence genes in L. monocytogenes. Mol. Microbiol. 11:1141-1150[CrossRef][Medline]. |
| 55. | Boland, A., S. Havaux, and G. R. Cornelis. 1998. Heterogeneity of the Yersinia YopM protein. Microb. Pathog. 25:343-348[CrossRef][Medline]. |
| 56. |
Boockvar, K. S.,
D. L. Granger,
R. M. Poston,
M. Maybodi,
M. K. Washington,
J. B. Hibbs, Jr., and R. L. Kurlander.
1994.
Nitric oxide produced during murine listeriosis is protective.
Infect. Immun.
62:1089-1100 |
| 57. |
Bortolussi, R.,
C. M. J. E. Vandenbroucke-Grauls,
B. S. van Asbeck, and J. Verhoef.
1987.
Relationship of bacterial growth phase to killing of Listeria monocytogenes by oxidative agents generated by neutrophils and enzyme systems.
Infect. Immun.
55:3197-3203 |
| 58. | Bortolussi, R., N. Campbell, and V. Krause. 1984. Dynamics of Listeria monocytogenes type 4b infection in pregnant and infant rats. Clin. Investig. Med. 7:273-279[Medline]. |
| 59. |
Bouwer, H. G. A.,
C. S. Nelson,
B. L. Gibbins,
D. A. Portnoy, and D. J. Hinrichs.
1992.
Listeriolysin O is the target of the immune response to Listeria monocytogenes.
J. Exp. Med.
175:1467-1471 |
| 60. | Braun, L., S. Dramsi, P. Dehoux, H. Bierne, G. Lindahl, and P. Cossart. 1997. InlB: an invasion protein of Listeria monocytogenes with a novel type of surface association. Mol. Microbiol. 25:285-294[CrossRef][Medline]. |
| 61. | Braun, L., B. Ghebrehiwet, and P. Cossart. 2000. gC1q-R/p32, a Clq-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J. 19:1458-1466[CrossRef][Medline]. |
| 62. | Braun, L., F. Nato, B. Payrastre, J.-C. Mazié, and P. Cossart. 1999. The 213-amino-acid leucine-rich repeat region of the Listeria monocytogenes InlB protein is sufficient for entry into mammalian cells, stimulation of PI 3-kinase and membrane ruffling. Mol. Microbiol. 34:10-23[CrossRef][Medline]. |
| 63. | Braun, L., H. Ohayon, and P. Cossart. 1998. The InlB protein of Listeria monocytogenes is sufficient to promote entry into mammalian cells. Mol. Microbiol. 27:1077-1087[CrossRef][Medline]. |
| 64. | Reference deleted. |
| 65. | Brehm, K., A. Haas, W. Goebel, and J. Kreft. 1992. A gene encoding a superoxide dismutase of the facultative intracellular bacterium Listeria monocytogenes. Gene 118:121-125[CrossRef][Medline]. |
| 66. | Brehm, K., J. Kreft, M.-T. Ripio, and J.-A. Vazquez-Boland. 1996. Regulation of virulence gene expression in pathogenic Listeria. Microbiol. SEM 12:219-236. |
| 67. |
Brehm, K.,
M.-T. Ripio,
J. Kreft, and J.-A. Vázquez-Boland.
1999.
The bvr locus of Listeria monocytogenes mediates virulence gene repression by -glucosides.
J. Bacteriol.
181:5024-5032 |
| 68. | Brosch, R., B. Catimel, G. Milon, C. Buchrieser, E. Vindel, and J. Rocourt. 1993. Virulence heterogeneity of Listeria monocytogenes strains from various sources (food, human, animal) in immunocompetent mice and its association with typing characteristics. J. Food Protect. 56:296-301. |
| 69. |
Brun-Buisson, C. J.,
E. De Gialluly,
R. Gherardi,
G. Otterbein,
F. Gray, and M. Rapin.
1985.
Fatal nonmeningitic Listeria rhombencephalitis: reports of two cases.
Arch. Intern. Med.
145:1982-1985 |
| 70. |
Brundage, R. A.,
G. A. Smith,
A. Camilli,
J. A. Theriot, and D. A. Portnoy.
1993.
Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells.
Proc. Natl. Acad. Sci. USA
90:11890-11894 |
| 71. | Brunt, L. M., D. A. Portnoy, and E. R. Unanue. 1990. Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J. Immunol. 145:3540-3546[Abstract]. |
| 72. | Bubert, A., H. Kestler, M. Götz, R. Böckmann, and W. Goebel. 1997. The Listeria monocytogenes iap gene as an indicator gene for the study of PrfA-dependent regulation. Mol. Gen. Genet. 256:54-62[CrossRef][Medline]. |
| 73. |
Bubert, A.,
M. Kuhn,
W. Goebel, and S. Köhler.
1992.
Structural and functional properties of the p60 proteins from different Listeria species.
J. Bacteriol.
174:8166-8171 |
| 74. |
Bubert, A.,
S. Köhler, and W. Goebel.
1992.
The homologous and heterologous regions within the iap gene allows genus- and species-specific identification of Listeria spp. by polymerase chain reaction.
Appl. Environ. Microbiol.
58:2625-2632 |
| 75. | Bubert, A., Z. Sokolovic, S.-K. Chun, L. Papatheodorou, A. Simm, and W. Goebel. 1999. Differential expression of Listeria monocytogenes virulence genes in mammalian host cells. Mol. Gen. Genet. 261:323-336[Medline]. |
| 76. | Bubert, A., J. Riebe, N. Schnitzler, A. Schönberg, W. Goebel, and P. Schubert. 1997. Isolation of catalase-negative Listeria monocytogenes strains from listeriosis patients and their rapid identification by anti-p60 antibodies and/or PCR. J. Clin. Microbiol. 35:179-183[Abstract]. |
| 77. |
Bubert, A.,
P. Schubert,
S. Köhler,
R. Frank, and W. Goebel.
1994.
Synthetic peptides derived from the Listeria monocytogenes p60 protein as antigens for the generation of polyclonal antibodies specific for secreted cell-free L. monocytogenes p60 proteins.
Appl. Environ. Microbiol.
60:3120-3127 |
| 78. |
Buchmeier, N. A., and F. Heffron.
1990.
Induction of Salmonella stress proteins upon infection of macrophages.
Science
248:730-732 |
| 79. | Busch, D. H., H. G. A. Bouwer, D. Hinrichs, and E. G. Pamer. 1997. A nonamer peptide derived from Listeria monocytogenes metalloprotease is presented to cytolytic T lymphocytes. Infect. Immun. 65:5326-5329[Abstract]. |
| 80. |
Busque, P.,
A. Letellier,
J. Harel, and J. D. Dubreuil.
1995.
Production of Escherichia coli STb enterotoxin is subjected to catabolite repression.
Microbiology
141:1621-1627 |
| 81. |
Cameron, L. A.,
M. J. Footer,
A. van Oudenaarden, and J. A. Theriot.
1999.
Motility of ActA protein-coated microspheres driven by actin polymerization.
Proc. Natl. Acad. Sci. USA.
96:4908-4913 |
| 82. |
Camilli, A.,
H. Goldfine, and D. A. Portnoy.
1991.
Listeria monocytogenes mutants lacking phosphatidylinositol-specific phospholipase C are avirulent.
J. Exp. Med.
173:751-754 |
| 83. | Camilli, A., L. G. Tilney, and D. A. Portnoy. 1993. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol. Microbiol. 8:143-157[Medline]. |
| 84. | Campbell, P. A. 1993. Macrophage-Listeria interactions, p. 313-328. In B. S. Zwilling, and T. K. Eisenstein (ed.), Macrophage-pathogen interactions. Marcel Dekker Inc., New York, N.Y. |
| 85. | Carl, U. D., M. Pollmann, E. Orr, F. B. Gertler, T. Chakraborty, and J. Wehland. 1999. Aromatic and basic residues within the EVH1 domain of VASP specify its interaction with proline-rich ligands. Curr. Biol. 9:715-718[CrossRef][Medline]. |
| 86. |
Carlier, M. F.,
V. Laurent,
J. Santolini,
R. Melki,
D. Didry,
G.-X. Xia,
Y. Hong,
N.-H. Chua, and D. Pantaloni.
1997.
Actin depolimerizing factor (ADF/cofilin) enhances the rate of filament turnover: implication in actin-based motility.
J. Cell Biol.
136:1307-1322 |
| 87. | Chakraborty, T. 1996. The molecular mechanisms of actin-based intracellular motility by Listeria monocytogenes. Microbiol. SEM 12:237-244. |
| 88. | Chakraborty, T., F. Ebel, E. Domann, B. Gerstel, S. Pistor, C. J. Temm-Grove, B. M. Jockusch, M. Reinhard, U. Walter, and J. Wehland. 1995. A novel focal adhesion factor directly linking intracellular motile Listeria monocytogenes and Listeria ivanovii to the actin-based cytoskeleton of mammalian cells. EMBO J. 14:1314-1321[Medline]. |
| 88a. | Chakraborty, T., T. Hain, and E. Domann. 2000. Genome organization and the evolution of the virulence gene locus in Listeria species. Int. J. Med. Microbiol. 290:167-174[Medline]. |
| 89. |
Chakraborty, T.,
M. Leimeister-Wachter,
E. Domann,
M. Hartl,
W. Goebel,
T. Nichterlein, and S. Notermans.
1992.
Coordinate regulation of virulence genes in Listeria monocytogenes requires the product of the prfA gene.
J. Bacteriol.
174:568-574 |
| 90. | Chand, P., and J. R. Sadana. 1999. Outbreak of Listeria ivanovii abortion in sheep in India. Vet. Rec. 145:83-84[Medline]. |
| 91. | Charlton, K. M. 1977. Spontanelous listeric encephalitis in sheep. Electron microscopic studies. Vet. Pathol. 14:429-434[Abstract]. |
| 92. | Charlton, K. M., and M. M. Garcia. 1977. Spontaneous listeric encephalitis and neuritis in sheep. Vet. Pathol. 14:297-313[Abstract]. |
| 93. |
Cheers, C.,
I. F. C. McKenzie,
H. Pavlov,
C. Waid, and J. York.
1978.
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant and susceptible mice.
Infect. Immun.
19:763-770 |
| 94. | Cheers, C., and Y. Zhan. 1996. How do macrophages distinguish the living from the dead? Trends Microbiol. 4:453-455[CrossRef][Medline]. |
| 95. |
Chen, C.-Y.,
N. A. Buchmeier,
S. Libby,
F. C. Fang,
M. Krause, and D. G. Guiney.
1995.
Central regulatory role for the RpoS sigma factor in expression of Salmonella dublin plasmid virulence genes.
J. Bacteriol.
177:5303-5309 |
| 96. |
Cicchetti, G.,
P. Maurer,
P. Wagener, and C. Kocks.
1999.
Actin and phosphoinositide binding by the ActA protein of the bacterial pathogen Listeria monocytogenes.
J. Biol. Chem.
274:33616-33626 |
| 97. |
Coconnier, M.-H.,
E. Dlissi,
M. Robard,
C. L. Laboisse,
J.-L. Gaillard, and A. L. Servin.
1998.
Listeria monocytogenes stimulates mucus exocytosis in cultured human polarized mucosecreting intestinal cells through action of listeriolysin O.
Infect. Immun.
66:3673-3681 |
| 97a. |
Cohen, P.,
M. Bouaboula,
M. Bellis,
V. Baron,
O. Jbilo,
C. Poinot-Chazel,
S. Galiegue,
E. H. Hadibi, and P. Casellas.
2000.
Monitoring cellular responses to Listeria monocytogenes with oligonucleotide arrays.
J. Biol. Chem.
275:11181-11190 |
| 98. |
Collins, M. D.,
S. Wallbanks,
D. J. Lane,
J. Shah,
R. Nietupski,
J. Smida,
M. Dorsch, and E. Stackebrandt.
1991.
Phylogenetic analysis of the genus Listeria based on reverse transcriptase sequencing of 16S rRNA.
Int. J. Syst. Bacteriol.
41:240-246 |
| 99. |
Conlan, J. C., and R. J. North.
1991.
Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium.
J. Exp. Med.
174:741-744 |
| 100. |
Conlan, J. W., and R. J. North.
1992.
Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes.
Infect. Immun.
60:5164-5171 |
| 101. | Conte, M. P., C. Longhi, M. Polidoro, G. Petrone, V. Buonfiglio, S. Di Santo, E. Papi, L. Seganti, P. Visca, and P. Valenti. 1996. Iron availability affects entry of Listeria monocytogenes into enterocytelike cell line Caco-2. Infect. Immun. 64:3925-3929[Abstract]. |
| 101a. | Conte, M. P., G. Petrone, A. M. Di Biase, M. G. Ammendolia, F. Superti, and L. Seganti. 2000. Acid tolerance in listeria monocytogenes influences invasiveness of enterocyte-like cells and macrophage-like cells. Microb. Pathog. 29:137-144[CrossRef][Medline]. |
| 102. |
Conte, M. P.,
G. Petrone,
C. Longhi,
P. Valenti,
R. Morelli,
F. Superti, and L. Seganti.
1996.
The effects of inhibitors of vacuolar acidification on the release of Listeria monocytogenes from phagosomes of Caco-2 cells.
J. Med. Microbiol.
44:418-424 |
| 103. | Cordy, D. R., and J. W. Osebold. 1959. The neuropathogenesis of Listeria encephalomyelitis in sheep and mice. J. Infect. Dis. 104:164-173. |
| 104. |
Cornell, K. A.,
H. G. Bouwer,
D. J. Hinrichs, and R. A. Barry.
1999.
Genetic immunization of mice against Listeria monoctogenes using plasmid DNA encoding listeriolysin O.
J. Immunol.
163:322-329 |
| 105. | Cossart, P. 1995. Actin-based bacterial motility. Curr. Opin. Cell Biol. 7:94-101[CrossRef][Medline]. |
| 105a. | Cossart, P. 2000. Actin-based motility of pathogens: the Arp2/3 complex is a central player. Cell. Microbiol. 2:195-205[CrossRef][Medline]. |
| 105b. |
Cossart, P., and R. Jonquières.
2000.
Sortase, a universal target for therapeutic agents against Gram-positive bacteria?
Proc. Natl. Acad. Sci. USA
97:5013-5015 |
| 106. | Cossart, P., and M. Lecuit. 1998. Interaction of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. EMBO J. 17:3797-3806[CrossRef][Medline]. |
| 107. | Cossart, P., and J. Mengaud. 1989. Listeria monocytogenes, a model system for the molecular study of intracellular parasitism. Mol. Biol. Med. 6:463-474[Medline]. |
| 108. |
Cossart, P.,
M. F. Vincente,
J. Mengaud,
F. Baquero,
J. C. Perez-Diaz, and P. Berche.
1989.
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation.
Infect. Immun.
57:3629-3636 |
| 109. |
Cotter, P. D.,
N. Emerson,
C. G. M. Gahan, and C. Hill.
1999.
Identification and disruption of lisRK, a genetic locus encoding a two-component signal transduction system involved in stress tolerance and virulence in Listeria monocytogenes.
J. Bacteriol.
181:6840-6843 |
| 110. | Cottin, J., O. Loiseau, R. Robert, C. Mahaza, B. Carbonelle, and J. M. Senet. 1990. Surface Listeria monocytogenes carbohydrate-binding components revealed by agglutination with neoglycoproteins. FEMS Microbiol. Lett. 68:301-306. |
| 111. | Coulanges, V., P. Andre, and D. J. Vidon. 1998. Effects of siderophores, catecholamines, and catechol compounds on Listeria spp. Growth in iron-complexed medium. Biochem. Biophys. Res. Commun. 249:526-530[CrossRef][Medline]. |
| 112. | Coulanges, V., P. Andre, O. Ziegler, L. Buchheit, and D. J. Vidon. 1997. Utilization of iron-catecholamine complexes involving ferric reductase activity in Listeria monocytogenes. Infect. Immun. 65:2778-2785[Abstract]. |
| 112a. | Cousens, L. P., and E. J. Wing. 2000. Innate defenses in the liver during Listeria infection. Immunol. Rev. 174:150-159[CrossRef][Medline]. |
| 113. | Cowart, R. E., and B. G. Foster. 1981. The role of iron in the production of haemolysin by Listeria monocytogenes. Curr. Microbiol. 6:287-290[CrossRef]. |
| 114. | Cowart, R. E., J. Lashmet, M. E. McIntosh, and T. J. Adams. 1990. Adherence of virulent strains of Listeria monocytogenes to the surface of hepatocarcinoma cell line via lectin-substrate interaction. Arch. Microbiol. 153:282-286[CrossRef][Medline]. |
| 115. |
Croize, J.,
J. Arvieux,
P. Berche, and M. G. Colomb.
1993.
Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria.
Infect. Immun.
61:5134-5139 |
| 116. | Cummins, A. J., A. K. Fielding, and J. McLauchlin. 1994. Listeria ivanovii infection in a patient with AIDS. J. Infect. 28:89-91[CrossRef][Medline]. |
| 117. |
Dabiri, G. A.,
J. M. Sanger,
D. A. Portnoy, and F. S. Southwick.
1990.
Listeria monocytogenes moves rapidly through the host-cell cytoplasm by inducing directional actin assembly.
Proc. Natl. Acad. Sci. USA
87:6068-6072 |
| 118. |
Dalton, C. B.,
C. C. Austin,
J. Sobel,
P. S. Hayes,
W. F. Bibb,
L. M. Graves,
B. Swaminathan,
M. E. Proctor, and P. M. Griffin.
1997.
An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk.
N. Engl. J. Med.
336:100-105 |
| 119. | Daniels, J. J., I. B. Autenrieth, and W. Goebel. 2000. Interaction of Listeria monocytogenes with the intestinal epithelium. FEMS Microbiol. Lett. 190:323-328[CrossRef][Medline]. |
| 120. |
Darji, A.,
D. Bruder,
S. zur Lage,
B. Gerstel,
T. Chakraborty,
J. Wehland, and S. Weiss.
1998.
The role of the bacterial membrane protein ActA in immunity and protection against Listeria monocytogenes.
J. Immunol.
161:2414-2420 |
| 121. | Darji, A., T. Chakraborty, J. Wehland, and S. Weiss. 1995. Listeriolysin generates a route for the presentation of exogenous antigens by major histocompatibility complex class I. Eur. J. Immunol. 25:2967-2971[Medline]. |
| 122. | Darji, A., T. Chakraborty, J. Wehland, and S. Weiss. 1997. TAP-dependent major histocompatibility complex class I presentation of soluble proteins using listeriolysin. Eur. J. Immunol. 27:1353-1359[Medline]. |
| 123. | Darji, A., K. Niebuhr, M. Hense, J. Wehland, T. Chakraborty, and S. Weiss. 1996. Neutralizing monoclonal antibodies against listeriolysin: mapping of epitopes involved in pore formation. Infect. Immun. 64:2356-2358[Abstract]. |
| 124. |
Datta, A. R., and M. H. Kothary.
1993.
Effects of glucose, growth temperature, and pH on listeriolysin O production in Listeria monocytogenes.
Appl. Environ. Microbiol.
59:3495-3497 |
| 125. | Daugelat, S., and S. H. E. Kaufmann. 1996. Role of Th1 and Th2 cells in bacterial infections. Chem. Immunol. 63:66-97[Medline]. |
| 126. | David, V., E. Gouin, M. V. Troys, A. Grogan, A. W. Segal, C. Ampe, and P. Cossart. 1998. Identification of cofilin, coronin, Rac and CapZ in actin tails using a Listeria affinity approach. J. Cell Sci. 111:2877-2884[Abstract]. |
| 127. | Davies, W. A. 1983. Kinetics of killing Listeria monocytogenes by macrophages: rapid killing accompanying phagocytosis. J. Reticuloendothel. Soc. 34:131-141[Medline]. |
| 127a. |
Decatur, A. L., and D. A. Portnoy.
2000.
A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity.
Science
290:992-995 |
| 128. |
De Chastellier, C., and P. Berche.
1994.
Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria.
Infect. Immun.
62:543-553 |
| 129. | Del Corral, F., R. L. Buchanan, M. M. Bencivengo, and P. H. Cooke. 1990. Quantitative comparison of selected virulence associated characteristics in food and clinical isolates of Listeria. J. Food Protect. 53:1003-1009. |
| 130. | De los Toyos, J. R., F. J. Méndez, J. F. Aparicio, F. Vázquez, M. M. García Suárez, A. Fleites, C. Hardisson, P. J. Morgan, P. W. Andrew, and T. J. Mitchell. 1996. Functional analysis of pneumolysin by use of monoclonal antibodies. Infect. Immun. 64:480-484[Abstract]. |
| 131. |
Demuth, A.,
T. Chakraborty,
G. Krohne, and W. Goebel.
1994.
Mammalian cells transfected with the listeriolysin gene exhibit enhanced proliferation and focus formation.
Infect. Immun.
62:5102-5111 |
| 132. | Demuth, A., W. Goebel, H. U. Beuscher, and M. Kuhn. 1996. Differential regulation of cytokine and cytokine receptor mRNA expression upon infection of bone marrow-derived macrophages with Listeria monocytogenes. Infect. Immun. 64:3475-3483[Abstract]. |
| 133. |
Deneer, H. G.,
V. Healey, and I. Boychuk.
1995.
Reduction of exogenous ferric iron by a surface-associated ferric reductase of Listeria spp.
Microbiology
141:1985-1992 |
| 134. | Dennis, S. M. 1975. Perinatal lamb mortality in Western Australia. 6. Listeric infection. Aust. Vet. J. 51:75-79[Medline]. |
| 135. | Dhar, G., K. F. Faull, and O. Schneewind. 2000. Anchor structure of cell wall surface proteins in Listeria monocytogenes. Biochemistry 39:3725-3733[CrossRef][Medline]. |
| 136. | Dickneite, C., R. Böckmann, A. Spory, W. Goebel, and Z. Sokolovic. 1998. Differential interaction of the transcription factor PrfA and the PrfA-activating factor (Paf) of Listeria monocytogenes with target sequences. Mol. Microbiol. 27:915-928[CrossRef][Medline]. |
| 137. | Dietrich, G., A. Bubert, I. Gentschev, Z. Sokolovic, A. Simm, A. Catic, S. H. E. Kaufmann, J. Hess, A. A. Szalay, and W. Goebel. 1998. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat. Biotechnol. 16:181-185[CrossRef][Medline]. |
| 138. | Dijkstra, R. G. 1987. Listeriosis in animals: clinical signs, diagnosis and treatment, p. 68-76. In A. Schönberg (ed.), Listeriosis: Joint WHO/ROI consultation on prevention and control. VetMed Hefte 5/1987. Institut für Veterinärmedizin des Bundesgesundheitsamtes, Berlin, Germany. |
| 139. | Dold, F. G., J. M. Sanger, and J. W. Sanger. 1994. Intact alpha-actinin molecules are needed for both the assembly of actin into tails and the locomotion of Listeria monocytogenes inside infected cells. Cell Motil. Cytoskelet. 28:97-107[CrossRef][Medline]. |
| 140. |
Domann, E.,
M. Leimeister-Wächter,
W. Goebel, and T. Chakraborty.
1991.
Molecular cloning, sequencing, and identification of a metalloprotease gene from Listeria monocytogenes that is species specific and physically linked to the listeriolysin gene.
Infect. Immun.
59:65-72 |
| 141. |
Domann, E.,
J. Wehland,
K. Niebuhr,
C. Haffner,
M. Leimeister-Wächter, and T. Chakraborty.
1993.
Detection of a prfA-independent promoter responsible for listeriolysin gene expression in mutant Listeria monocytogenes strains lacking the PrfA regulator.
Infect. Immun.
61:3073-3075 |
| 142. | Domann, E., J. Wehland, M. Rohde, S. Pistor, M. Hartl, W. Goebel, M. Leimeister-Wächter, M. Wuenscher, and T. Chakraborty. 1992. A novel bacterial virulence gene in Listeria monocytogenes required for host cell microfilament interaction with homology to the proline-rich region of vinculin. EMBO J. 11:1981-1990[Medline]. |
| 143. | Domann, E., S. Zechel, A. Lingnau, T. Hain, A. Darji, T. Nichterlein, J. Wehland, and T. Chakraborty. 1997. Identification and characterization of a novel PrfA-regulated gene in Listeria monocytogenes whose product, IrpA, is highly homologous to internalin proteins, which contain leucine-rich repeats. Infect. Immun. 65:101-109[Abstract]. |
| 144. | Reference deleted. |
| 145. | Donnelly, C. W. 1994. Listeria monocytogenes, p. 215-252. In Y. H. Hui, J. R. Gorham, K. D. Murrell, and D. O. Cliver (ed.), Foodborne disease handbook: diseases caused by bacteria, vol. 1. Marcel Dekker, New York, N.Y. |
| 146. | Dons, L., K. Weclewicz, Y. Jin, E. Bindseil, J. E. Olsen, and K. Kristenson. 1999. Rat dorsal root ganglia neurons as a model for Listeria monocytogenes infections in culture. Med. Microbiol. Immunol. 188:15-21[CrossRef][Medline]. |
| 147. | Dramsi, S., and P. Cossart. 1998. Intracellular pathogens and the actin cytoskeleton. Annu. Rev. Cell Dev. Biol. 14:137-166[CrossRef][Medline]. |
| 148. | Dramsi, S., C. Kocks, C. Forestier, and P. Cossart. 1993. Internalin-mediated invasion of epithelial cells by Listeria monocytogenes is regulated by the bacterial growth state, temperature and the pleiotropic activator PrfA. Mol. Microbiol. 9:931-941[Medline]. |
| 149. | Dramsi, S., I. Biswas, E. Maguin, L. Braun, P. Mastroeni, and P. Cossart. 1995. Entry of Listeria monocytogenes into hepatocytes requires the expression of InlB, a surface protein of the internalin multigene family. Mol. Microbiol. 16:251-261[Medline]. |
| 150. | Dramsi, S., P. Dehoux, M. Lebrun, P. L. Goossens, and P. Cossart. 1997. Identification of four new members of the internalin multigene family of Listeria monocytogenes EGD. Infect. Immun. 65:1615-1625[Abstract]. |
| 151. |
Dramsi, S.,
S. Lévi,
A. Thriller, and P. Cossart.
1998.
Entry of Listeria monocytogenes into neurons occurs by cell-to-cell spread: an in vitro study.
Infect. Immun.
66:4461-4468 |
| 152. | Drevets, D. A. 1997. Listeria monocytogenes infection of cultured endothelial cells stimulates neutrophil adhesion and adhesion molecule expression. J. Immunol. 158:5305-5313[Abstract]. |
| 153. |
Drevets, D. A.
1998.
Listeria monocytogenes virulence factors that stimulate endothelial cells.
Infect. Immun.
66:232-238 |
| 154. |
Drevets, D. A.
1999.
Dissemination of Listeria monocytogenes by infected phgagocytes.
Infect. Immun.
67:3512-3517 |
| 155. |
Drevets, D. A., and P. A. Campbell.
1991.
Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages.
Infect. Immun.
59:2645-2652 |
| 156. | Drevets, D. A., P. J. M. Leenen, and P. A. Campbell. 1993. Complement receptor type 3 (CD11b/CD18) involvement is essential for killing of Listeria monocytogenes by mouse macrophages. J. Immunol. 151:5431-5439[Abstract]. |
| 157. | Drevets, D. A., R. T. Sawyer, T. A. Potter, and P. A. Campbell. 1995. Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect. Immun. 63:4268-4276[Abstract]. |
| 158. |
Dubail, I.,
P. Berche, and A. Charbit.
2000.
Listeriolysin O as a reporter to identify constitutive and in vivo-inducible promoters in the pathogen Listeria monocytogenes.
Infect. Immun.
68:3242-3250 |
| 159. | Dumont, J., and L. Cotoni. 1921. Bacille semblable à celui du rouget du porc rencontré dans le L.C.R. d'un méningitique. Ann. Inst. Pasteur 35:625-633. |
| 160. |
Dunne, D. W.,
D. Resnick,
J. Greenberg,
M. Krieger, and K. A. Joiner.
1994.
The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid.
Proc. Natl. Acad. Sci. USA
91:1863-1867 |
| 161. | Ebe, Y., G. Hasegawa, H. Takatsuka, H. Umezu, M. Mitsuyama, M. Arakawa, N. Mukaida, and M. Naito. 1999. The role of Kupffer cells and regulation of neutrophil migration into the liver by macrophage inflammatory protein-2 in primary listeriosis in mice. Pathol. Int. 49:519-532[CrossRef][Medline]. |
| 162. | Ebel, F., C. von Eichel-Streiber, J. Wehland, and T. Chakraborty. 1999. Entry and intracellular motility of Listeria monocytogenes are not dependent on the small GTP-binding proteins of the Rho- and Rac-subfamilies. FEMS Microbiol. Lett. 176:117-124[CrossRef][Medline]. |
| 163. | Edelson, B. T., P. Cossart, and E. R. Unanue. 1999. Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. J. Immunol. 15:163:4087-4090. |
| 164. |
Egile, C.,
T. P. Loisel,
V. Laurent,
R. Li,
D. Pantaloni,
P. J. Sansonetti, and M. F. Carlier.
1999.
Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility.
J. Cell Biol.
146:1319-1332 |
| 165. | Elsner, H.-A., I. Sobottka, A. Bubert, H. Albrecht, R. Laufs, and D. Mack. 1996. Catalase-negative Listeria monocytogenes causing lethal sepsis and meningitis in an adult hematologic patient. Eur. J. Clin. Microbiol. Infect. Dis. 15:965-966[CrossRef][Medline]. |
| 166. | Emoto, Y., M. Emoto, and S. H. E. Kaufmann. 1997. Transient control of interleukin-4-producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12. Infect. Immun. 65:5003-5009[Abstract]. |
| 167. | Engelbrecht, F., S.-K. Chun, C. Ochs, J. Hess, F. Lottspeich, W. Goebel, and Z. Sokolovic. 1996. A new PrfA-regulated gene of Listeria monocytogenes encoding a small, secreted protein which belongs to the family of internalins. Mol. Microbiol. 21:823-837[CrossRef][Medline]. |
| 168. | Engelbrecht, F., C. Dickneite, R. Lampidis, M. Götz, U. DasGupta, and W. Goebel. 1998. Sequence comparison of the chromosomal regions encompassing the internalin C genes (inlC) of Listeria monocytogenes and Listeria ivanovii. Mol. Gen. Genet. 257:186-197[CrossRef][Medline]. |
| 169. | Engelbrecht, F., G. Dominguez-Bernal, C. Dickneite, J. Hess, L. Greiffenberg, R. Lampidis, D. Raffelsbauer, S. H. E. Kaufmann, J. Kreft, J.-A. Vazquez-Boland, and W. Goebel. 1998. A novel PrfA-regulated chromosomal locus of Listeria ivanovii encoding two small, secreted internalins is essential for virulence in mice. Mol. Microbiol. 30:405-417[CrossRef][Medline]. |
| 170. | Reference deleted. |
| 171. | Ermolaeva, S., N. Varfolomeeva, Y. Belyi, and I. Tartakovskii. 1997. Isolation and characterization of a Listeria monocytogenes mutant strain hyperproducing virulence factors. FEMS Microbiol. Lett. 150:189-195[Medline]. |
| 172. | Espaze, E. P., J. Rocourt, and A. L. Courtieu. 1991. La listériose en France en 1989. Étude à partir des souches adressées au centre national de référence. Bull. Epidémiol. Hebdom. 3:9-10. |
| 173. | Evans, J. R., A. C. Allen, R. Bortolussi, T. B. Issekutz, and D. A. Stinson. 1984. Follow-up study of survivors of fetal and early-onset neonatal listeriosis. Clin. Investig. Med. 7:329-334[Medline]. |
| 174. |
Facinelli, B.,
E. Giovanetti,
G. Magi,
F. Biavasco, and P. E. Varaldo.
1998.
Lectin reactivity and virulence among strains of Listeria monocytogenes determined in vitro using enterocyte-like cell line Caco-2.
Microbiol.
144:109-118 |
| 175. | Fang, F. C. 1997. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 99:2818-2825[Medline]. |
| 176. |
Farber, J. M., and P. I. Peterkin.
1991.
Listeria monocytogenes, a food-borne pathogen.
Microbiol. Rev.
55:476-511 |
| 177. | Farber, J. M., P. I. Peterkin, A. O. Carter, P. V. Varughese, F. E. Ashton, and E. P. Ewan. 1991. Neonatal listeriosis due to cross-infection confirmed by isoenzyme typing and DNA fingerprinting. J. Infect. Dis. 163:927-928[Medline]. |
| 178. | Fenlon, D. R. 1999. Listeria monocytogenes in the natural environment, p. 21-37. In E. T. Ryser, and E. H. Marth (ed.), Listeria, listeriosis, and food safety, 2nd ed. Marcel Dekker Inc., New York, N.Y. |
| 179. | Fischetti, V. A., V. Pancholi, and O. Schneewind. 1990. Conservation of a hexapeptide sequence in the anchor region of surface protein from gram-positive cocci. Mol. Microbiol. 4:1603-1605[Medline]. |
| 180. |
Fleming, D. W.,
M. D. Cochi,
K. L. MacDonald,
J. Brondum,
P. S. Hayes,
B. D. Plikaytis,
M. B. Holmes,
A. Audurier,
C. V. Broome, and A. L. Reingold.
1985.
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis.
N. Engl. J. Med.
312:404-407 |
| 181. | Fleming, S. D., and P. A. Campbell. 1997. Some macrophages kill Listeria monocytogenes while others do not. Immunol. Rev. 158:69-77[CrossRef][Medline]. |
| 182. | Francis, M. S., and C. J. Thomas. 1997. Mutants in the CtpA copper transporting P-type ATPase reduce virulence of Listeria monocytogenes. Microb. Pathog. 22:67-78[CrossRef][Medline]. |
| 183. | Frankel, F. R., S. Hedge, J. Lieberman, and Y. Paterson. 1995. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 gag protein by using Listeria monocytogenes as a live vaccine vector. J. Immunol. 155:4775-4782[Abstract]. |
| 184. |
Franzon, V. L.,
J. Arondel, and P. J. Sansonetti.
1990.
Contribution of superoxide dismutase and catalase activities to Shigella flexneri pathogenesis.
Infect. Immun.
58:529-535 |
| 185. |
Freitag, N. E., and K. E. Jacobs.
1999.
Examination of Listeria monocytogenes intracellular gene expression by using the green fluorescent protein of Aquorea victoria.
Infect. Immun.
67:1844-1852 |
| 186. | Freitag, N. E., and D. A. Portnoy. 1994. Dual promoters of the Listeria monocytogenes prfA transcriptional activator appear essential in vitro but are redundant in vivo. Mol. Microbiol. 12:845-853[Medline]. |
| 187. |
Freitag, N. E.,
L. Rong, and D. A. Portnoy.
1993.
Regulation of the prfA transcriptional activator of Listeria monocytogenes: multiple promoter elements contribute to intracellular growth and cell-to-cell spread.
Infect. Immun.
61:2537-2544 |
| 188. |
Freitag, N. E.,
P. Youngman, and D. A. Portnoy.
1992.
Transcriptional activation of the Listeria monocytogenes hemolysin gene in Bacillus subtilis.
J. Bacteriol.
174:1293-1298 |
| 189. | Friederich, E., E. Gouin, R. Hellio, C. Kocks, P. Cossart, and D. Louvard. 1995. Targeting of Listeria monocytogenes to the plasma membran as a tool to dissect both actin-based cell morphogenesis and ActA function. EMBO J. 14:2731-2744[Medline]. |
| 190. | Frischknecht, F., V. Moreau, S. Rottger, S. Gonfloni, I. Reckmann, G. Superti-Furga, and M. Way. 1999. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401:926-929[CrossRef][Medline]. |
| 191. | Füzi, M., and I. Pillis. 1962. Production of opacity in egg-yolk medium by Listeria monocytogenes. Nature 13:195. |
| 192. | Gahan, C. G., and C. Hill. 2000. The use of listeriolysin to identify in vivo induced genes in the gram-positive intracellular pathogen Listeria monocytogenes. Mol. Microbiol. 36:498-507[CrossRef][Medline]. |
| 193. | Gaillard, J.-L., P. Berche, C. Frehel, E. Gouin, and P. Cossart. 1991. Entry of Listeria monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell 65:1127-1141[CrossRef][Medline]. |
| 194. |
Gaillard, J.-L.,
P. Berche,
J. Mounier,
S. Richard, and P. Sansonetti.
1987.
In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2.
Infect. Immun.
55:2822-2829 |
| 195. |
Gaillard, J.-L.,
P. Berche, and P. Sansonetti.
1986.
Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes.
Infect. Immun.
52:50-55 |
| 196. | Gaillard, J.-L., and B. B. Finlay. 1996. Effect of cell polarization and differentiation on entry of Listeria monocytogenes into the enterocyte-like Caco-2 cell line. Infect. Immun. 64:1299-1308[Abstract]. |
| 197. |
Gaillard, J.-L.,
F. Jaubert, and P. Berche.
1996.
The inlAB locus mediates the entry of Listeria monocytogenes into hepatocytes in vivo.
J. Exp. Med.
183:359-369 |
| 198. | Gaillot, O., E. Pellegrini, S. Bregenholt, S. Nair, and P. Berche. 2000. The serine-protease ClpP is essential for the intracellular parasitism of the pathogen Listeria monocytogenes. Mol. Microbiol. 35:1286-1294[CrossRef][Medline]. |
| 199. | Gallaguer, P. G., and C. Watakunakorn. 1988. Listeria monocytogenes endocarditis: a review of the literature 1950-1986. Scand. J. Infect. Dis. 20:359-368[Medline]. |
| 200. |
Gandhi, A. J.,
B. Perussia, and H. Goldfine.
1993.
Listeria monocytogenes phosphatidylinositol (PI)-specific phospholipase C has low activity on glycosyl-PI-anchored proteins.
J. Bacteriol.
175:8014-8017 |
| 201. | Gauto, A. R., L. A. Cone, D. R. Woodward, R. J. Mahler, R. D. Lynch, and D. H. Stolzman. 1992. Arterial infections due to Listeria monocytogenes: report of four cases and review of the world literature. Clin. Infect. Dis. 14:23-28[Medline]. |
| 202. |
Gedde, M. M.,
D. E. Higgins,
L. G. Tilney, and D. A. Portnoy.
2000.
Role of listeriolysin o in cell-to-cell spread of Listeria monocytogenes.
Infect. Immun.
68:999-1003 |
| 203. |
Geginat, G.,
M. Lalic,
M. Kretschmar,
W. Goebel,
H. Hof,
D. Palm, and A. Bubert.
1998.
Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo.
J. Immunol.
160:6046-6055 |
| 204. |
Geginat, G.,
T. Nichterlein,
M. Kretschmar,
S. Schenk,
H. Hof,
M. Lalic-Mülthaler,
W. Goebel, and A. Bubert.
1999.
Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua.
J. Immunol.
162:4781-4789 |
| 205. | Geiger, B., and O. Ayalon. 1992. Cadherins. Annu. Rev. Cell Biol. 8:307-332[CrossRef]. |
| 206. |
Geoffroy, C.,
J. Raveneau,
J.-L. Beretti,
A. Lecroisey,
J.-A. Vazquez-Boland,
J. E. Alouf, and P. Berche.
1991.
Purification and characterization of an extracellular 29-kilodalton phospholipase C from Listeria monocytogenes.
Infect. Immun.
59:2382-2388 |
| 207. |
Geoffroy, C.,
J.-L. Gaillard,
J. E. Alouf, and P. Berche.
1987.
Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes.
Infect. Immun.
55:1641-1646 |
| 208. |
Geoffroy, C.,
J.-L. Gaillard,
J. E. Alouf, and P. Berche.
1989.
Production of thiol-dependent haemolysins by Listeria monocytogenes and related species.
J. Gen. Microbiol.
135:481-487 |
| 209. | Gerstel, B., L. Gröbe, S. Pistor, T. Chakraborty, and J. Wehland. 1996. The ActA polypeptides of Listeria ivanovii and Listeria monocytogenes harbor related binding sites for host microfilament proteins. Infect. Immun. 64:1929-1936[Abstract]. |
| 210. | Gertler, F. B., K. Niebuhr, M. Reinhard, J. Wehland, and P. Soriano. 1996. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87:227-239[CrossRef][Medline]. |
| 211. | Gholizadeh, Y., M. Juvin, J.-L. Beretti, P. Berche, and J.-L. Gaillard. 1997. Culture-negative listeriosis of the central nervous system diagnosed by detection of antibodies to listeriolysin O. Eur. J. Clin. Microbiol. Infect. Dis. 16:176-178[CrossRef][Medline]. |
| 212. | Gholizadeh, Y., C. Poyart, M. Juvin, J.-L. Beretti, J. Croizé, P. Berche, and J.-L. Gaillard. 1996. Serodiagnosis of listeriosis based upon detection of antibodies against recombinant truncated forms of listeriolysin O. J. Clin. Microbiol. 34:1391-1395[Abstract]. |
| 213. | Gilbert, R. J., J. Rossjohn, M. W. Parker, R. K. Tweten, P. J. Morgan, T. J. Mitchell, N. Errington, A. J. Rowe, P. W. Andrew, and O. Byron. 1998. Self-interaction of pneumolysin, the pore-forming protein toxin of Streptococcus pneumoniae. J. Mol. Biol. 284:1223-1237[CrossRef][Medline]. |
| 214. | Gilbert, R. J. C., J. L. Jiménez, S. Chen, I. J. Tickel, J. Rossjohn, M. Parker, P. W. Andrew, and H. R. Saibil. 1999. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97:647-655[CrossRef][Medline]. |
| 215. | Gill, D. A. 1933. "Circling" disease: a meningoencephalitis of sheep in New Zealand. Vet. J. 89:258-270. |
| 216. | Gill, D. A. 1937. Ovine bacterial encephalitis (circling disease) and the bacterial genus Listerella. Aust. Vet. J. 13:46-56[CrossRef]. |
| 217. |
Gilot, P.,
P. André, and J. Content.
1999.
Listeria monocytogenes possesses adhesins for fibronectin.
Infect. Immun.
67:6698-6701 |
| 218. |
Girard, K. F.,
A. J. Sbarra, and W. A. Bardawil.
1963.
Serology of Listeria monocytogenes. I. Characteristics of the soluble hemolysin.
J. Bacteriol.
85:349-355 |
| 219. | Gitter, M. 1986. A changing pattern of ovine listeriosis in Gt. Britain, p. 294-299. In A. L. Courtieu, E. P. Espaze, and A. E. Reynaud (ed.), Listeria-listeriosis 1985-1986. University of Nantes, Nantes, France. |
| 220. | Goebel, W., and J. Kreft. 1997. Cytolysins and the intracellular life of bacteria. Trends Microbiol. 5:86-88[CrossRef][Medline]. |
| 221. | Goebel, W., J. Kreft, and R. Böckmann. 2000. Regulation of virulence genes in pathogenic Listeria, p. 499-506. In V. A. Fischetti, et al. (ed.), Gram-positive pathogens. American Society for Microbiology, Washington, D.C. |
| 222. |
Goldfine, H., and C. Knob.
1992.
Purification and characterization of Listeria monocytogenes phosphatidylinositol-specific phospholipase C.
Infect. Immun.
60:4059-4067 |
| 223. |
Goldfine, H.,
N. C. Johnston, and C. Knob.
1993.
Nonspecific phospholipase C of Listeria monocytogenes: activity on phospholipids in Triton X-100-mixed micelles and in biological membranes.
J. Bacteriol.
175:4298-4306 |
| 224. | Golsteyn, R. M., M. C. Beckerle, T. Koay, and E. Friederich. 1997. Structural and functional similarities between the human cytoskeletal protein zyxin and the ActA protein of Listeria monocytogenes. J. Cell Sci. 110:1893-1906[Abstract]. |
| 225. | González-Zorn, B., G. Domínguez-Bernal, M. Suárez, M.-T. Ripio, Y. Vega, S. Novella, A. Rodriguez, I. Chico, A. Tierrez, and J.-A. Vázquez-Boland. 2000. SmcL, a novel membrane-damaging virulence factor in Listeria. Int. J. Med. Microbiol. Infect. Dis. 290:369-374. |
| 226. | González-Zorn, B., G. Dominguez-Bernal, M. Suarez, M. T. Ripio, Y. Vega, S. Novella, and J.-A. Vázquez-Boland. 1999. The smcL gene of Listeria ivanovii encodes a sphingomyelinase C that mediates bacterial escape from the phagocytic vacuole. Mol. Microbiol. 33:510-523[CrossRef][Medline]. |
| 227. |
Goossens, P. L.,
G. Milon,
P. Cossart, and M. F. Saron.
1995.
Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus.
Int. Immunol.
7:797-805 |
| 228. | Gormley, E., J. Mengaud, and P. Cossart. 1989. Sequences homologous to the listeriolysin O gene region of Listeria monocytogenes are present in virulent and avirulent haemolytic species of the genus Listeria. Res. Microbiol. 140:631-643[Medline]. |
| 229. |
Gottesmann, S.,
S. Wickner, and M. R. Maurizi.
1997.
Protein quality control: triage by chaperones and proteases.
Genes Dev.
11:815-823 |
| 230. | Gouin, E., P. Dehoux, J. Mengaud, C. Kocks, and P. Cossart. 1995. iactA of Listeria ivanovii, although distantly related to Listeria monocytogenes actA, restores actin tail formation in an L. monocytogenes actA mutant. Infect. Immun. 63:2729-2737[Abstract]. |
| 231. | Gouin, E., H. Gantelet, C. Egile, I. Lasa, H. Ohayon, V. Villiers, P. Gounon, P. J. Sansonetti, and P. Cossart. 1999. A comparative study of the actin-based motilities of the pathogenic bacteria Listeria monocytogenes, Shigella flexneri and Rickettsia conorii. J. Cell Sci. 112:1697-1708[Abstract]. |
| 232. |
Gouin, E.,
J. Mengaud, and P. Cossart.
1994.
The virulence gene cluster of Listeria monocytogenes is also present in Listeria ivanoii, an animal pathogen, and Listeria seeligeri, a nonpathogenic species.
Infect. Immun.
62:3550-3553 |
| 233. | Goulet, V., A. Lepoutre, J. Rocourt, A.-L. Courtieu, P. Dehaumont, and P. Veit. 1993. Épidémie de listériose en France. Bilan final et résultats de l'enquète épidémiologique. Bull. Épidemiol. Hebdom. 4/1993:13-14. |
| 234. | Goulet, V., and S. Brohier. 1989. Listeriosis in France in 1986: survey of hospital laboratories. Pathol. Biol. 37:206-211[Medline]. |
| 235. | Goulet, V., F. Le Magny, I. Rebiere, and E. P. Espaze. 1989. La listériose en France en 1987. Etude rétrospective à partir d'un échantillon d'hôpitaux publics. Bull. Epidémiol. Hebdom. 12:45-46. |
| 236. | Graham, T., E. J. Goldsteyn-Thomas, V. P. J. Gannon, and J. E. Thomas. 1996. Genus-and species-specific detection of Listeria monocytogenes using polymerase chain reaction assays targeting the 16S/23S intergenic spacer region of the rRNA operon. Can. J. Microbiol. 42:1155-1162[Medline]. |
| 237. | Gravani, R. 1999. Incidence and control of Listeria in food-processing facilities, p. 657-709. In E. T. Ryser, and E. H. Marth (ed.), Listeria, listeriosis, and food safety, 2nd ed. Marcel Dekker Inc., New York, N.Y. |
| 238. | Gray, M. L., and A. M. Killinger. 1966. Listeria monocytogenes and listeric infections. Bacteriol. Rev. 30:304-328. |
| 239. | Gray, M. L., C. Singh, and F. Thorp, Jr. 1955. Abortion, stillbirth, early death of young rabbits by Listeria monocytogenes. II. Oral exposure. Proc. Soc. Exp. Biol. Med. 89:169-175. |
| 240. | Greenberg, J. W., W. Fischer, and K. A. Joiner. 1996. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect. Immun. 64:3318-3325[Abstract]. |
| 241. | Gregory, S. H., L. K. Barczynski, and E. J. Wing. 1992. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections. J. Leukocyte Biol. 51:421-424[Abstract]. |
| 241a. | Gregory, S. H., and C. C. Liu. 2000. CD8+ T-cell-mediated response to Listeria monocytogenes taken up in the liver and replicating within hepatocytes. Immunol. Rev. 174:112-122[CrossRef][Medline]. |
| 242. | Gregory, S. H., A. J. Sagnimeni, and E. J. Wing. 1996. Expression of the inlAB operon by Listeria monocytogenes is not required for entry into hepatic cell s in vivo. Infect. Immun. 64:3983-3986[Abstract]. |
| 243. |
Gregory, S. H., and E. J. Wing.
1990.
Accessory function of Kupffer cells in the antigen-specific blastogenic response of an L3T4+ T-lymphocyte clone to Listeria monocytogenes.
Infect. Immun.
58:2313-2319 |
| 244. |
Gregory, S. H., and E. J. Wing.
1993.
IFN- inhibits the replication of Listeria monocytogenes in hepatocytes.
J. Immunol.
151:1401-1409[Abstract].
|
| 245. |
Greiffenberg, L.,
W. Goebel,
K. S. Kim,
J. Daniels, and M. Kuhn.
2000.
Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: an electron microscopic study.
Infect. Immun.
68:3275-3279 |
| 246. | Greiffenberg, L., W. Goebel, K. S. Kim, I. Weiglein, A. Bubert, F. Engelbrecht, M. Stins, and M. Kuhn. 1998. Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth and spread from macrophages to endothelial cells. Infe |